<?xml version="1.0" encoding="utf-8"?><Regulation lims:pit-date="2024-11-29" hasPreviousVersion="true" lims:lastAmendedDate="2024-01-03" lims:current-date="2024-12-08" lims:inforce-start-date="2018-12-29" lims:fid="1021329" lims:id="1021329" regulation-type="SOR" xml:lang="en" xmlns:lims="http://justice.gc.ca/lims"><Identification lims:inforce-start-date="2018-12-29" lims:fid="1021330" lims:id="1021330"><InstrumentNumber>SOR/98-282</InstrumentNumber><RegistrationDate><Date><YYYY>1998</YYYY><MM>5</MM><DD>7</DD></Date></RegistrationDate><ConsolidationDate lims:inforce-start-date="2018-12-29"><Date><YYYY>2024</YYYY><MM>12</MM><DD>9</DD></Date></ConsolidationDate><EnablingAuthority lims:inforce-start-date="2018-12-29" lims:fid="1021332" lims:id="1021332"><XRefExternal reference-type="act" link="F-27">FOOD AND DRUGS ACT</XRefExternal></EnablingAuthority><LongTitle lims:inforce-start-date="2018-12-29" lims:fid="1021333" lims:id="1021333">Medical Devices Regulations</LongTitle><RegulationMakerOrder><RegulationMaker>P.C.</RegulationMaker><OrderNumber>1998-783</OrderNumber><Date><YYYY>1998</YYYY><MM>5</MM><DD>7</DD></Date></RegulationMakerOrder></Identification><Order lims:inforce-start-date="2018-12-29" lims:fid="1021334" lims:id="1021334"><Provision lims:inforce-start-date="2018-12-29" lims:fid="1021335" lims:id="1021335" format-ref="indent-0-0" language-align="yes" list-item="no"><Text>His Excellency the Governor General in Council, on the recommendation of the Minister of Health, pursuant to subsections 3(3), 30(1) and 37(1)<FootnoteRef idref="footnotea_e">a</FootnoteRef> of the <XRefExternal reference-type="act" link="F-27">Food and Drugs Act</XRefExternal>, hereby makes the annexed <XRefExternal reference-type="regulation" link="SOR-98-282">Medical Devices Regulations</XRefExternal>.</Text><Footnote id="footnotea_e" placement="page" status="official"><Label>a</Label><Text>S.C. 1993, c. 34, s. 73</Text></Footnote></Provision></Order><Body lims:inforce-start-date="2018-12-29" lims:fid="1021336" lims:id="1021336"><Heading lims:inforce-start-date="2018-12-29" lims:fid="1021337" lims:id="1021337" level="1"><TitleText>Interpretation</TitleText></Heading><Section lims:inforce-start-date="2016-07-17" lims:lastAmendedDate="2022-03-02" lims:fid="1021338" lims:id="1021338"><Label>1</Label><Text>The definitions in this section apply in these Regulations.</Text><Definition lims:inforce-start-date="2016-07-17" lims:fid="1021339" lims:id="1021339" generate-in-text="no"><Text><DefinedTermEn>Act</DefinedTermEn> means the <XRefExternal reference-type="act" link="F-27">Food and Drugs Act</XRefExternal>. (<DefinedTermFr>Loi</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2016-07-17" lims:fid="1021340" lims:id="1021340" generate-in-text="no"><Text><DefinedTermEn>active device</DefinedTermEn> means a medical device that depends for its operation on a source of energy other than energy generated by the human body or gravity. A medical device that transmits or withdraws energy or a substance to or from a patient without substantially altering the energy or the substance is not an active device. (<DefinedTermFr>instrument actif</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2016-07-17" lims:fid="1021341" lims:id="1021341" generate-in-text="no"><Text><DefinedTermEn>active diagnostic device</DefinedTermEn> means an active device that, whether used alone or in combination with another medical device, is intended to supply information for the purpose of detecting, monitoring or treating a physiological condition, state of health, illness or congenital deformity. (<DefinedTermFr>instrument diagnostique actif</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2016-07-17" lims:fid="1021342" lims:id="1021342" generate-in-text="no"><Text><DefinedTermEn>active therapeutic device</DefinedTermEn> means an active device that, whether used alone or in combination with another medical device, is intended to support, modify, replace or restore a biological function or structure for the purpose of treating or mitigating an illness or injury or a symptom of an illness or injury. (<DefinedTermFr>instrument thérapeutique actif</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2016-07-17" lims:fid="1021343" lims:id="1021343" generate-in-text="no"><Text><DefinedTermEn>applicable requirements of sections 10 to 20</DefinedTermEn> means</Text><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021344" lims:id="1021344"><Label>(a)</Label><Text>in respect of a decorative contact lens, the requirements set out in section 10, subsections 11(2) and 12(2) and sections 13 to 17; and</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021345" lims:id="1021345"><Label>(b)</Label><Text>in respect of any other medical device, the requirements set out in section 10, subsections 11(1) and 12(1) and sections 13 to 20. (<DefinedTermFr>exigences applicables prévues aux articles 10 à 20</DefinedTermFr>)</Text></Paragraph></Definition><Definition lims:inforce-start-date="2016-07-17" lims:fid="1021346" lims:id="1021346" generate-in-text="no"><Text><DefinedTermEn>bar code</DefinedTermEn> means a unique bar code in the symbology of the Universal Product Code (UPC), the Health Industry Business Communications Council (HIBCC) or the European Article Number (EAN), assigned to a medical device by the manufacturer. (<DefinedTermFr>code à barres</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2016-07-17" lims:fid="1021347" lims:id="1021347" generate-in-text="no"><Text><DefinedTermEn>body orifice</DefinedTermEn> means a natural opening or a permanent artificial opening in the body, such as a stoma. (<DefinedTermFr>orifice du corps</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339842" lims:id="1339842"><Text><DefinedTermEn>business day</DefinedTermEn> means a day other than</Text><Paragraph lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339843" lims:id="1339843"><Label>(a)</Label><Text>a Saturday; or</Text></Paragraph><Paragraph lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339844" lims:id="1339844"><Label>(b)</Label><Text>a Sunday or other holiday. (<DefinedTermFr>jour ouvrable</DefinedTermFr>)</Text></Paragraph></Definition><Definition lims:inforce-start-date="2016-07-17" lims:fid="1021348" lims:id="1021348" generate-in-text="no"><Text><DefinedTermEn>central cardiovascular system</DefinedTermEn> means the heart, pericardium, pulmonary veins, pulmonary arteries, cardiac veins, coronary arteries, common carotid arteries, cerebral arteries, brachiocephalic artery, aorta, inferior and superior vena cava, renal arteries, iliac arteries and femoral arteries. (<DefinedTermFr>système cardiovasculaire central</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2016-07-17" lims:fid="1021349" lims:id="1021349" generate-in-text="no"><Text><DefinedTermEn>central nervous system</DefinedTermEn> means the brain, meninges, spinal cord and cerebrospinal fluid. (<DefinedTermFr>système nerveux central</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2016-07-17" lims:fid="1021350" lims:id="1021350" generate-in-text="no"><Text><DefinedTermEn>closed-loop system</DefinedTermEn>, in respect of a medical device, means a system that enables the device to sense, interpret and treat a medical condition without human intervention. (<DefinedTermFr>système à boucle fermée</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2016-07-17" lims:fid="1021351" lims:id="1021351" generate-in-text="no"><Text><DefinedTermEn>Commissioner of Patents</DefinedTermEn> means the Commissioner of Patents appointed under subsection 4(1) of the Patent Act. (<DefinedTermFr>commissaire aux brevets</DefinedTermFr>) </Text></Definition><Definition lims:inforce-start-date="2016-07-17" lims:fid="1021352" lims:id="1021352" generate-in-text="no"><Text><DefinedTermEn>control number</DefinedTermEn> means a unique series of letters, numbers or symbols, or any combination of these, that is assigned to a medical device by the manufacturer and from which a history of the manufacture, packaging, labelling and distribution of a unit, lot or batch of the device can be determined. (<DefinedTermFr>numéro de contrôle</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2016-07-17" lims:fid="1021353" lims:id="1021353" generate-in-text="no"><Text><DefinedTermEn>custom-made device</DefinedTermEn> means a medical device, other than a mass-produced medical device, that</Text><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021354" lims:id="1021354"><Label>(a)</Label><Text>is manufactured in accordance with a health care professional’s written direction giving its design characteristics;</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021355" lims:id="1021355"><Label>(b)</Label><Text>differs from medical devices generally available for sale or from a dispenser; and</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021356" lims:id="1021356"><Label>(c)</Label><Text>is</Text><Subparagraph lims:inforce-start-date="2016-07-17" lims:fid="1021357" lims:id="1021357"><Label>(i)</Label><Text>for the sole use of a particular patient of that professional, or</Text></Subparagraph><Subparagraph lims:inforce-start-date="2016-07-17" lims:fid="1021358" lims:id="1021358"><Label>(ii)</Label><Text>for use by that professional to meet special needs arising in the course of his or her practice. (<DefinedTermFr>instrument fait sur mesure</DefinedTermFr>)</Text></Subparagraph></Paragraph></Definition><Definition lims:inforce-start-date="2016-07-17" lims:fid="1021359" lims:id="1021359" generate-in-text="no"><Text><DefinedTermEn>decorative contact lens</DefinedTermEn> means a device referred to in section 2.1 of the Act. (<DefinedTermFr>lentilles cornéennes à but esthétique</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2016-07-17" lims:fid="1021360" lims:id="1021360" generate-in-text="no"><Text><DefinedTermEn>dental material</DefinedTermEn><Repealed>[Repealed, SOR/2002-190, s. 1]</Repealed></Text></Definition><Definition lims:inforce-start-date="2016-07-17" lims:fid="1021361" lims:id="1021361" generate-in-text="no"><Text><DefinedTermEn>directions for use</DefinedTermEn>, in respect of a medical device, means full information as to the procedures recommended for achieving the optimum performance of the device, and includes cautions, warnings, contra-indications and possible adverse effects. (<DefinedTermFr>mode d’emploi</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2016-07-17" lims:fid="1021362" lims:id="1021362" generate-in-text="no"><Text><DefinedTermEn>dispenser</DefinedTermEn> means a person who is a member of a professional governing body and who is entitled, by virtue of their membership in that body, to manufacture or adapt a medical device in accordance with a health care professional’s written directions in order to meet the specific requirements of a patient. (<DefinedTermFr>préparateur</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2016-07-17" lims:fid="1021363" lims:id="1021363" generate-in-text="no"><Text><DefinedTermEn>General Council Decision</DefinedTermEn> has the meaning assigned by subsection 30(6) of the Act. (<DefinedTermFr>décision du Conseil général</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2016-07-17" lims:fid="1021364" lims:id="1021364" generate-in-text="no"><Text><DefinedTermEn>genetic testing</DefinedTermEn> means the analysis of DNA, RNA or chromosomes for purposes such as the prediction of disease or vertical transmission risks, or monitoring, diagnosis or prognosis. (<DefinedTermFr>test génétique</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2016-07-17" lims:fid="1021365" lims:id="1021365" generate-in-text="no"><Text><DefinedTermEn>health care facility</DefinedTermEn> means a facility that provides diagnostic or therapeutic services to patients. It includes a group of such facilities that report to one common management that has responsibility for the activities carried out in those facilities. (<DefinedTermFr>établissement de santé</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2016-07-17" lims:fid="1021366" lims:id="1021366" generate-in-text="no"><Text><DefinedTermEn>health care professional</DefinedTermEn> means a person who is entitled under the laws of a province to provide health services in the province. (<DefinedTermFr>professionnel de la santé</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2016-07-17" lims:fid="1021367" lims:id="1021367" generate-in-text="no"><Text><DefinedTermEn>identifier</DefinedTermEn> means a unique series of letters or numbers or any combination of these or a bar code that is assigned to a medical device by the manufacturer and that identifies it and distinguishes it from similar devices. (<DefinedTermFr>identificateur</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2016-07-17" lims:fid="1021368" lims:id="1021368" generate-in-text="no"><Text><DefinedTermEn>implant</DefinedTermEn> means a medical device that is listed in Schedule 2. (<DefinedTermFr>implant</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2016-07-17" lims:fid="1021369" lims:id="1021369" generate-in-text="no"><Text><DefinedTermEn>invasive device</DefinedTermEn> means a medical device that is intended to come into contact with the surface of the eye or penetrate the body, either through a body orifice or through the body surface. (<DefinedTermFr>instrument effractif</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2016-07-17" lims:fid="1021370" lims:id="1021370" generate-in-text="no"><Text><DefinedTermEn><Language xml:lang="la">in vitro</Language> diagnostic device</DefinedTermEn> or <DefinedTermEn>IVDD</DefinedTermEn> means a medical device that is intended to be used <Language xml:lang="la">in vitro</Language> for the examination of specimens taken from the body. (<DefinedTermFr>instrument diagnostique <Language xml:lang="la">in vitro</Language></DefinedTermFr> ou <DefinedTermFr>IDIV</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2019-06-17" lims:enacted-date="2014-06-19" lims:fid="1021371" lims:id="1146040" generate-in-text="no"><Text><DefinedTermEn>manufacturer</DefinedTermEn> means a person who sells a medical device under their own name, or under a trademark, design, trade name or other name or mark owned or controlled by the person, and who is responsible for designing, manufacturing, assembling, processing, labelling, packaging, refurbishing or modifying the device, or for assigning to it a purpose, whether those tasks are performed by that person or on their behalf. (<DefinedTermFr>fabricant</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2016-07-17" lims:fid="1021372" lims:id="1021372" generate-in-text="no"><Text><DefinedTermEn>medical device</DefinedTermEn> means a device within the meaning of the Act, but does not include any device that is intended for use in relation to animals. (<DefinedTermFr>instrument médical</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2016-07-17" lims:fid="1021373" lims:id="1021373" generate-in-text="no"><Text><DefinedTermEn>medical device family</DefinedTermEn> means a group of medical devices that are made by the same manufacturer, that differ only in shape, colour, flavour or size, that have the same design and manufacturing process and that have the same intended use. (<DefinedTermFr>famille d’instruments</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2016-07-17" lims:fid="1021374" lims:id="1021374" generate-in-text="no"><Text><DefinedTermEn>medical device group</DefinedTermEn> means a medical device comprising a collection of medical devices, such as a procedure pack or tray, that is sold under a single name. (<DefinedTermFr>ensemble d’instruments</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2016-07-17" lims:fid="1021375" lims:id="1021375" generate-in-text="no"><Text><DefinedTermEn>medical device group family</DefinedTermEn> means a collection of medical device groups that are made by the same manufacturer, that have the same generic name specifying their intended use, and that differ only in the number and combination of products that comprise each group. (<DefinedTermFr>famille d’ensembles d’instruments</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2016-07-17" lims:fid="1021376" lims:id="1021376" generate-in-text="no"><Text><DefinedTermEn>name of the device</DefinedTermEn>, in respect of a medical device, includes any information necessary for the user to identify the device and to distinguish it from similar devices. (<DefinedTermFr>nom de l’instrument</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2016-07-17" lims:fid="1021377" lims:id="1021377" generate-in-text="no"><Text><DefinedTermEn>near patient <Language xml:lang="la">in vitro</Language> diagnostic device</DefinedTermEn> or <DefinedTermEn>near patient IVDD</DefinedTermEn> means an <Language xml:lang="la">in vitro</Language> diagnostic device that is intended for use outside a laboratory, for testing at home or at the point of care, such as a pharmacy, a health care professional’s office or the bedside. (<DefinedTermFr>instrument diagnostique clinique <Language xml:lang="la">in vitro</Language></DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2016-07-17" lims:fid="1021378" lims:id="1021378" generate-in-text="no"><Text><DefinedTermEn>objective evidence</DefinedTermEn> means information that can be proved true, based on facts obtained through observation, measurement, testing or other means, as set out in the definition <DefinedTermEn>objective evidence</DefinedTermEn> in section 2.19 of International Organization for Standardization standard ISO 8402:1994, <XRefExternal reference-type="standard">Quality management and quality assurance - Vocabulary</XRefExternal>, as amended from time to time. (<DefinedTermFr>preuve tangible</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2016-07-17" lims:fid="1021379" lims:id="1021379" generate-in-text="no"><Text><DefinedTermEn>person</DefinedTermEn> includes a partnership and an association. (<DefinedTermFr>personne</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2016-07-17" lims:fid="1021380" lims:id="1021380" generate-in-text="no"><Text><DefinedTermEn>qualified investigator</DefinedTermEn> means a person who is a member in good standing of a professional association of persons entitled under the laws of a province to provide health care in the province and who is designated, by the ethics committee of the health care facility at which investigational testing is to be conducted, as the person to conduct the testing. (<DefinedTermFr>chercheur compétent</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2016-07-17" lims:fid="1021381" lims:id="1021381" generate-in-text="no"><Text><DefinedTermEn>quality management system certificate</DefinedTermEn> means a valid quality management system certificate described in paragraph 32(2)(f), 3(j) or (4)(p), as applicable, that is issued by a registrar recognized by the Minister under section 32.1. (<DefinedTermFr>certificat de système de gestion de la qualité</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2016-07-17" lims:fid="1021382" lims:id="1021382" generate-in-text="no"><Text><DefinedTermEn>quality system certificate</DefinedTermEn><Repealed>[Repealed, SOR/2006-197, s. 1]</Repealed></Text></Definition><Definition lims:inforce-start-date="2016-07-17" lims:fid="1021383" lims:id="1021383" generate-in-text="no"><Text><DefinedTermEn>recall</DefinedTermEn>, in respect of a medical device that has been sold, means any action taken by the manufacturer, importer or distributor of the device to recall or correct the device, or to notify its owners and users of its defectiveness or potential defectiveness, after becoming aware that the device</Text><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021384" lims:id="1021384"><Label>(a)</Label><Text>may be hazardous to health;</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021385" lims:id="1021385"><Label>(b)</Label><Text>may fail to conform to any claim made by the manufacturer or importer relating to its effectiveness, benefits, performance characteristics or safety; or</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021386" lims:id="1021386"><Label>(c)</Label><Text>may not meet the requirements of the Act or these Regulations. (<DefinedTermFr>rappel</DefinedTermFr>)</Text></Paragraph></Definition><Definition lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1300764" lims:id="1300764"><Text><DefinedTermEn>regulatory agency</DefinedTermEn> means a government agency or other entity outside Canada that has a legal right to control the manufacturing, use or sale of medical devices within its jurisdiction and that may take enforcement action to ensure that medical devices marketed within its jurisdiction comply with the applicable legal requirements. (<DefinedTermFr>organisme de réglementation</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2016-07-17" lims:fid="1021387" lims:id="1021387" generate-in-text="no"><Text><DefinedTermEn>safety and effectiveness requirements</DefinedTermEn><Repealed>[Repealed, SOR/2015-193, s. 1]</Repealed></Text></Definition><Definition lims:inforce-start-date="2016-07-17" lims:fid="1021388" lims:id="1021388" generate-in-text="no"><Text><DefinedTermEn>serious deterioration in the state of health</DefinedTermEn> means a life-threatening disease, disorder or abnormal physical state, the permanent impairment of a body function or permanent damage to a body structure, or a condition that necessitates an unexpected medical or surgical intervention to prevent such a disease, disorder or abnormal physical state or permanent impairment or damage. (<DefinedTermFr>détérioration grave de l’état de santé</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339845" lims:id="1339845"><Text><DefinedTermEn>shortage</DefinedTermEn>, in respect of a medical device, means a situation in which the manufacturer of the device is unable to meet the demand for the device in Canada. (<DefinedTermFr>pénurie</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2016-07-17" lims:fid="1021389" lims:id="1021389" generate-in-text="no"><Text><DefinedTermEn>significant change</DefinedTermEn> means a change that could reasonably be expected to affect the safety or effectiveness of a medical device. It includes a change to any of the following:</Text><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021390" lims:id="1021390"><Label>(a)</Label><Text>the manufacturing process, facility or equipment;</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021391" lims:id="1021391"><Label>(b)</Label><Text>the manufacturing quality control procedures, including the methods, tests or procedures used to control the quality, purity and sterility of the device or of the materials used in its manufacture;</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021392" lims:id="1021392"><Label>(c)</Label><Text>the design of the device, including its performance characteristics, principles of operation and specifications of materials, energy source, software or accessories; and</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021393" lims:id="1021393"><Label>(d)</Label><Text>the intended use of the device, including any new or extended use, any addition or deletion of a contra-indication for the device and any change to the period used to establish its expiry date. (<DefinedTermFr>modification importante</DefinedTermFr>)</Text></Paragraph></Definition><Definition lims:inforce-start-date="2016-07-17" lims:fid="1021394" lims:id="1021394" generate-in-text="no"><Text><DefinedTermEn>surgical or dental instrument</DefinedTermEn> means a reusable medical device that is intended for surgical or dental use, including cutting, drilling, sawing, scraping, clamping, hammering, puncturing, dilating, retracting or clipping, without connection to an active device. (<DefinedTermFr>instrument chirurgical ou dentaire</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2016-07-17" lims:fid="1021395" lims:id="1021395" generate-in-text="no"><Text><DefinedTermEn>surgically invasive device</DefinedTermEn> means an invasive device that is intended to enter the body through an artificially created opening that provides access to body structures and fluids. (<DefinedTermFr>instrument effractif chirurgical</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2016-07-17" lims:fid="1021396" lims:id="1021396" generate-in-text="no"><Text><DefinedTermEn>system</DefinedTermEn> means a medical device comprising a number of components or parts intended to be used together to fulfil some or all of the device’s intended functions, and that is sold under a single name. (<DefinedTermFr>système</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2016-07-17" lims:fid="1021397" lims:id="1021397" generate-in-text="no"><Text><DefinedTermEn>test kit</DefinedTermEn> means an <Language xml:lang="la">in vitro</Language> diagnostic device that consists of reagents or articles, or any combination of these, and that is intended to be used to conduct a specific test. (<DefinedTermFr>trousse d’essai</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2016-07-17" lims:fid="1021398" lims:id="1021398" generate-in-text="no"><Text><DefinedTermEn>validation</DefinedTermEn> means confirmation by examination and the provision of objective evidence that the requirements for a specific intended use have been fulfilled, as set out in the definition <DefinedTermEn>validation</DefinedTermEn> in section 2.18 of International Organization for Standardization standard ISO 8402:1994, <XRefExternal reference-type="standard">Quality management and quality assurance - Vocabulary</XRefExternal>, as amended from time to time. (<DefinedTermFr>validation</DefinedTermFr>)</Text></Definition><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2019-06-17" lims:enacted-date="2014-06-19" lims:fid="1021400" lims:id="1146041" lims:enactId="1044114">SOR/2002-190, s. 1; SOR/2003-173, s. 1; SOR/2005-142, s. 1; SOR/2006-197, s. 1; 2014, c. 20, s. 366(E); SOR/2015-193, s. 1</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2019-03-01" lims:enacted-date="2019-02-11" lims:fid="1116574" lims:id="1116574" lims:enactId="1112370">SOR/2019-44, s. 1(F)</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1300765" lims:id="1300765" lims:enactId="1278653">SOR/2020-262, s. 6</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339846" lims:id="1339846" lims:enactId="1314955">SOR/2021-199, s. 6</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-12-29" lims:fid="1021401" lims:id="1021401" level="1"><TitleText>Application</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1021402" lims:id="1021402"><Label>2</Label><Text>These Regulations apply to</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021403" lims:id="1021403"><Label>(a)</Label><Text>the sale and advertising for sale of a medical device; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021404" lims:id="1021404"><Label>(b)</Label><Text>the importation of a medical device for sale or for use on individuals, other than importation for personal use.</Text></Paragraph></Section><Section lims:inforce-start-date="2018-10-17" lims:lastAmendedDate="2018-10-17" lims:fid="1021405" lims:id="1021405"><Label>3</Label><Subsection lims:inforce-start-date="2018-10-17" lims:fid="1021406" lims:id="1021406"><Label>(1)</Label><Text>These Regulations also apply to an <Language xml:lang="la">in vitro</Language> diagnostic product that is a drug or that contains a drug, as if the product were an <Language xml:lang="la">in vitro</Language> diagnostic device.</Text></Subsection><Subsection lims:inforce-start-date="2018-10-17" lims:fid="1021407" lims:id="1021407"><Label>(2)</Label><Text>Subsection (1) does not apply to a <DefinitionRef>drug</DefinitionRef>, as defined in subsection <XRefInternal>1</XRefInternal>(2) of the <XRefExternal reference-type="regulation" link="SOR-2018-144">Cannabis Regulations</XRefExternal>, containing <DefinitionRef>cannabis</DefinitionRef>, as defined in subsection 2(1) of the <XRefExternal reference-type="act" link="C-24.5">Cannabis Act</XRefExternal>, or a drug listed in Schedule E or F to the Act, in the schedule to Part G or J of the <XRefExternal reference-type="regulation" link="C.R.C.,_c._870">Food and Drug Regulations</XRefExternal>, in the schedules to the <XRefExternal reference-type="act" link="C-38.8">Controlled Drugs and Substances Act</XRefExternal> or in the schedule to the <XRefExternal reference-type="regulation" link="C.R.C.,_c._1041">Narcotic Control Regulations</XRefExternal>.</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2018-10-17" lims:fid="1021409" lims:id="1021409">SOR/2018-144, s. 371</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1021410" lims:id="1021410"><Label>4</Label><Text>Only sections 26 to 31, 37, 70, 75, 80, 86 and 87 apply to a dispenser.</Text></Section><Section lims:inforce-start-date="2017-02-13" lims:lastAmendedDate="2017-02-13" lims:fid="1021411" lims:id="1021411"><Label>5</Label><Text>These Regulations do not apply to a medical gas piping system that is assembled on site at a health care facility and permanently built into the structure of the facility.</Text><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2017-02-13" lims:fid="1021413" lims:id="1021413">SOR/2017-18, s. 22</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-12-29" lims:fid="1021414" lims:id="1021414" level="1"><TitleText>Classification of Medical Devices</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1021415" lims:id="1021415"><Label>6</Label><Text>Medical devices are classified into one of Classes I to IV by means of the classification rules set out in Schedule 1, where Class I represents the lowest risk and Class IV represents the highest risk.</Text></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1021416" lims:id="1021416"><Label>7</Label><Text>If a medical device can be classified into more than one class, the class representing the higher risk applies.</Text></Section><Heading lims:inforce-start-date="2018-12-29" lims:fid="1021417" lims:id="1021417" level="1"><Label>PART 1</Label><TitleText>General</TitleText></Heading><Heading lims:inforce-start-date="2018-12-29" lims:fid="1021418" lims:id="1021418" level="2"><TitleText>Application</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1021419" lims:id="1021419"><Label>8</Label><Text>This Part applies to medical devices that are not subject to Part 2 or 3.</Text></Section><Heading lims:inforce-start-date="2018-12-29" lims:fid="1021420" lims:id="1021420" level="2"><TitleText>Manufacturer’s Obligations</TitleText></Heading><Section lims:inforce-start-date="2016-07-17" lims:lastAmendedDate="2016-07-17" lims:fid="1021421" lims:id="1021421"><Label>9</Label><Subsection lims:inforce-start-date="2016-07-17" lims:fid="1021422" lims:id="1021422"><Label>(1)</Label><Text>A manufacturer shall ensure that the medical device meets the applicable requirements of sections 10 to 20.</Text></Subsection><Subsection lims:inforce-start-date="2016-07-17" lims:fid="1021423" lims:id="1021423"><Label>(2)</Label><Text>A manufacturer shall keep objective evidence to establish that the medical device meets those requirements.</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2016-07-17" lims:fid="1021425" lims:id="1021425">SOR/2015-193, s. 7</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-12-29" lims:fid="1021426" lims:id="1021426" level="2"><TitleText>Safety and Effectiveness Requirements</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2022-09-27" lims:fid="1021427" lims:id="1021427"><Label>10</Label><Text>A medical device shall be designed and manufactured to be safe, and to this end the manufacturer shall, in particular, take reasonable measures to</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021428" lims:id="1021428"><Label>(a)</Label><Text>identify the risks inherent in the device;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021429" lims:id="1021429"><Label>(b)</Label><Text>if the risks can be eliminated, eliminate them;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021430" lims:id="1021430"><Label>(c)</Label><Text>if the risks cannot be eliminated,</Text><Subparagraph lims:inforce-start-date="2006-03-22" lims:fid="1021431" lims:id="1021431"><Label>(i)</Label><Text>reduce the risks to the extent possible,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2006-03-22" lims:fid="1021432" lims:id="1021432"><Label>(ii)</Label><Text>provide for protection appropriate to those risks, including the provision of alarms, and</Text></Subparagraph><Subparagraph lims:inforce-start-date="2006-03-22" lims:fid="1021433" lims:id="1021433"><Label>(iii)</Label><Text>provide, with the device, information relative to the risks that remain; and</Text></Subparagraph></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021434" lims:id="1021434"><Label>(d)</Label><Text>minimize the hazard from potential failures during the projected useful life of the device.</Text></Paragraph><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2022-09-27" lims:enacted-date="2022-09-27" lims:fid="1376720" lims:id="1376720" lims:enactId="1375648">SOR/2022-197, s. 12(F)</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2016-07-17" lims:lastAmendedDate="2016-07-17" lims:fid="1021435" lims:id="1021435"><Label>11</Label><Subsection lims:inforce-start-date="2016-07-17" lims:fid="1021436" lims:id="1021436"><Label>(1)</Label><Text>A medical device other than a decorative contact lens shall not, when used for the medical conditions, purposes or uses for which it is manufactured, sold or represented, adversely affect the health or safety of a patient, user or other person, except to the extent that a possible adverse effect of the device constitutes an acceptable risk when weighed against the benefits to the patient and the risk is compatible with a high level of protection of health and safety.</Text></Subsection><Subsection lims:inforce-start-date="2016-07-17" lims:fid="1021437" lims:id="1021437"><Label>(2)</Label><Text>A decorative contact lens shall not adversely affect the health or safety of a user, except to the extent that a possible adverse effect of the device constitutes a risk that is compatible with a high level of protection of health and safety.</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2016-07-17" lims:fid="1021439" lims:id="1021439">SOR/2015-193, s. 2</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2016-07-17" lims:lastAmendedDate="2016-07-17" lims:fid="1021440" lims:id="1021440"><Label>12</Label><Subsection lims:inforce-start-date="2016-07-17" lims:fid="1021441" lims:id="1021441"><Label>(1)</Label><Text>A medical device other than a decorative contact lens shall perform as intended by the manufacturer and shall be effective for the medical conditions, purposes and uses for which it is manufactured, sold or represented.</Text></Subsection><Subsection lims:inforce-start-date="2016-07-17" lims:fid="1021442" lims:id="1021442"><Label>(2)</Label><Text>A decorative contact lens shall perform as intended by the manufacturer.</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2016-07-17" lims:fid="1021444" lims:id="1021444">SOR/2015-193, s. 2</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1021445" lims:id="1021445"><Label>13</Label><Text>During the projected useful life of a medical device, its characteristics and performance shall not deteriorate under normal use to such a degree that the health or safety of a patient, user or other person is adversely affected.</Text></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1021446" lims:id="1021446"><Label>14</Label><Text>The characteristics and performance of a medical device shall not be adversely affected by transport or conditions of storage, taking into account the manufacturer’s instructions and information for transport and storage.</Text></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1021447" lims:id="1021447"><Label>15</Label><Text>Reasonable measures shall be taken to ensure that every material used in the manufacture of a medical device shall be compatible with every other material with which it interacts and with material that may come into contact with it in normal use, and shall not pose any undue risk to a patient, user or other person.</Text></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1021448" lims:id="1021448"><Label>16</Label><Text>The design, manufacture and packaging of a medical device shall minimize any risk to a patient, user or other person from reasonably foreseeable hazards, including</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021449" lims:id="1021449"><Label>(a)</Label><Text>flammability or explosion;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021450" lims:id="1021450"><Label>(b)</Label><Text>presence of a contaminant or chemical or microbial residue;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021451" lims:id="1021451"><Label>(c)</Label><Text>radiation;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021452" lims:id="1021452"><Label>(d)</Label><Text>electrical, mechanical or thermal hazards; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021453" lims:id="1021453"><Label>(e)</Label><Text>fluid leaking from or entering into the device.</Text></Paragraph></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1021454" lims:id="1021454"><Label>17</Label><Text>A medical device that is to be sold in a sterile condition shall be manufactured and sterilized under appropriately controlled conditions, and the sterilization method used shall be validated.</Text></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2023-11-24" lims:fid="1021455" lims:id="1021455"><Label>18</Label><Text>A medical device that is part of a system shall be compatible with every other component or part of the system with which it interacts and shall not adversely affect the performance of that system.</Text><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2023-11-24" lims:enacted-date="2023-11-24" lims:fid="1429454" lims:id="1429454" lims:enactId="1428998">SOR/2023-247, s. 8(F)</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1021456" lims:id="1021456"><Label>19</Label><Text>A medical device that performs a measuring function shall be designed to perform that function within tolerance limits that are appropriate for the medical conditions, purposes and uses for which the device is manufactured, sold or represented.</Text></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1021457" lims:id="1021457"><Label>20</Label><Text>If a medical device consists of or contains software, the software shall be designed to perform as intended by the manufacturer, and the performance of the software shall be validated.</Text></Section><Heading lims:inforce-start-date="2018-12-29" lims:fid="1021458" lims:id="1021458" level="2"><TitleText>Labelling Requirements</TitleText></Heading><Section lims:inforce-start-date="2016-07-17" lims:lastAmendedDate="2016-07-17" lims:fid="1021459" lims:id="1021459"><Label>21</Label><Subsection lims:inforce-start-date="2016-07-17" lims:fid="1021460" lims:id="1021460"><Label>(1)</Label><Text>No person shall import or sell a medical device unless the device has a label that sets out the following information:</Text><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021461" lims:id="1021461"><Label>(a)</Label><Text>the name of the device;</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021462" lims:id="1021462"><Label>(b)</Label><Text>the name and address of the manufacturer;</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021463" lims:id="1021463"><Label>(c)</Label><Text>the identifier of the device, including the identifier of any medical device that is part of a system, test kit, medical device group, medical device family or medical device group family;</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021464" lims:id="1021464"><Label>(d)</Label><Text>in the case of a Class III or IV device, the control number;</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021465" lims:id="1021465"><Label>(e)</Label><Text>if the contents are not readily apparent, an indication of what the package contains, expressed in terms appropriate to the device, such as the size, net weight, length, volume or number of units;</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021466" lims:id="1021466"><Label>(f)</Label><Text>the word “Sterile”, if the manufacturer intends the device to be sold in a sterile condition;</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021467" lims:id="1021467"><Label>(g)</Label><Text>the expiry date of the device, if the device has one, to be determined by the manufacturer on the basis of the component that has the shortest projected useful life;</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021468" lims:id="1021468"><Label>(h)</Label><Text>unless self-evident to the intended user, the medical conditions, purposes and uses for which the device is manufactured, sold or represented, as well as the performance specifications of the device if those specifications are necessary for proper use;</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021469" lims:id="1021469"><Label>(i)</Label><Text>the directions for use, unless directions are not required</Text><Subparagraph lims:inforce-start-date="2016-07-17" lims:fid="1021470" lims:id="1021470"><Label>(i)</Label><Text>in the case of a decorative contact lens, for the device to be used safely, and</Text></Subparagraph><Subparagraph lims:inforce-start-date="2016-07-17" lims:fid="1021471" lims:id="1021471"><Label>(ii)</Label><Text>in the case of any other medical device, for the device to be used safely and effectively; and</Text></Subparagraph></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021472" lims:id="1021472"><Label>(j)</Label><Text>any special storage conditions applicable to the device.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2016-07-17" lims:fid="1021473" lims:id="1021473"><Label>(2)</Label><Text>The information required pursuant to subsection (1) shall be expressed in a legible, permanent and prominent manner, in terms that are easily understood by the intended user.</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2016-07-17" lims:fid="1021475" lims:id="1021475">SOR/2002-190, s. 2; SOR/2015-193, s. 3</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2018-12-29" lims:lastAmendedDate="2018-12-29" lims:fid="1021476" lims:id="1021476"><Label>21.1</Label><Text>Despite section 21, any person who imports for sale a medical device that is not labelled in accordance with these Regulations shall ensure</Text><Paragraph lims:inforce-start-date="2018-12-29" lims:fid="1021477" lims:id="1021477"><Label>(a)</Label><Text>if that person holds an establishment licence to import the medical device, that they send prior notice of the proposed importation to the Minister or, if they do not hold such a licence, that the manufacturer of the medical device sends the prior notice; and</Text></Paragraph><Paragraph lims:inforce-start-date="2018-12-29" lims:fid="1021478" lims:id="1021478"><Label>(b)</Label><Text>before selling the medical device, that the manufacturer of the medical device has relabelled it in accordance with these Regulations within three months after the date of its importation.</Text></Paragraph><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2018-12-29" lims:fid="1021480" lims:id="1021480">SOR/2018-225, s. 1</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2018-12-29" lims:lastAmendedDate="2018-12-29" lims:fid="1021481" lims:id="1021481"><Label>21.2</Label><Text>Any person who imports for sale a medical device that is not labelled in accordance with these Regulations shall ensure that the manufacturer of the medical device notifies the Minister in writing of the name of the person who will relabel it in Canada if it is to be relabelled on the manufacturer’s behalf.</Text><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2018-12-29" lims:fid="1021483" lims:id="1021483">SOR/2018-225, s. 1</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1021484" lims:id="1021484"><Label>22</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1021485" lims:id="1021485"><Label>(1)</Label><Text>Subject to subsection (2), if a medical device is intended to be sold to the general public, the information required by subsection 21(1) shall</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021486" lims:id="1021486"><Label>(a)</Label><Text>be set out on the outside of the package that contains the device; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021487" lims:id="1021487"><Label>(b)</Label><Text>be visible under normal conditions of sale.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1021488" lims:id="1021488"><Label>(2)</Label><Text>Where a package that contains a medical device is too small to display all the information in accordance with section 21, the directions for use shall accompany the device but need not be set out on the outside of the package or be visible under normal conditions of sale.</Text></Subsection></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1021489" lims:id="1021489"><Label>23</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1021490" lims:id="1021490"><Label>(1)</Label><Text>Subject to subsection (3), the information required by subsection 21(1) shall, as a minimum, be in either English or French.</Text></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1021491" lims:id="1021491"><Label>(2)</Label><Text>Subject to subsection (3), where the directions for use are supplied in only one official language at the time of sale, directions for use in the other official language shall be made available by the manufacturer as soon as possible at the request of the purchaser.</Text></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1021492" lims:id="1021492"><Label>(3)</Label><Text>In respect of a medical device to be sold to the general public, the information required by paragraphs 21(1)(a) and (e) to (j) shall, as a minimum, be in both English and French.</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2006-03-22" lims:fid="1021494" lims:id="1021494">SOR/2002-190, s. 3</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-12-29" lims:fid="1021495" lims:id="1021495" level="2"><TitleText>Contraceptive Devices — Advertising</TitleText></Heading><Section lims:inforce-start-date="2008-06-01" lims:lastAmendedDate="2008-06-01" lims:fid="1021496" lims:id="1021496"><Label>24</Label><Subsection lims:inforce-start-date="2008-06-01" lims:fid="1021497" lims:id="1021497"><Label>(1)</Label><Text>For the purposes of subsections 3(1) and (2) of the Act and subject to section 27, a condom may be advertised and sold to the general public for the purpose of preventing the transmission of sexually transmitted diseases if the advertisement and the label of the condom claim only that the condom reduces the risk of transmitting sexually transmitted diseases.</Text></Subsection><Subsection lims:inforce-start-date="2008-06-01" lims:fid="1021498" lims:id="1021498"><Label>(2)</Label><Text>For the purpose of subsection 3(3) of the Act and subject to section 27, contraceptive devices, other than intrauterine devices, may be advertised to the general public by any means other than by the distribution of samples of the devices door-to-door or through the mail.</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2008-06-01" lims:fid="1021500" lims:id="1021500">SOR/2002-190, s. 4; SOR/2007-289, s. 3</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-12-29" lims:fid="1021501" lims:id="1021501" level="2"><TitleText>Class I Medical Devices</TitleText></Heading><Section lims:inforce-start-date="2016-07-17" lims:lastAmendedDate="2021-06-23" lims:fid="1021502" lims:id="1021502"><Label>25</Label><Subsection lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1021503" lims:id="1300766"><Label>(1)</Label><Text>If the Minister believes on reasonable grounds, after reviewing a report or information brought to his or her attention, that a Class I medical device may not meet the applicable requirements of sections 10 to 20, the Minister may request the manufacturer to submit, on or before the day specified in the request, an analysis or other information to enable him or her to determine whether the device meets those requirements.</Text></Subsection><Subsection lims:inforce-start-date="2016-07-17" lims:fid="1021504" lims:id="1021504"><Label>(2)</Label><Text lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1278782" lims:id="1300767">The Minister may direct the manufacturer to stop the sale of the medical device if</Text><Paragraph lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1021505" lims:id="1300768"><Label>(a)</Label><Text>the manufacturer has not complied with the request on or before the day specified in the request; or</Text></Paragraph><Paragraph lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1021506" lims:id="1300769"><Label>(b)</Label><Text>the Minister determines, on the basis of the information submitted, that the device does not meet the applicable requirements of sections 10 to 20.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2016-07-17" lims:fid="1021507" lims:id="1021507"><Label>(3)</Label><Text lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1278783" lims:id="1300770">The Minister shall lift the direction to stop the sale if</Text><Paragraph lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1021508" lims:id="1300771"><Label>(a)</Label><Text>the Minister determines, on the basis of the information submitted, that the medical device meets the applicable requirements of sections 10 to 20;</Text></Paragraph><Paragraph lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1021509" lims:id="1300772"><Label>(b)</Label><Text>corrective action has been taken to ensure that the medical device meets the applicable requirements of sections 10 to 20; or</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021510" lims:id="1021510"><Label>(c)</Label><Text>the Minister’s determination was unfounded.</Text></Paragraph></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2016-07-17" lims:fid="1021512" lims:id="1021512">SOR/2015-193, s. 7</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1300773" lims:id="1300773" lims:enactId="1278658">SOR/2020-262, s. 7</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-12-29" lims:fid="1021513" lims:id="1021513" level="2"><TitleText>Class II, III and IV Medical Devices</TitleText></Heading><Heading lims:inforce-start-date="2018-12-29" lims:fid="1021514" lims:id="1021514" level="3"><TitleText>Prohibition</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1021515" lims:id="1021515"><Label>26</Label><Text>Subject to section 37, no person shall import or sell a Class II, III or IV medical device unless the manufacturer of the device holds a licence in respect of that device or, if the medical device has been subjected to a change described in section 34, an amended medical device licence.</Text></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2023-02-22" lims:fid="1021516" lims:id="1021516"><Label>27</Label><Text>No person shall advertise a Class II, III or IV medical device for the purpose of sale unless</Text><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1021517" lims:id="1391351"><Label>(a)</Label><Text>the manufacturer of the device holds a licence in respect of that device or, if the device has been subjected to a change described in section 34, an amended medical device licence;</Text></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391350" lims:id="1391350"><Label>(a.1)</Label><Text>the manufacturer of the device holds an authorization issued under section 68.12 in respect of that device or, if the device has been subjected to a change described in section 68.13, an amended authorization; or</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021518" lims:id="1021518"><Label>(b)</Label><Text>the advertisement is placed only in a catalogue that includes a clear and visible warning that the devices advertised in the catalogue may not have been licensed in accordance with Canadian law.</Text></Paragraph><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391353" lims:id="1391353" lims:enactId="1390883">SOR/2023-19, s. 1</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-12-29" lims:fid="1021519" lims:id="1021519" level="3"><TitleText>Medical Devices Deemed Licensed</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1021520" lims:id="1021520"><Label>28</Label><Text>If a system is licensed, all of its components or parts that are manufactured by the manufacturer of the system are deemed, for the purposes of its importation, sale or advertisement, to have been licensed.</Text></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1021521" lims:id="1021521"><Label>29</Label><Text>If a test kit is licensed, all of its reagents or articles that are manufactured by the manufacturer of the test kit are deemed, for the purposes of its importation, sale or advertisement, to have been licensed.</Text></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1021522" lims:id="1021522"><Label>30</Label><Text>If a medical device or a medical device group is licensed and forms part of a medical device family or a medical device group family, as the case may be, all other medical devices or medical device groups in the family are deemed to have been licensed.</Text></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1021523" lims:id="1021523"><Label>31</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1021524" lims:id="1021524"><Label>(1)</Label><Text>If all the medical devices that form part of a medical device group are licensed, that medical device group is deemed to have been licensed.</Text></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1021525" lims:id="1021525"><Label>(2)</Label><Text>If a medical device group is licensed, all the medical devices that form part of the medical device group are deemed, for the purposes of its importation, sale or advertisement, to have been licensed.</Text></Subsection></Section><Heading lims:inforce-start-date="2018-12-29" lims:fid="1021526" lims:id="1021526" level="3"><TitleText>Application for a Medical Device Licence</TitleText></Heading><Section lims:inforce-start-date="2016-07-17" lims:lastAmendedDate="2021-06-23" lims:fid="1021527" lims:id="1021527"><Label>32</Label><Subsection lims:inforce-start-date="2016-07-17" lims:fid="1021528" lims:id="1021528"><Label>(1)</Label><Text>An application for a medical device licence shall be submitted to the Minister by the manufacturer of the medical device in a format established by the Minister and shall contain the following:</Text><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021529" lims:id="1021529"><Label>(a)</Label><Text>the name of the device;</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021530" lims:id="1021530"><Label>(b)</Label><Text>the class of the device;</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021531" lims:id="1021531"><Label>(c)</Label><Text>the identifier of the device, including the identifier of any medical device that is part of a system, test kit, medical device group, medical device family or medical device group family;</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021532" lims:id="1021532"><Label>(d)</Label><Text>the name and address of the manufacturer as it appears on the device label; and</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021533" lims:id="1021533"><Label>(e)</Label><Text>the name and address of the establishment where the device is being manufactured, if different from the one referred to in paragraph (d).</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2016-07-17" lims:fid="1021534" lims:id="1021534"><Label>(2)</Label><Text>An application for a Class II medical device licence shall contain, in addition to the information and documents set out in subsection (1), the following:</Text><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021535" lims:id="1021535"><Label>(a)</Label><Text>a description of the medical conditions, purposes and uses for which the device is manufactured, sold or represented;</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021536" lims:id="1021536"><Label>(b)</Label><Text>a list of the standards complied with in the manufacture of the device to satisfy the applicable requirements of sections 10 to 20;</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021537" lims:id="1021537"><Label>(c)</Label><Text>an attestation by a senior official of the manufacturer that the manufacturer has objective evidence to establish that the device meets the applicable requirements of sections 10 to 20;</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021538" lims:id="1021538"><Label>(d)</Label><Text>a copy of the device label;</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021539" lims:id="1021539"><Label>(e)</Label><Text>in the case of a near patient <Language xml:lang="la">in vitro</Language> diagnostic device, an attestation by a senior official of the manufacturer that investigational testing has been conducted on the device using human subjects representative of the intended users and under conditions similar to the conditions of use; and</Text></Paragraph><Paragraph lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1021540" lims:id="1300774"><Label>(f)</Label><Text>a copy of the quality management system certificate certifying that the quality management system under which the device is manufactured meets the requirements set out in the National Standard of Canada CAN/CSA-ISO 13485, <XRefExternal reference-type="standard">Medical devices — Quality management systems — Requirements for regulatory purposes</XRefExternal>, as amended from time to time.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2016-07-17" lims:fid="1021541" lims:id="1021541"><Label>(3)</Label><Text>An application for a Class III medical device licence shall contain, in addition to the information and documents set out in subsection (1), the following:</Text><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021542" lims:id="1021542"><Label>(a)</Label><Text>a description of the device and of the materials used in its manufacture and packaging;</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021543" lims:id="1021543"><Label>(b)</Label><Text>a description of the features of the device that permit it to be used for the medical conditions, purposes and uses for which it is manufactured, sold or represented;</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021544" lims:id="1021544"><Label>(c)</Label><Text>a list of the countries other than Canada where the device has been sold, the total number of units sold in those countries, and a summary of any reported problems with the device and any recalls of the device in those countries;</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021545" lims:id="1021545"><Label>(d)</Label><Text>a list of the standards complied with in the design and manufacture of the device to satisfy the applicable requirements of sections 10 to 20;</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021546" lims:id="1021546"><Label>(e)</Label><Text>in the case of a device to be sold in a sterile condition, a description of the sterilization method used;</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021547" lims:id="1021547"><Label>(f)</Label><Text>a summary of all studies on which the manufacturer relies to ensure that the device meets the applicable requirements of sections 10 to 20, and the conclusions drawn from those studies by the manufacturer;</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021548" lims:id="1021548"><Label>(g)</Label><Text>a copy of the device label;</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021549" lims:id="1021549"><Label>(h)</Label><Text>in the case of a near patient <Language xml:lang="la">in vitro</Language> diagnostic device, a summary of investigational testing conducted on the device using human subjects representative of the intended users and under conditions similar to the conditions of use;</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021550" lims:id="1021550"><Label>(i)</Label><Text>a bibliography of all published reports dealing with the use, safety and effectiveness of the device; and</Text></Paragraph><Paragraph lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1021551" lims:id="1300775"><Label>(j)</Label><Text>a copy of the quality management system certificate certifying that the quality management system under which the device is designed and manufactured meets the requirements set out in the National Standard of Canada CAN/CSA-ISO 13485, <XRefExternal reference-type="standard">Medical devices — Quality management systems — Requirements for regulatory purposes</XRefExternal>, as amended from time to time.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2016-07-17" lims:fid="1021552" lims:id="1021552"><Label>(4)</Label><Text>An application for a Class IV medical device licence shall contain, in addition to the information and documents set out in subsection (1), the following:</Text><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021553" lims:id="1021553"><Label>(a)</Label><Text>a description of the device and of the materials used in its manufacture and packaging;</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021554" lims:id="1021554"><Label>(b)</Label><Text>a description of the features of the device that permit it to be used for the medical conditions, purposes and uses for which it is manufactured, sold or represented;</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021555" lims:id="1021555"><Label>(c)</Label><Text>a list of the countries other than Canada where the device has been sold, the total number of units sold in those countries, and a summary of any reported problems with the device and any recalls of the device in those countries;</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021556" lims:id="1021556"><Label>(d)</Label><Text>a risk assessment comprising an analysis and evaluation of the risks, and the risk reduction measures adopted to satisfy the applicable requirements of sections 10 to 20;</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021557" lims:id="1021557"><Label>(e)</Label><Text>a quality plan setting out the specific quality practices, resources and sequence of activities relevant to the device;</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021558" lims:id="1021558"><Label>(f)</Label><Text>the specifications of the materials used in the manufacture and packaging of the device;</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021559" lims:id="1021559"><Label>(g)</Label><Text>the manufacturing process of the device;</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021560" lims:id="1021560"><Label>(h)</Label><Text>a list of the standards complied with in the design and manufacture of the device to satisfy the applicable requirements of sections 10 to 20;</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021561" lims:id="1021561"><Label>(i)</Label><Text>detailed information on all studies on which the manufacturer relies to ensure that the device meets the applicable requirements of sections 10 to 20, including</Text><Subparagraph lims:inforce-start-date="2016-07-17" lims:fid="1021562" lims:id="1021562"><Label>(i)</Label><Text>pre-clinical and clinical studies,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2016-07-17" lims:fid="1021563" lims:id="1021563"><Label>(ii)</Label><Text>process validation studies,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2016-07-17" lims:fid="1021564" lims:id="1021564"><Label>(iii)</Label><Text>if appropriate, software validation studies, and</Text></Subparagraph><Subparagraph lims:inforce-start-date="2016-07-17" lims:fid="1021565" lims:id="1021565"><Label>(iv)</Label><Text>literature studies;</Text></Subparagraph></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021566" lims:id="1021566"><Label>(j)</Label><Text>in the case of a medical device other than an <Language xml:lang="la">in vitro</Language> diagnostic device, manufactured from or incorporating animal or human tissue or their derivative, objective evidence of the biological safety of the device;</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021567" lims:id="1021567"><Label>(k)</Label><Text>in the case of a near patient <Language xml:lang="la">in vitro</Language> diagnostic device, detailed information on investigational testing conducted on the device using human subjects representative of the intended users and under conditions similar to the conditions of use;</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021568" lims:id="1021568"><Label>(l)</Label><Text>a summary of the studies referred to in paragraph (i) and the conclusions drawn from those studies by the manufacturer;</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021569" lims:id="1021569"><Label>(m)</Label><Text>a summary of the investigational testing referred to in paragraph (k) and the conclusions drawn from that testing by the manufacturer;</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021570" lims:id="1021570"><Label>(n)</Label><Text>a bibliography of all published reports dealing with the use, safety and effectiveness of the device;</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021571" lims:id="1021571"><Label>(o)</Label><Text>a copy of the device label; and</Text></Paragraph><Paragraph lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1021572" lims:id="1300776"><Label>(p)</Label><Text>a copy of the quality management system certificate certifying that the quality management system under which the device is designed and manufactured meets the requirements set out in the National Standard of Canada CAN/CSA-ISO 13485, <XRefExternal reference-type="standard">Medical devices — Quality management systems — Requirements for regulatory purposes</XRefExternal>, as amended from time to time.</Text></Paragraph></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2016-07-17" lims:fid="1021574" lims:id="1021574">SOR/2003-173, s. 2; SOR/2006-197, s. 2; SOR/2015-193, ss. 4, 7</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2019-03-01" lims:enacted-date="2019-02-11" lims:fid="1116573" lims:id="1116573" lims:enactId="1112371">SOR/2019-44, s. 2</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1300777" lims:id="1300777" lims:enactId="1278667">SOR/2020-262, s. 8</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-12-29" lims:fid="1021575" lims:id="1021575" level="3"><TitleText>Quality Management System Certificate</TitleText></Heading><Section lims:inforce-start-date="2009-11-19" lims:lastAmendedDate="2009-11-19" lims:fid="1021576" lims:id="1021576"><Label>32.1</Label><Text>The Minister shall recognize a person as a registrar for the purpose of issuing, renewing, suspending or cancelling quality management system certificates if the person</Text><Paragraph lims:inforce-start-date="2009-11-19" lims:fid="1021577" lims:id="1021577"><Label>(a)</Label><Text>has sufficient training, experience and technical knowledge in the design and manufacture of medical devices and in the effective implementation of quality management systems to determine whether a quality management system satisfies a standard referred to in paragraph 32(2)(f), (3)(j) or (4)(p); and</Text></Paragraph><Paragraph lims:inforce-start-date="2009-11-19" lims:fid="1021578" lims:id="1021578"><Label>(b)</Label><Text>conducts quality management system audits and issues, renews, suspends and cancels quality management system certificates in accordance with the applicable guidelines and practices established by the International Organization for Standardization.</Text></Paragraph><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2009-11-19" lims:fid="1021580" lims:id="1021580">SOR/2003-173, s. 3; SOR/2006-197, s. 3; SOR/2009-303, s. 1</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2006-07-15" lims:lastAmendedDate="2006-07-15" lims:fid="1021581" lims:id="1021581"><Label>32.2</Label><Text>A quality management system certificate is valid for the period, not exceeding three years, specified in it.</Text><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2006-07-15" lims:fid="1021583" lims:id="1021583">SOR/2003-173, s. 3; SOR/2006-197, s. 4</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2006-07-15" lims:lastAmendedDate="2006-07-15" lims:fid="1021584" lims:id="1021584"><Label>32.3</Label><Text>A registrar shall notify the Minister in writing within 15 days after suspending or cancelling a quality management system certificate.</Text><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2006-07-15" lims:fid="1021586" lims:id="1021586">SOR/2003-173, s. 3; SOR/2006-197, s. 4</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2006-07-15" lims:lastAmendedDate="2006-07-15" lims:fid="1021587" lims:id="1021587"><Label>32.4</Label><Text>A registrar shall notify the Minister in writing within 15 days after the expiry of a quality management system certificate if the certificate has not been renewed.</Text><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2006-07-15" lims:fid="1021589" lims:id="1021589">SOR/2003-173, s. 3; SOR/2006-197, s. 4</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2009-11-19" lims:lastAmendedDate="2009-11-19" lims:fid="1021590" lims:id="1021590"><Label>32.5</Label><Subsection lims:inforce-start-date="2009-11-19" lims:fid="1021591" lims:id="1021591"><Label>(1)</Label><Text>Subject to subsection (2), the Minister may cease to recognize a person as a registrar if the Minister has reasonable grounds to believe that the person no longer meets the requirements of section 32.1 or fails to comply with section 32.3 or 32.4.</Text></Subsection><Subsection lims:inforce-start-date="2009-11-19" lims:fid="1021592" lims:id="1021592"><Label>(2)</Label><Text>Subject to section 32.6, the Minister shall not cease to recognize a person as a registrar unless</Text><Paragraph lims:inforce-start-date="2009-11-19" lims:fid="1021593" lims:id="1021593"><Label>(a)</Label><Text>the Minister has sent the registrar a written notice that sets out the reason for the proposed cessation of recognition, any corrective action required to be taken and the time within which it must be taken;</Text></Paragraph><Paragraph lims:inforce-start-date="2009-11-19" lims:fid="1021594" lims:id="1021594"><Label>(b)</Label><Text>if corrective action is required, the time set out in the notice has passed without the action having been taken; and</Text></Paragraph><Paragraph lims:inforce-start-date="2009-11-19" lims:fid="1021595" lims:id="1021595"><Label>(c)</Label><Text>the registrar has been given an opportunity to be heard in respect of the proposed cessation of recognition.</Text></Paragraph></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2009-11-19" lims:fid="1021597" lims:id="1021597">SOR/2003-173, s. 3; SOR/2009-303, s. 2</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2009-11-19" lims:lastAmendedDate="2009-11-19" lims:fid="1021598" lims:id="1021598"><Label>32.6</Label><Subsection lims:inforce-start-date="2009-11-19" lims:fid="1021599" lims:id="1021599"><Label>(1)</Label><Text>The Minister may cease to recognize a person as a registrar without giving the registrar an opportunity to be heard if it is necessary to do so to prevent injury to the health or safety of patients, users or other persons, by giving the registrar a notice in writing that states the reason for the cessation of recognition.</Text></Subsection><Subsection lims:inforce-start-date="2009-11-19" lims:fid="1021600" lims:id="1021600"><Label>(2)</Label><Text>A registrar may ask the Minister, in writing, that the cessation of recognition be reconsidered.</Text></Subsection><Subsection lims:inforce-start-date="2009-11-19" lims:fid="1021601" lims:id="1021601"><Label>(3)</Label><Text>The Minister shall, within 45 days after the date of receiving the request for reconsideration, provide the registrar with an opportunity to be heard.</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2009-11-19" lims:fid="1021603" lims:id="1021603">SOR/2009-303, s. 2</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2011-12-16" lims:lastAmendedDate="2011-12-16" lims:fid="1021604" lims:id="1021604"><Label>32.7</Label><Text>The Minister shall reinstate the recognition of a person as a registrar if the situation that gave rise to the cessation of recognition has been corrected or if the cessation of recognition was unfounded.</Text><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2011-12-16" lims:fid="1021606" lims:id="1021606">SOR/2009-303, s. 2; SOR/2011-322, s. 1</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-12-29" lims:fid="1021607" lims:id="1021607" level="3"><TitleText>Foreign Manufacturers</TitleText></Heading><Section lims:inforce-start-date="2016-07-17" lims:lastAmendedDate="2016-07-17" lims:fid="1021608" lims:id="1021608"><Label>33</Label><Subsection lims:inforce-start-date="2016-07-17" lims:fid="1021609" lims:id="1021609"><Label>(1)</Label><Text>If an application for a medical device licence is submitted by a manufacturer of a country other than Canada, the information and documents described in subsections 32(2) to (4) need not be submitted if</Text><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021610" lims:id="1021610"><Label>(a)</Label><Text>the applicant is governed, in that country, by a regulatory authority that is recognized by the Minister; and</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021611" lims:id="1021611"><Label>(b)</Label><Text>the application is accompanied by a certificate of compliance and a supporting summary report, issued by a conformity assessment body of that country that is recognized by the Minister, which certify that the medical device meets the applicable requirements of sections 10 to 20.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2016-07-17" lims:fid="1021612" lims:id="1021612"><Label>(2)</Label><Text>For the purposes of subsection (1), the Minister may recognize a regulatory authority and a conformity assessment body of a country other than Canada only if it has the ability to determine whether the device meets the applicable requirements of sections 10 to 20.</Text></Subsection><Subsection lims:inforce-start-date="2016-07-17" lims:fid="1021613" lims:id="1021613"><Label>(3)</Label><Text>The Minister shall, on request, make available to any interested persons the list of recognized regulatory authorities and conformity assessment bodies of countries other than Canada.</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2016-07-17" lims:fid="1021615" lims:id="1021615">SOR/2015-193, s. 7</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-12-29" lims:fid="1021616" lims:id="1021616" level="3"><TitleText>Application for a Medical Device Licence Amendment</TitleText></Heading><Section lims:inforce-start-date="2016-07-17" lims:lastAmendedDate="2016-07-17" lims:fid="1021617" lims:id="1021617"><Label>34</Label><Text>If the manufacturer proposes to make one or more of the following changes, the manufacturer shall submit to the Minister, in a format established by the Minister, an application for a medical device licence amendment including the information and documents set out in section 32 that are relevant to the change:</Text><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021618" lims:id="1021618"><Label>(a)</Label><Text>in the case of a Class III or IV medical device, a significant change;</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021619" lims:id="1021619"><Label>(b)</Label><Text>a change that would affect the class of the device;</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021620" lims:id="1021620"><Label>(c)</Label><Text>a change in the name of the manufacturer;</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021621" lims:id="1021621"><Label>(d)</Label><Text>a change in the name of the device;</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021622" lims:id="1021622"><Label>(e)</Label><Text>a change in the identifier of the device, including the identifier of any medical device that is part of a system, test kit, medical device group, medical device family or medical device group family;</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021623" lims:id="1021623"><Label>(f)</Label><Text>in the case of a Class II medical device other than a decorative contact lens, a change in the medical conditions, purposes or uses for which the device is manufactured, sold or represented.</Text></Paragraph><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2016-07-17" lims:fid="1021625" lims:id="1021625">SOR/2015-193, s. 5</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-12-29" lims:fid="1021626" lims:id="1021626" level="3"><TitleText>Additional Information and Samples</TitleText></Heading><Section lims:inforce-start-date="2016-07-17" lims:lastAmendedDate="2016-07-17" lims:fid="1021627" lims:id="1021627"><Label>35</Label><Subsection lims:inforce-start-date="2016-07-17" lims:fid="1021628" lims:id="1021628"><Label>(1)</Label><Text>If the information and documents submitted in respect of an application for a medical device licence or a medical device licence amendment are insufficient to enable the Minister to determine whether a medical device meets the applicable requirements of sections 10 to 20, the Minister may request the manufacturer to submit, on or before a specified day, additional information necessary for making the determination.</Text></Subsection><Subsection lims:inforce-start-date="2016-07-17" lims:fid="1021629" lims:id="1021629"><Label>(2)</Label><Text>In the course of examining the application, the Minister may require the applicant to provide samples of the medical device.</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2016-07-17" lims:fid="1021631" lims:id="1021631">SOR/2015-193, s. 7</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-12-29" lims:fid="1021632" lims:id="1021632" level="3"><TitleText>Issuance</TitleText></Heading><Section lims:inforce-start-date="2016-07-17" lims:lastAmendedDate="2016-07-17" lims:fid="1021633" lims:id="1021633"><Label>36</Label><Subsection lims:inforce-start-date="2016-07-17" lims:fid="1021634" lims:id="1021634"><Label>(1)</Label><Text>If the Minister determines that a medical device in respect of which an application is submitted meets the applicable requirements of sections 10 to 20, the Minister shall</Text><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021635" lims:id="1021635"><Label>(a)</Label><Text>issue to the manufacturer of the device a medical device licence, in the case of an application for a medical device licence; or</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021636" lims:id="1021636"><Label>(b)</Label><Text>amend the medical device licence, in the case of an application for a medical device licence amendment.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2016-07-17" lims:fid="1021637" lims:id="1021637"><Label>(2)</Label><Text>The Minister may set out in a medical device licence terms and conditions respecting</Text><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021638" lims:id="1021638"><Label>(a)</Label><Text>the tests to be performed on a device to ensure that it continues to meet the applicable requirements of sections 10 to 20; and</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021639" lims:id="1021639"><Label>(b)</Label><Text>the requirement to submit the results and protocols of any tests performed.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2016-07-17" lims:fid="1021640" lims:id="1021640"><Label>(3)</Label><Text>The Minister may amend the terms and conditions of the medical device licence to take into account any new development with respect to the device.</Text></Subsection><Subsection lims:inforce-start-date="2016-07-17" lims:fid="1021641" lims:id="1021641"><Label>(4)</Label><Text>The holder of the medical device licence shall comply with the terms and conditions of the licence.</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2016-07-17" lims:fid="1021643" lims:id="1021643">SOR/2015-193, s. 7</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-12-29" lims:fid="1021644" lims:id="1021644" level="3"><TitleText>Lot of <Language xml:lang="la">In Vitro</Language> Diagnostic Devices</TitleText></Heading><Section lims:inforce-start-date="2016-07-17" lims:lastAmendedDate="2016-07-17" lims:fid="1021645" lims:id="1021645"><Label>37</Label><Text>No person shall sell a medical device from a lot of licensed <Language xml:lang="la">in vitro</Language> diagnostic devices in respect of which terms and conditions were set out in the licence pursuant to section 36, unless</Text><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021646" lims:id="1021646"><Label>(a)</Label><Text>the results and protocol of any test performed on the device in accordance with those terms and conditions have been provided to the Minister; and</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021647" lims:id="1021647"><Label>(b)</Label><Text>the Minister determines, on the basis of the information received under paragraph (a), that the device continues to meet the applicable requirements of sections 10 to 20.</Text></Paragraph><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2016-07-17" lims:fid="1021649" lims:id="1021649">SOR/2015-193, s. 7</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-12-29" lims:fid="1021650" lims:id="1021650" level="3"><TitleText>Refusal to Issue</TitleText></Heading><Section lims:inforce-start-date="2016-07-17" lims:lastAmendedDate="2016-07-17" lims:fid="1021651" lims:id="1021651"><Label>38</Label><Subsection lims:inforce-start-date="2016-07-17" lims:fid="1021652" lims:id="1021652"><Label>(1)</Label><Text>The Minister may refuse to issue or amend a medical device licence if</Text><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021653" lims:id="1021653"><Label>(a)</Label><Text>the applicant does not comply with these Regulations or any provisions of the Act relating to medical devices;</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021654" lims:id="1021654"><Label>(b)</Label><Text>the applicant has made a false or misleading statement in the application;</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021655" lims:id="1021655"><Label>(c)</Label><Text>the medical device does not comply with the labelling requirements set out in sections 21 to 23; or</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021656" lims:id="1021656"><Label>(d)</Label><Text>the applicant has not complied with a request for additional information or samples made pursuant to section 35 by the day specified in the request.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2016-07-17" lims:fid="1021657" lims:id="1021657"><Label>(2)</Label><Text>The Minister shall refuse to issue or amend a medical device licence if the medical device does not meet the applicable requirements of sections 10 to 20 or if the information or samples provided pursuant to section 35 are insufficient to enable the Minister to determine whether the medical device meets those requirements.</Text></Subsection><Subsection lims:inforce-start-date="2016-07-17" lims:fid="1021658" lims:id="1021658"><Label>(3)</Label><Text>If the Minister refuses to issue or amend a medical device licence, the Minister shall</Text><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021659" lims:id="1021659"><Label>(a)</Label><Text>notify the applicant in writing of the reasons for the refusal; and</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021660" lims:id="1021660"><Label>(b)</Label><Text>give the applicant an opportunity to be heard.</Text></Paragraph></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2016-07-17" lims:fid="1021662" lims:id="1021662">SOR/2015-193, s. 7</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1021663" lims:id="1300780" level="3"><TitleText>Requests by Minister</TitleText></Heading><Section lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:lastAmendedDate="2021-06-23" lims:fid="1021664" lims:id="1300778"><Label>39</Label><Text>If the Minister believes on reasonable grounds, after reviewing a report or information brought to his or her attention, that a licensed medical device may not meet the applicable requirements of sections 10 to 20, the Minister may request the manufacturer to submit, on or before the day specified in the request, samples — or an analysis or other information — to enable him or her to determine whether the device meets those requirements.</Text><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2016-07-17" lims:fid="1021666" lims:id="1021666">SOR/2015-193, s. 7</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1300779" lims:id="1300779" lims:enactId="1278674">SOR/2020-262, s. 9</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-12-29" lims:fid="1021667" lims:id="1021667" level="3"><TitleText>Suspension</TitleText></Heading><Section lims:inforce-start-date="2016-07-17" lims:lastAmendedDate="2021-06-23" lims:fid="1021668" lims:id="1021668"><Label>40</Label><Subsection lims:inforce-start-date="2016-07-17" lims:fid="1021669" lims:id="1021669"><Label>(1)</Label><Text>Subject to subsection (3), the Minister may suspend a medical device licence if the Minister has reasonable grounds to believe that</Text><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021670" lims:id="1021670"><Label>(a)</Label><Text>the licensee has contravened these Regulations or any provision of the Act relating to medical devices;</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021671" lims:id="1021671"><Label>(b)</Label><Text>the licensee has made a false or misleading statement in the application;</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021672" lims:id="1021672"><Label>(c)</Label><Text>the licensee has failed to comply with the terms and conditions of the licence;</Text></Paragraph><Paragraph lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1021673" lims:id="1300782"><Label>(d)</Label><Text>the licensee has not complied with a request made under section 39 on or before the day specified in the request;</Text></Paragraph><Paragraph lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1300781" lims:id="1300781"><Label>(d.1)</Label><Text>the samples — or the analysis or other information — submitted by the licensee in response to a request made under section 39 are insufficient to enable the Minister to determine whether the medical device meets the applicable requirements of sections 10 to 20;</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021674" lims:id="1021674"><Label>(e)</Label><Text>the medical device no longer meets the applicable requirements of sections 10 to 20; or</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021675" lims:id="1021675"><Label>(f)</Label><Text>on the basis of information obtained after the device was licensed, the quality management system under which the device has been designed, in the case of a Class III or IV device, or manufactured, assembled, processed, packaged, refurbished or modified, in the case of a Class II, III or IV device, is inadequate to ensure that the device meets its specifications.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2016-07-17" lims:fid="1021676" lims:id="1021676"><Label>(2)</Label><Text>Before suspending a medical device licence, the Minister shall consider</Text><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021677" lims:id="1021677"><Label>(a)</Label><Text>the licensee’s history of compliance with these Regulations and with the provisions of the Act relating to medical devices; and</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021678" lims:id="1021678"><Label>(b)</Label><Text>the risk that allowing the licence to continue to be in force would constitute for the health or safety of patients, users or other persons.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2016-07-17" lims:fid="1021679" lims:id="1021679"><Label>(3)</Label><Text>Subject to section 41, the Minister shall not suspend a medical device licence until</Text><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021680" lims:id="1021680"><Label>(a)</Label><Text>the Minister has sent the licensee a written notice that sets out the reason for the proposed suspension, any corrective action required to be taken and the time within which it must be taken;</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021681" lims:id="1021681"><Label>(b)</Label><Text>if corrective action is required, the time set out in the notice has passed without the action having been taken; and</Text></Paragraph><Paragraph lims:inforce-start-date="2016-07-17" lims:fid="1021682" lims:id="1021682"><Label>(c)</Label><Text>the licensee has been given an opportunity to be heard in respect of the suspension.</Text></Paragraph></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2016-07-17" lims:fid="1021684" lims:id="1021684">SOR/2006-197, s. 4; SOR/2015-193, s. 7</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1300783" lims:id="1300783" lims:enactId="1278676">SOR/2020-262, s. 10</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1021685" lims:id="1021685"><Label>41</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1021686" lims:id="1021686"><Label>(1)</Label><Text>The Minister may suspend a medical device licence without giving the licensee an opportunity to be heard if it is necessary to do so to prevent injury to the health or safety of patients, users or other persons, by giving the licensee a notice in writing that states the reason for the suspension.</Text></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1021687" lims:id="1021687"><Label>(2)</Label><Text>A licensee may ask the Minister, in writing, that the suspension be reconsidered.</Text></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1021688" lims:id="1021688"><Label>(3)</Label><Text>The Minister shall, within 45 days after the date of receiving the request, provide the licensee with an opportunity to be heard.</Text></Subsection></Section><Section lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:lastAmendedDate="2021-06-23" lims:fid="1300784" lims:id="1300784"><Label>41.1</Label><Text>The Minister may suspend a medical device licence if, after he or she has, under section 21.31 of the Act, ordered the licensee to conduct an assessment of the medical device in order to provide evidence establishing that the benefits associated with the device outweigh the risks to the health or safety of patients, users or other persons,</Text><Paragraph lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1300785" lims:id="1300785"><Label>(a)</Label><Text>the licensee has not complied with the order; or</Text></Paragraph><Paragraph lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1300786" lims:id="1300786"><Label>(b)</Label><Text>the licensee has complied with the order but the Minister determines that the results of the assessment are not sufficient to establish that the benefits associated with the device outweigh the risks to the health or safety of patients, users or other persons.</Text></Paragraph><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1300788" lims:id="1300788" lims:enactId="1278678">SOR/2020-262, s. 11</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1021689" lims:id="1021689"><Label>42</Label><Text>The Minister may reinstate a medical device licence if the situation giving rise to the suspension has been corrected or if the reason for the suspension was unfounded.</Text></Section><Heading lims:inforce-start-date="2018-12-29" lims:fid="1021690" lims:id="1021690" level="3"><TitleText>Obligation to Inform</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1021691" lims:id="1021691"><Label>43</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1021692" lims:id="1021692"><Label>(1)</Label><Text>Every manufacturer of a licensed medical device shall, annually before November 1 and in a form authorized by the Minister, furnish the Minister with a statement signed by the manufacturer or by a person authorized to sign on the manufacturer’s behalf</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021693" lims:id="1021693"><Label>(a)</Label><Text>confirming that all the information and documents supplied by the manufacturer with respect to the device are still correct; or</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021694" lims:id="1021694"><Label>(b)</Label><Text>describing any change to the information and documents supplied by the manufacturer with respect to the device, other than those to be submitted under section 34 or 43.1.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1021695" lims:id="1021695"><Label>(2)</Label><Text>If the manufacturer fails to comply with subsection (1), the Minister may cancel the medical device licence.</Text></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1021696" lims:id="1021696"><Label>(3)</Label><Text>If the holder of a medical device licence discontinues the sale of the medical device in Canada, the licensee shall inform the Minister within 30 days after the discontinuance, and the licence shall be cancelled at the time that the Minister is informed.</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2006-03-22" lims:fid="1021698" lims:id="1021698">SOR/2003-173, s. 4</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-12-29" lims:fid="1021699" lims:id="1021699" level="3"><TitleText>Obligation to Submit Certificate</TitleText></Heading><Section lims:inforce-start-date="2006-07-15" lims:lastAmendedDate="2006-07-15" lims:fid="1021700" lims:id="1021700"><Label>43.1</Label><Text>Subject to section 34, if a new or modified quality management system certificate is issued in respect of a licensed medical device, the manufacturer of the device shall submit a copy of the certificate to the Minister within 30 days after it is issued.</Text><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2006-07-15" lims:fid="1021702" lims:id="1021702">SOR/2003-173, s. 5; SOR/2006-197, s. 4</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2019-03-04" lims:enacted-date="2019-03-04" lims:fid="1117703" lims:id="1117703" level="3"><TitleText>Disclosure of Information in Respect of Clinical Studies or Investigational Testing</TitleText></Heading><Section lims:inforce-start-date="2019-03-04" lims:enacted-date="2019-03-04" lims:lastAmendedDate="2019-03-04" lims:fid="1117704" lims:id="1117704"><Label>43.11</Label><Text>In sections 43.12 and 43.13, <DefinedTermEn>information in respect of a clinical study or investigational testing</DefinedTermEn> means information in respect of a clinical study, or investigational testing, involving human subjects that is contained in an application for a Class III or IV medical device licence made under section 32 or in an application to amend such a licence made under section 34.</Text><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2019-03-04" lims:enacted-date="2019-03-04" lims:fid="1117706" lims:id="1117706" lims:enactId="1115990">SOR/2019-63, s. 1</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2019-03-04" lims:enacted-date="2019-03-04" lims:lastAmendedDate="2019-03-04" lims:fid="1117707" lims:id="1117707"><Label>43.12</Label><Subsection lims:inforce-start-date="2019-03-04" lims:enacted-date="2019-03-04" lims:fid="1117708" lims:id="1117708"><Label>(1)</Label><Text>Information in respect of a clinical study or investigational testing that is confidential business information ceases to be confidential business information when one of the following circumstances occurs with respect to the application:</Text><Paragraph lims:inforce-start-date="2019-03-04" lims:enacted-date="2019-03-04" lims:fid="1117709" lims:id="1117709"><Label>(a)</Label><Text>the Minister issues a licence under paragraph 36(1)(a);</Text></Paragraph><Paragraph lims:inforce-start-date="2019-03-04" lims:enacted-date="2019-03-04" lims:fid="1117710" lims:id="1117710"><Label>(b)</Label><Text>the Minister amends a licence under paragraph 36(1)(b);</Text></Paragraph><Paragraph lims:inforce-start-date="2019-03-04" lims:enacted-date="2019-03-04" lims:fid="1117711" lims:id="1117711"><Label>(c)</Label><Text>the Minister refuses to issue a licence or amend a licence under section 38.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2019-03-04" lims:enacted-date="2019-03-04" lims:fid="1117712" lims:id="1117712"><Label>(2)</Label><Text>Subsection (1) does not apply to information in respect of a clinical study or investigational testing that</Text><Paragraph lims:inforce-start-date="2019-03-04" lims:enacted-date="2019-03-04" lims:fid="1117713" lims:id="1117713"><Label>(a)</Label><Text>was not used by the manufacturer in the application to support the information referred to in paragraph 32(3)(b) or paragraph 32(4)(b); or</Text></Paragraph><Paragraph lims:inforce-start-date="2019-03-04" lims:enacted-date="2019-03-04" lims:fid="1117714" lims:id="1117714"><Label>(b)</Label><Text>describes tests, methods or assays that are used exclusively by the manufacturer.</Text></Paragraph></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2019-03-04" lims:enacted-date="2019-03-04" lims:fid="1117716" lims:id="1117716" lims:enactId="1115990">SOR/2019-63, s. 1</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2019-03-04" lims:enacted-date="2019-03-04" lims:lastAmendedDate="2019-03-04" lims:fid="1117717" lims:id="1117717"><Label>43.13</Label><Text>The Minister may disclose, without notifying the person to whose business or affairs the information relates or obtaining their consent, any information in respect of a clinical study or investigational testing that has ceased to be confidential business information.</Text><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2019-03-04" lims:enacted-date="2019-03-04" lims:fid="1117719" lims:id="1117719" lims:enactId="1115990">SOR/2019-63, s. 1</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-12-29" lims:fid="1021703" lims:id="1021703" level="3"><TitleText>Medical Devices to Be Sold for the Purposes of Implementing the General Council Decision</TitleText></Heading><Heading lims:inforce-start-date="2018-12-29" lims:fid="1021704" lims:id="1021704" level="4"><TitleText>Application</TitleText></Heading><Section lims:inforce-start-date="2011-02-10" lims:lastAmendedDate="2011-02-10" lims:fid="1021705" lims:id="1021705"><Label>43.2</Label><Text>Sections 43.3 to 43.6 apply, for the purposes of implementing the General Council Decision, to a medical device in respect of which a manufacturer has applied to the Commissioner of Patents for an authorization under section 21.04 of the <XRefExternal reference-type="act" link="P-4">Patent Act</XRefExternal>.</Text><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2011-02-10" lims:fid="1021707" lims:id="1021707">SOR/2005-142, s. 2; SOR/2011-42, s. 1</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-12-29" lims:fid="1021708" lims:id="1021708" level="4"><TitleText>Notices to Commissioner of Patents</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1021709" lims:id="1021709"><Label>43.3</Label><Text>The Minister shall notify the manufacturer and the Commissioner of Patents for the purposes of paragraph 21.04(3)(b) of the Patent Act that the manufacturer’s medical device meets the requirements of the Act and these Regulations if</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021710" lims:id="1021710"><Label>(a)</Label><Text>the manufacturer holds a medical device licence in respect of the device issued in accordance with section 36;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021711" lims:id="1021711"><Label>(b)</Label><Text>the Minister is satisfied that the manufacturer and the device comply with the Act and these Regulations;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021712" lims:id="1021712"><Label>(c)</Label><Text>the manufacturer has submitted to the Minister a copy of the application filed by the manufacturer with the Commissioner of Patents under section 21.04 of the <XRefExternal reference-type="act" link="P-4">Patent Act</XRefExternal>;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021713" lims:id="1021713"><Label>(d)</Label><Text>the manufacturer has submitted to the Minister information regarding the manner in which the mark referred to in paragraph 43.5(1)(a) is applied to all permanent components of the device; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021714" lims:id="1021714"><Label>(e)</Label><Text>the manufacturer has submitted to the Minister a sample of the label for the device that includes the information required by paragraph 43.5(1)(b).</Text></Paragraph><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2006-03-22" lims:fid="1021716" lims:id="1021716">SOR/2005-142, s. 2</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1021717" lims:id="1021717"><Label>43.4</Label><Text>The Minister shall notify the manufacturer and the Commissioner of Patents for the purposes of paragraph 21.13(b) of the <XRefExternal reference-type="act" link="P-4">Patent Act</XRefExternal> in the event that the Minister is of the opinion that the manufacturer’s medical device referred to in section 43.2 has ceased to meet the requirements of the Act and these Regulations.</Text><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2006-03-22" lims:fid="1021719" lims:id="1021719">SOR/2005-142, s. 2</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-12-29" lims:fid="1021720" lims:id="1021720" level="4"><TitleText>Marking and Labelling</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1021721" lims:id="1021721"><Label>43.5</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1021722" lims:id="1021722"><Label>(1)</Label><Text>No person shall sell a medical device referred to in section 43.2 unless</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021723" lims:id="1021723"><Label>(a)</Label><Text>the mark “XCL” is displayed on all permanent components of the device; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021724" lims:id="1021724"><Label>(b)</Label><Text>the label of the device displays the mark “XCL” followed by the control number referred to in paragraph 21(1)(d) and the words “FOR EXPORT UNDER THE GENERAL COUNCIL DECISION. NOT FOR SALE IN CANADA.” or “<Language xml:lang="fr">POUR EXPORTATION AUX TERMES DE LA DÉCISION DU CONSEIL GÉNÉRAL. VENTE INTERDITE AU CANADA.</Language>”.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1021725" lims:id="1021725"><Label>(2)</Label><Text>The information required by subsection (1) shall be expressed in a legible, permanent and prominent manner.</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2006-03-22" lims:fid="1021727" lims:id="1021727">SOR/2005-142, s. 2</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-12-29" lims:fid="1021728" lims:id="1021728" level="4"><TitleText>Notice to Minister</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1021729" lims:id="1021729"><Label>43.6</Label><Text>The manufacturer of a medical device referred to in section 43.2 shall notify the Minister in writing not less than 15 days prior to commencing the manufacture of the device.</Text><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2006-03-22" lims:fid="1021731" lims:id="1021731">SOR/2005-142, s. 2</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-12-29" lims:fid="1021732" lims:id="1021732" level="2"><TitleText>Establishment Licence</TitleText></Heading><Heading lims:inforce-start-date="2018-12-29" lims:fid="1021733" lims:id="1021733" level="3"><TitleText>Prohibition</TitleText></Heading><Section lims:inforce-start-date="2018-12-29" lims:lastAmendedDate="2018-12-29" lims:fid="1021734" lims:id="1021734"><Label>44</Label><Subsection lims:inforce-start-date="2018-12-29" lims:fid="1021735" lims:id="1021735"><Label>(1)</Label><Text>No person shall import or sell a medical device unless the person holds an establishment licence.</Text></Subsection><Subsection lims:inforce-start-date="2018-12-29" lims:fid="1021736" lims:id="1021736"><Label>(2)</Label><Text>Subsection (1) does not apply to the importation or sale of a medical device by</Text><Paragraph lims:inforce-start-date="2018-12-29" lims:fid="1021737" lims:id="1021737"><Label>(a)</Label><Text>a retailer;</Text></Paragraph><Paragraph lims:inforce-start-date="2018-12-29" lims:fid="1021738" lims:id="1021738"><Label>(b)</Label><Text>a health care facility;</Text></Paragraph><Paragraph lims:inforce-start-date="2018-12-29" lims:fid="1021739" lims:id="1021739"><Label>(c)</Label><Text>in the case of a Class II, III or IV medical device, the manufacturer of the medical device; or</Text></Paragraph><Paragraph lims:inforce-start-date="2018-12-29" lims:fid="1021740" lims:id="1021740"><Label>(d)</Label><Text>in the case of a Class I device, the manufacturer of the medical device, if the manufacturer imports or distributes solely through a person who holds an establishment licence.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2018-12-29" lims:fid="1021741" lims:id="1021741"><Label>(3)</Label><Text>Any person who imports a medical device shall ensure that the person from whom they import it holds an establishment licence.</Text></Subsection><Subsection lims:inforce-start-date="2018-12-29" lims:fid="1021742" lims:id="1021742"><Label>(4)</Label><Text>Subsection (3) does not apply where a person imports</Text><Paragraph lims:inforce-start-date="2018-12-29" lims:fid="1021743" lims:id="1021743"><Label>(a)</Label><Text>in the case of a Class I medical device, from the manufacturer of that medical device if the person importing it holds an establishment licence; and</Text></Paragraph><Paragraph lims:inforce-start-date="2018-12-29" lims:fid="1021744" lims:id="1021744"><Label>(b)</Label><Text>in the case of a Class II, III or IV medical device, from the manufacturer of that medical device.</Text></Paragraph></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2018-12-29" lims:fid="1021746" lims:id="1021746">SOR/2018-225, s. 2</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-12-29" lims:fid="1021747" lims:id="1021747" level="3"><TitleText>Application</TitleText></Heading><Section lims:inforce-start-date="2018-12-29" lims:lastAmendedDate="2021-06-23" lims:fid="1021748" lims:id="1021748"><Label>45</Label><Text>A person who wishes to apply for an establishment licence shall submit an application to the Minister, in a form established by the Minister, that contains the following information and documents:</Text><Paragraph lims:inforce-start-date="2018-12-29" lims:fid="1021749" lims:id="1021749"><Label>(a)</Label><Text>the name and address of the establishment;</Text></Paragraph><Paragraph lims:inforce-start-date="2018-12-29" lims:fid="1021750" lims:id="1021750"><Label>(b)</Label><Text>the name, title and telephone number of the representative of the establishment to contact for any information concerning the application;</Text></Paragraph><Paragraph lims:inforce-start-date="2018-12-29" lims:fid="1021751" lims:id="1021751"><Label>(c)</Label><Text>a statement as to whether the activity of the establishment is importation or distribution, or both;</Text></Paragraph><Paragraph lims:inforce-start-date="2018-12-29" lims:fid="1021752" lims:id="1021752"><Label>(d)</Label><Text>the names and addresses of the manufacturers of the devices that are being imported or distributed;</Text></Paragraph><Paragraph lims:inforce-start-date="2018-12-29" lims:fid="1021753" lims:id="1021753"><Label>(e)</Label><Text>for each manufacturer, in respect of a medical device other than a decorative contact lens, the medical specialities in respect of which the device is imported or distributed;</Text></Paragraph><Paragraph lims:inforce-start-date="2018-12-29" lims:fid="1021754" lims:id="1021754"><Label>(f)</Label><Text>for each manufacturer, the classes of the devices that are being imported or distributed;</Text></Paragraph><Paragraph lims:inforce-start-date="2018-12-29" lims:fid="1021755" lims:id="1021755"><Label>(g)</Label><Text>an attestation by a senior official of the establishment that the establishment has documented procedures in place in respect of distribution records, complaint handling and recalls;</Text></Paragraph><Paragraph lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1021756" lims:id="1300790"><Label>(h)</Label><Text>if the establishment imports Class I medical devices, an attestation by a senior official of the establishment that the establishment has documented procedures in place in respect of the making of reports under subsections 59(1) and (1.1);</Text></Paragraph><Paragraph lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1300789" lims:id="1300789"><Label>(h.1)</Label><Text>if the establishment imports Class II, III or IV medical devices, an attestation by a senior official of the establishment that the establishment has documented procedures in place in respect of the making of reports under subsection 59(1) and the provision of information under section 61.2;</Text></Paragraph><Paragraph lims:inforce-start-date="2018-12-29" lims:fid="1021757" lims:id="1021757"><Label>(i)</Label><Text>if the establishment imports or distributes Class II, III or IV devices, an attestation by a senior official of the establishment that the establishment has documented procedures in place, where applicable, for handling, storage, delivery, installation, corrective action and servicing in respect of those devices; and</Text></Paragraph><Paragraph lims:inforce-start-date="2018-12-29" lims:fid="1021758" lims:id="1021758"><Label>(j)</Label><Text>the address of each building where the procedures described in paragraphs (g) to (i) are in place.</Text></Paragraph><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2018-12-29" lims:fid="1021760" lims:id="1021760">SOR/2011-82, s. 1(E); SOR/2015-193, s. 6; SOR/2018-225, s. 3</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1300791" lims:id="1300791" lims:enactId="1278680">SOR/2020-262, s. 12</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-12-29" lims:fid="1021761" lims:id="1021761" level="3"><TitleText>Issuance</TitleText></Heading><Section lims:inforce-start-date="2011-04-01" lims:lastAmendedDate="2011-04-01" lims:fid="1021762" lims:id="1021762"><Label>46</Label><Text>Subject to section 47, the Minister shall issue an establishment licence if the Minister determines that the application meets the requirements of section 45.</Text><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2011-04-01" lims:fid="1021764" lims:id="1021764">SOR/2011-82, s. 2</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-12-29" lims:fid="1021765" lims:id="1021765" level="3"><TitleText>Annual Review of Licence</TitleText></Heading><Section lims:inforce-start-date="2011-04-01" lims:lastAmendedDate="2011-04-01" lims:fid="1021766" lims:id="1021766"><Label>46.1</Label><Subsection lims:inforce-start-date="2011-04-01" lims:fid="1021767" lims:id="1021767"><Label>(1)</Label><Text>The holder of an establishment licence that is not suspended shall submit an application for the review of their licence to the Minister before April 1 of each year and include with it the information and documents referred to in section 45.</Text></Subsection><Subsection lims:inforce-start-date="2011-04-01" lims:fid="1021768" lims:id="1021768"><Label>(2)</Label><Text>The Minister shall conduct an annual review of the licence on the basis of the information and documents submitted by the holder and any other relevant information in the Minister’s possession.</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2011-04-01" lims:fid="1021770" lims:id="1021770">SOR/2011-82, s. 2</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-12-29" lims:fid="1021771" lims:id="1021771" level="3"><TitleText>Refusal</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1021772" lims:id="1021772"><Label>47</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1021773" lims:id="1021773"><Label>(1)</Label><Text>The Minister may refuse to issue an establishment licence if the applicant has made a false or misleading statement in the application.</Text></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1021774" lims:id="1021774"><Label>(2)</Label><Text>The Minister shall refuse to issue an establishment licence if the Minister has reasonable grounds to believe that issuing such a licence would constitute a risk to the health or safety of patients, users or other persons.</Text></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1021775" lims:id="1021775"><Label>(3)</Label><Text>If the Minister refuses to issue an establishment licence, the Minister shall</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021776" lims:id="1021776"><Label>(a)</Label><Text>notify the applicant in writing of the reasons for the refusal; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021777" lims:id="1021777"><Label>(b)</Label><Text>give the applicant an opportunity to be heard.</Text></Paragraph></Subsection></Section><Heading lims:inforce-start-date="2018-12-29" lims:fid="1021778" lims:id="1021778" level="3"><TitleText>Notification</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1021779" lims:id="1021779"><Label>48</Label><Text>If, following the issuance of an establishment licence, there is a change to any of the information submitted in accordance with paragraph 45(a) or (b), the holder of the establishment licence shall submit the new information to the Minister within 15 days of the change.</Text></Section><Heading lims:inforce-start-date="2018-12-29" lims:fid="1021780" lims:id="1021780" level="3"><TitleText>Suspension</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1021781" lims:id="1021781"><Label>49</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1021782" lims:id="1021782"><Label>(1)</Label><Text>Subject to subsection (3), the Minister may suspend an establishment licence if the Minister has reasonable grounds to believe that</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021783" lims:id="1021783"><Label>(a)</Label><Text>the licensee has contravened these Regulations or any provision of the Act relating to medical devices;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021784" lims:id="1021784"><Label>(b)</Label><Text>the licensee has made a false or misleading statement in the application; or</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021785" lims:id="1021785"><Label>(c)</Label><Text>failure to suspend the establishment licence would constitute a risk to the health or safety of patients, users or other persons.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1021786" lims:id="1021786"><Label>(2)</Label><Text>Before suspending an establishment licence, the Minister shall consider</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021787" lims:id="1021787"><Label>(a)</Label><Text>the licensee’s history of compliance with these Regulations and with the provisions of the Act relating to medical devices; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021788" lims:id="1021788"><Label>(b)</Label><Text>the risk that allowing the licence to continue to be in force would constitute for the health or safety of patients, users or other persons.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1021789" lims:id="1021789"><Label>(3)</Label><Text>Subject to section 50, the Minister shall not suspend an establishment licence until</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021790" lims:id="1021790"><Label>(a)</Label><Text>the Minister has sent the licensee a written notice that sets out the reason for the proposed suspension, any corrective action required to be taken and the time within which it must be taken;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021791" lims:id="1021791"><Label>(b)</Label><Text>if corrective action is required, the time set out in the notice has passed without the action having been taken; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021792" lims:id="1021792"><Label>(c)</Label><Text>the licensee has been given an opportunity to be heard in respect of the suspension.</Text></Paragraph></Subsection></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2021-03-31" lims:fid="1021793" lims:id="1021793"><Label>50</Label><Subsection lims:inforce-start-date="2021-03-31" lims:enacted-date="2021-03-18" lims:fid="1021794" lims:id="1289990"><Label>(1)</Label><Text>The Minister may suspend an establishment licence without giving the licensee an opportunity to be heard if it is necessary to do so to prevent risk to the health or safety of patients, users or other persons, by giving the licensee a notice in writing that states the reason for the suspension.</Text></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1021795" lims:id="1021795"><Label>(2)</Label><Text>A licensee may ask the Minister, in writing, that the suspension be reconsidered.</Text></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1021796" lims:id="1021796"><Label>(3)</Label><Text>The Minister shall, within 45 days after the date of receiving the request, provide the licensee with an opportunity to be heard.</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2021-03-31" lims:enacted-date="2021-03-18" lims:fid="1289989" lims:id="1289989" lims:enactId="1288922">SOR/2021-46, s. 12(E)</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2011-04-01" lims:lastAmendedDate="2011-04-01" lims:fid="1021797" lims:id="1021797"><Label>51</Label><Text>The Minister shall reinstate an establishment licence if the situation that gave rise to the suspension has been corrected or if the reason for the suspension was unfounded.</Text><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2011-04-01" lims:fid="1021799" lims:id="1021799">SOR/2011-82, s. 3</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-12-29" lims:fid="1021800" lims:id="1021800" level="3"><TitleText>Cancellation</TitleText></Heading><Section lims:inforce-start-date="2011-04-01" lims:lastAmendedDate="2011-04-01" lims:fid="1021801" lims:id="1021801"><Label>51.1</Label><Text>The Minister shall cancel an establishment licence in either of the following circumstances:</Text><Paragraph lims:inforce-start-date="2011-04-01" lims:fid="1021802" lims:id="1021802"><Label>(a)</Label><Text>the licence has been suspended for a period of more than 12 months, or</Text></Paragraph><Paragraph lims:inforce-start-date="2011-04-01" lims:fid="1021803" lims:id="1021803"><Label>(b)</Label><Text>the licence holder has failed to submit an application for the review of their licence in accordance with subsection 46.1(1).</Text></Paragraph><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2011-04-01" lims:fid="1021805" lims:id="1021805">SOR/2011-82, s. 3</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-12-29" lims:fid="1021806" lims:id="1021806" level="2"><TitleText>Distribution Records</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1021807" lims:id="1021807"><Label>52</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1021808" lims:id="1021808"><Label>(1)</Label><Text>The manufacturer, importer and distributor of a medical device shall each maintain a distribution record in respect of each device.</Text></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1021809" lims:id="1021809"><Label>(2)</Label><Text>Subsection (1) does not apply to</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021810" lims:id="1021810"><Label>(a)</Label><Text>a retailer; or</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021811" lims:id="1021811"><Label>(b)</Label><Text>a health care facility in respect of a medical device that is distributed for use within that facility.</Text></Paragraph></Subsection></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1021812" lims:id="1021812"><Label>53</Label><Text>The distribution record shall contain sufficient information to permit complete and rapid withdrawal of the medical device from the market.</Text></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1021813" lims:id="1021813"><Label>54</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1021814" lims:id="1021814"><Label>(1)</Label><Text>The distribution record maintained by a manufacturer of an implant shall also contain a record of the information received on the implant registration cards forwarded to the manufacturer from a health care facility pursuant to section 67.</Text></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1021815" lims:id="1021815"><Label>(2)</Label><Text>The manufacturer of an implant shall update the information referred to in subsection (1) in accordance with any information received from the health care facility or the patient.</Text></Subsection></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1021816" lims:id="1021816"><Label>55</Label><Text>The manufacturer, importer and distributor shall retain the distribution record maintained in respect of a medical device for the longer of</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021817" lims:id="1021817"><Label>(a)</Label><Text>the projected useful life of the device, and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021818" lims:id="1021818"><Label>(b)</Label><Text>two years after the date the device is shipped.</Text></Paragraph></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1021819" lims:id="1021819"><Label>56</Label><Text>Distribution records shall be maintained in a manner that will allow their timely retrieval.</Text></Section><Heading lims:inforce-start-date="2018-12-29" lims:fid="1021820" lims:id="1021820" level="2"><TitleText>Complaint Handling</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1021821" lims:id="1021821"><Label>57</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1021822" lims:id="1021822"><Label>(1)</Label><Text>The manufacturer, importer and distributor of a medical device shall each maintain records of the following:</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021823" lims:id="1021823"><Label>(a)</Label><Text>reported problems relating to the performance characteristics or safety of the device, including any consumer complaints, received by the manufacturer, importer or distributor after the device was first sold in Canada; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021824" lims:id="1021824"><Label>(b)</Label><Text>all actions taken by the manufacturer, importer or distributor in response to the problems referred to in paragraph (a).</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1021825" lims:id="1021825"><Label>(2)</Label><Text>Subsection (1) does not apply to</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021826" lims:id="1021826"><Label>(a)</Label><Text>a retailer; or</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021827" lims:id="1021827"><Label>(b)</Label><Text>a health care facility in respect of a medical device that is distributed for use within that facility.</Text></Paragraph></Subsection></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1021828" lims:id="1021828"><Label>58</Label><Text>The manufacturer, importer and distributor of a medical device shall each establish and implement documented procedures that will enable the manufacturer, importer or distributor to carry out</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021829" lims:id="1021829"><Label>(a)</Label><Text>an effective and timely investigation of the problems referred to in paragraph 57(1)(a); and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021830" lims:id="1021830"><Label>(b)</Label><Text>an effective and timely recall of the device.</Text></Paragraph></Section><Heading lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1021831" lims:id="1300792" level="2"><TitleText>Incident Reporting</TitleText><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1300794" lims:id="1300794" lims:enactId="1278682">SOR/2020-262, s. 13</HistoricalNoteSubItem></HistoricalNote></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2021-06-23" lims:fid="1021832" lims:id="1021832"><Label>59</Label><Subsection lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1021833" lims:id="1300796"><Label>(1)</Label><Text>The manufacturer and the importer of a medical device shall each make a preliminary and a final report to the Minister concerning any incident that comes to their attention occurring in Canada that involves the device if</Text><Paragraph lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1300797" lims:id="1300797"><Label>(a)</Label><Text>the device is sold in Canada; and</Text></Paragraph><Paragraph lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1300798" lims:id="1300798"><Label>(b)</Label><Text>the incident</Text><Subparagraph lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1300799" lims:id="1300799"><Label>(i)</Label><Text>is related to a failure of the device or a deterioration in its effectiveness or any inadequacy in its labelling or in its directions for use, and</Text></Subparagraph><Subparagraph lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1300800" lims:id="1300800"><Label>(ii)</Label><Text>has led to the death or a serious deterioration in the state of health of a patient, user or other person, or could do so were the incident to recur.</Text></Subparagraph></Paragraph></Subsection><Subsection lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1300795" lims:id="1300795"><Label>(1.1)</Label><Text>Subject to subsection (2), the manufacturer and the importer of a Class I medical device shall each make a preliminary and a final report to the Minister concerning any incident that comes to their attention occurring outside Canada that involves the device if the conditions in paragraphs (1)(a) and (b) are met.</Text></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1021836" lims:id="1021836"><Label>(2)</Label><Text>The requirement to report an incident that occurs outside Canada does not apply unless the manufacturer has indicated, to a regulatory agency of the country in which the incident occurred, the manufacturer’s intention to take corrective action, or unless the regulatory agency has required the manufacturer to take corrective action.</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1300802" lims:id="1300802" lims:enactId="1278684">SOR/2020-262, s. 14</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1021837" lims:id="1021837"><Label>60</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1021838" lims:id="1021838"><Label>(1)</Label><Text>A preliminary report shall be submitted to the Minister</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021839" lims:id="1021839"><Label>(a)</Label><Text>in respect of an incident that occurs in Canada</Text><Subparagraph lims:inforce-start-date="2006-03-22" lims:fid="1021840" lims:id="1021840"><Label>(i)</Label><Text>within 10 days after the manufacturer or importer of a medical device becomes aware of an incident, if the incident has led to the death or a serious deterioration in the state of health of a patient, user or other person, or</Text></Subparagraph><Subparagraph lims:inforce-start-date="2006-03-22" lims:fid="1021841" lims:id="1021841"><Label>(ii)</Label><Text>within 30 days after the manufacturer or importer of a medical device becomes aware of an incident, if the incident has not led to the death or a serious deterioration in the state of health of a patient, user or other person, but could do so were it to recur; and</Text></Subparagraph></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021842" lims:id="1021842"><Label>(b)</Label><Text>in respect of an incident that occurs outside Canada, as soon as possible after the manufacturer has indicated, to the regulatory agency referred to in paragraph 59(2), the manufacturer’s intention to take corrective action, or after the regulatory agency has required the manufacturer to take corrective action.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1021843" lims:id="1021843"><Label>(2)</Label><Text>The preliminary report shall contain the following information:</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021844" lims:id="1021844"><Label>(a)</Label><Text>the name of the device and its identifier, including the identifier of any medical device that is part of a system, test kit, medical device group, medical device family or medical device group family;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021845" lims:id="1021845"><Label>(b)</Label><Text>if the report is made by</Text><Subparagraph lims:inforce-start-date="2006-03-22" lims:fid="1021846" lims:id="1021846"><Label>(i)</Label><Text>the manufacturer, the name and address of that manufacturer and of any known importer, and the name, title and telephone and facsimile numbers of a representative of the manufacturer to contact for any information concerning the incident, or</Text></Subparagraph><Subparagraph lims:inforce-start-date="2006-03-22" lims:fid="1021847" lims:id="1021847"><Label>(ii)</Label><Text>the importer of the device, the name and address of the importer and of the manufacturer, and the name, title and telephone and facsimile numbers of a representative of the importer to contact for any information concerning the incident;</Text></Subparagraph></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021848" lims:id="1021848"><Label>(c)</Label><Text>the date on which the incident came to the attention of the manufacturer or importer;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021849" lims:id="1021849"><Label>(d)</Label><Text>the details known in respect of the incident, including the date on which the incident occurred and the consequences for the patient, user or other person;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021850" lims:id="1021850"><Label>(e)</Label><Text>the name, address and telephone number, if known, of the person who reported the incident to the manufacturer or importer;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021851" lims:id="1021851"><Label>(f)</Label><Text>the identity of any other medical devices or accessories involved in the incident, if known;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021852" lims:id="1021852"><Label>(g)</Label><Text>the manufacturer’s or importer’s preliminary comments with respect to the incident;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021853" lims:id="1021853"><Label>(h)</Label><Text>the course of action, including an investigation, that the manufacturer or importer proposes to follow in respect of the incident and a timetable for carrying out any proposed action and for submitting a final report; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021854" lims:id="1021854"><Label>(i)</Label><Text>a statement indicating whether a previous report has been made to the Minister with respect to the device and, if so, the date of the report.</Text></Paragraph></Subsection></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2023-11-24" lims:fid="1021855" lims:id="1021855"><Label>61</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1021856" lims:id="1021856"><Label>(1)</Label><Text>After the preliminary report is made in accordance with section 60, a final report shall be submitted to the Minister in accordance with the timetable established under paragraph 60(2)(h).</Text></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1021857" lims:id="1021857"><Label>(2)</Label><Text>The final report shall contain the following information:</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021858" lims:id="1021858"><Label>(a)</Label><Text>a description of the incident, including the number of persons who have experienced a serious deterioration in the state of their health or who have died;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021859" lims:id="1021859"><Label>(b)</Label><Text>a detailed explanation of the cause of the incident and a justification for the actions taken in respect of the incident; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021860" lims:id="1021860"><Label>(c)</Label><Text lims:inforce-start-date="2023-11-24" lims:enacted-date="2023-11-24" lims:fid="1429205" lims:id="1429452">any actions taken as a result of the investigation referred to in paragraph 60(2)(h), which may include</Text><Subparagraph lims:inforce-start-date="2006-03-22" lims:fid="1021861" lims:id="1021861"><Label>(i)</Label><Text>increased post-market surveillance of the device,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2006-03-22" lims:fid="1021862" lims:id="1021862"><Label>(ii)</Label><Text>corrective and preventive action respecting the design and manufacture of the device, and</Text></Subparagraph><Subparagraph lims:inforce-start-date="2006-03-22" lims:fid="1021863" lims:id="1021863"><Label>(iii)</Label><Text>recall of the device.</Text></Subparagraph></Paragraph></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2006-03-22" lims:fid="1021865" lims:id="1021865">SOR/2002-190, s. 5</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2023-11-24" lims:enacted-date="2023-11-24" lims:fid="1429455" lims:id="1429455" lims:enactId="1429000">SOR/2023-247, s. 9</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2021-06-23" lims:fid="1021866" lims:id="1021866"><Label>61.1</Label><Subsection lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1021867" lims:id="1300803"><Label>(1)</Label><Text>Despite subsection 59(1) or (1.1), the manufacturer of a medical device may permit the importer of the device to prepare and submit the preliminary and final reports on the manufacturer’s behalf if the information that the manufacturer and the importer must include is identical.</Text></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1021868" lims:id="1021868"><Label>(2)</Label><Text>The manufacturer shall advise the Minister in writing if the manufacturer has permitted the importer to prepare and submit the reports on the manufacturer’s behalf.</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2006-03-22" lims:fid="1021870" lims:id="1021870">SOR/2002-190, s. 5</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1300804" lims:id="1300804" lims:enactId="1278686">SOR/2020-262, s. 15</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1300805" lims:id="1300805" level="2"><TitleText>Serious Risk of Injury to Human Health</TitleText></Heading><Section lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:lastAmendedDate="2023-02-22" lims:fid="1300806" lims:id="1300806"><Label>61.2</Label><Subsection lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1300807" lims:id="1300807"><Label>(1)</Label><Text>This section applies to a holder of one of the following therapeutic product authorizations:</Text><Paragraph lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1300808" lims:id="1300808"><Label>(a)</Label><Text>a medical device licence; and</Text></Paragraph><Paragraph lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1300809" lims:id="1300809"><Label>(b)</Label><Text>an establishment licence to import Class II, III or IV medical devices.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1300810" lims:id="1300810"><Label>(2)</Label><Text>The holder of a therapeutic product authorization issued in respect of a medical device shall submit to the Minister information in respect of any serious risk of injury to human health that the holder receives or becomes aware of and that is relevant to the safety of the device, regarding</Text><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1300811" lims:id="1391354"><Label>(a)</Label><Text>risks that have been communicated by any regulatory agency that is set out in the <XRefExternal reference-type="other">List of Regulatory Agencies for the Purposes of Sections 61.2 and 68.3 of the Medical Devices Regulations</XRefExternal>, published by the Government of Canada on its website, as amended from time to time, or by any person who is authorized to manufacture or sell a medical device within the jurisdiction of such a regulatory agency, and the manner of the communication;</Text></Paragraph><Paragraph lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1300812" lims:id="1300812"><Label>(b)</Label><Text>changes that have been made to the labelling of any medical device and that have been communicated to or requested by any regulatory agency that is set out in the list referred to in paragraph (a); and</Text></Paragraph><Paragraph lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1300813" lims:id="1300813"><Label>(c)</Label><Text>recalls, reassessments and suspensions or revocations of authorizations, including licences, in respect of any medical device, that have taken place within the jurisdiction of any regulatory agency that is set out in the list referred to in paragraph (a).</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1300814" lims:id="1300814"><Label>(3)</Label><Text>The information shall be submitted to the Minister within 72 hours after the holder receives or becomes aware of it, whichever occurs first.</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1300816" lims:id="1300816" lims:enactId="1278688">SOR/2020-262, s. 16</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391355" lims:id="1391355" lims:enactId="1390885">SOR/2023-19, s. 2</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:lastAmendedDate="2021-06-23" lims:fid="1300817" lims:id="1300817"><Label>61.3</Label><Subsection lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1300818" lims:id="1300818"><Label>(1)</Label><Text>Despite subsection 61.2(2), if the holder of a therapeutic product authorization issued in respect of a medical device is the manufacturer, they may permit the importer of the device to submit the information required under that subsection on the manufacturer’s behalf if the information that the manufacturer and the importer must submit is identical.</Text></Subsection><Subsection lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1300819" lims:id="1300819"><Label>(2)</Label><Text>The manufacturer shall advise the Minister in writing if the manufacturer has permitted the importer to submit the information on the manufacturer’s behalf.</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1300821" lims:id="1300821" lims:enactId="1278688">SOR/2020-262, s. 16</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2021-12-23" lims:enacted-date="2020-12-04" lims:fid="1335370" lims:id="1335370" level="2"><TitleText>Summary Report</TitleText></Heading><Section lims:inforce-start-date="2021-12-23" lims:enacted-date="2020-12-04" lims:lastAmendedDate="2023-02-22" lims:fid="1335371" lims:id="1335371"><Label>61.4</Label><Subsection lims:inforce-start-date="2021-12-23" lims:enacted-date="2020-12-04" lims:fid="1335372" lims:id="1335372"><Label>(1)</Label><Text>The holder of a medical device licence shall prepare</Text><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1335373" lims:id="1391356"><Label>(a)</Label><Text>in the case of a Class II medical device, on a biennial basis, a summary report of the information referred to in subsection (2) that the holder received or became aware of during the previous 24 months; and</Text></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1335374" lims:id="1391357"><Label>(b)</Label><Text>in the case of a Class III or IV medical device, on an annual basis, a summary report of the information referred to in subsection (2) that the holder received or became aware of during the previous 12 months.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2021-12-23" lims:enacted-date="2020-12-04" lims:fid="1335375" lims:id="1335375"><Label>(2)</Label><Text lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1390986" lims:id="1391358">The information to be covered by the summary report is that in respect of</Text><Paragraph lims:inforce-start-date="2021-12-23" lims:enacted-date="2020-12-04" lims:fid="1335376" lims:id="1335376"><Label>(a)</Label><Text>adverse effects;</Text></Paragraph><Paragraph lims:inforce-start-date="2021-12-23" lims:enacted-date="2020-12-04" lims:fid="1335377" lims:id="1335377"><Label>(b)</Label><Text>problems referred to in paragraph 57(1)(a);</Text></Paragraph><Paragraph lims:inforce-start-date="2021-12-23" lims:enacted-date="2020-12-04" lims:fid="1335378" lims:id="1335378"><Label>(c)</Label><Text>incidents referred to in subsection 59(1); and</Text></Paragraph><Paragraph lims:inforce-start-date="2021-12-23" lims:enacted-date="2020-12-04" lims:fid="1335379" lims:id="1335379"><Label>(d)</Label><Text>serious risks of injury to human health that are relevant to the safety of the medical device and are referred to in subsection 61.2(2).</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1335380" lims:id="1391359"><Label>(3)</Label><Text>The summary report shall contain a concise critical analysis of the information referred to in subsection (2).</Text></Subsection><Subsection lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1335381" lims:id="1391360"><Label>(4)</Label><Text>In preparing the summary report, the holder shall determine, on the basis of the critical analysis, whether what is known about the benefits and risks associated with the medical device has changed in any of the following ways:</Text><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391361" lims:id="1391361"><Label>(a)</Label><Text>the potential benefits for patients through the use of the device may be less;</Text></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391362" lims:id="1391362"><Label>(b)</Label><Text>in respect of each of the risks,</Text><Subparagraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391363" lims:id="1391363"><Label>(i)</Label><Text>the harm associated with the risk is more likely to occur, or</Text></Subparagraph><Subparagraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391364" lims:id="1391364"><Label>(ii)</Label><Text>if the harm associated with the risk occurs, the consequences for the health or safety of patients, users or other persons could be more serious; and</Text></Subparagraph></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391365" lims:id="1391365"><Label>(c)</Label><Text>a new risk has been identified.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1335387" lims:id="1391366"><Label>(5)</Label><Text>The holder shall include the conclusions they reach under subsection (4) in the summary report.</Text></Subsection><Subsection lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1335388" lims:id="1391367"><Label>(6)</Label><Text>If, in preparing the summary report, the holder concludes that what is known about the benefits and risks associated with the medical device has changed in any of the ways referred to in paragraphs (4)(a) to (c), they shall notify the Minister, in writing, within 72 hours after having reached the conclusion, unless that has already been done.</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2021-12-23" lims:enacted-date="2020-12-04" lims:fid="1335390" lims:id="1335390" lims:enactId="1278688">SOR/2020-262, s. 16</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391368" lims:id="1391368" lims:enactId="1390887">SOR/2023-19, s. 3</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2021-12-23" lims:enacted-date="2020-12-04" lims:lastAmendedDate="2023-02-22" lims:fid="1335391" lims:id="1335391"><Label>61.5</Label><Subsection lims:inforce-start-date="2021-12-23" lims:enacted-date="2020-12-04" lims:fid="1335392" lims:id="1335392"><Label>(1)</Label><Text lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1390987" lims:id="1391369">The Minister may, for the purposes of determining whether a medical device meets the applicable requirements of sections 10 to 20, request that the holder of a medical device licence issued in respect of the device submit, within a specified time limit, any of the following:</Text><Paragraph lims:inforce-start-date="2021-12-23" lims:enacted-date="2020-12-04" lims:fid="1335393" lims:id="1335393"><Label>(a)</Label><Text>summary reports; or</Text></Paragraph><Paragraph lims:inforce-start-date="2021-12-23" lims:enacted-date="2020-12-04" lims:fid="1335394" lims:id="1335394"><Label>(b)</Label><Text>information on the basis of which summary reports were prepared.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1335395" lims:id="1391370"><Label>(2)</Label><Text>The holder shall submit to the Minister the summary reports or information, or both, that the Minister requests within the time limit specified in the request.</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2021-12-23" lims:enacted-date="2020-12-04" lims:fid="1335397" lims:id="1335397" lims:enactId="1278688">SOR/2020-262, s. 16</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391371" lims:id="1391371" lims:enactId="1390900">SOR/2023-19, s. 4</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2021-12-23" lims:enacted-date="2020-12-04" lims:lastAmendedDate="2023-02-22" lims:fid="1335398" lims:id="1335398"><Label>61.6</Label><Subsection lims:inforce-start-date="2021-12-23" lims:enacted-date="2020-12-04" lims:fid="1335399" lims:id="1335399"><Label>(1)</Label><Text>The holder of a medical device licence shall maintain records of the summary reports and the information on the basis of which those reports were prepared.</Text></Subsection><Subsection lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1335400" lims:id="1391372"><Label>(2)</Label><Text>The holder shall retain the records for seven years after the day on which they were created.</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2021-12-23" lims:enacted-date="2020-12-04" lims:fid="1335402" lims:id="1335402" lims:enactId="1278688">SOR/2020-262, s. 16</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391373" lims:id="1391373" lims:enactId="1390905">SOR/2023-19, s. 5</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2019-12-16" lims:enacted-date="2019-06-10" lims:fid="1210428" lims:id="1210428" level="2"><TitleText>Provision of Information Under Section 21.8 of Act</TitleText></Heading><Section lims:inforce-start-date="2019-12-16" lims:enacted-date="2019-06-10" lims:lastAmendedDate="2019-12-16" lims:fid="1021871" lims:id="1210430"><Label>62</Label><Subsection lims:inforce-start-date="2019-12-16" lims:enacted-date="2019-06-10" lims:fid="1210431" lims:id="1210431"><Label>(1)</Label><Text>For the purposes of section 21.8 of the Act, hospitals are the prescribed health care institutions that shall provide information that is in their control to the Minister about a medical device incident.</Text></Subsection><Subsection lims:inforce-start-date="2019-12-16" lims:enacted-date="2019-06-10" lims:fid="1210432" lims:id="1210432"><Label>(2)</Label><Text>The following prescribed information about a medical device incident that is in a hospital’s control shall be provided to the Minister in writing within 30 days after the day on which the medical device incident is first documented within the hospital:</Text><Paragraph lims:inforce-start-date="2019-12-16" lims:enacted-date="2019-06-10" lims:fid="1210433" lims:id="1210433"><Label>(a)</Label><Text>the name of the hospital and the contact information of a representative of that hospital;</Text></Paragraph><Paragraph lims:inforce-start-date="2019-12-16" lims:enacted-date="2019-06-10" lims:fid="1210434" lims:id="1210434"><Label>(b)</Label><Text>the name or identifier of the medical device;</Text></Paragraph><Paragraph lims:inforce-start-date="2019-12-16" lims:enacted-date="2019-06-10" lims:fid="1210435" lims:id="1210435"><Label>(c)</Label><Text>the date on which the medical device incident was first documented;</Text></Paragraph><Paragraph lims:inforce-start-date="2019-12-16" lims:enacted-date="2019-06-10" lims:fid="1210436" lims:id="1210436"><Label>(d)</Label><Text>the name of the manufacturer of the medical device;</Text></Paragraph><Paragraph lims:inforce-start-date="2019-12-16" lims:enacted-date="2019-06-10" lims:fid="1210437" lims:id="1210437"><Label>(e)</Label><Text>a description of the medical device incident;</Text></Paragraph><Paragraph lims:inforce-start-date="2019-12-16" lims:enacted-date="2019-06-10" lims:fid="1210438" lims:id="1210438"><Label>(f)</Label><Text>the lot number of the device or its serial number;</Text></Paragraph><Paragraph lims:inforce-start-date="2019-12-16" lims:enacted-date="2019-06-10" lims:fid="1210439" lims:id="1210439"><Label>(g)</Label><Text>any contributing factors to the medical device incident, including any medical condition of the patient that directly relates to the medical device incident; and</Text></Paragraph><Paragraph lims:inforce-start-date="2019-12-16" lims:enacted-date="2019-06-10" lims:fid="1210440" lims:id="1210440"><Label>(h)</Label><Text>the effect of the medical device incident on the patient’s health.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2019-12-16" lims:enacted-date="2019-06-10" lims:fid="1210441" lims:id="1210441"><Label>(3)</Label><Text>A hospital is exempt from section 21.8 of the Act in respect of the reporting of information referred to in subsection (2) if</Text><Paragraph lims:inforce-start-date="2019-12-16" lims:enacted-date="2019-06-10" lims:fid="1210442" lims:id="1210442"><Label>(a)</Label><Text>the hospital does not have in its control all of the information referred to in paragraphs (2)(b) and (e) in respect of the medical device incident; or</Text></Paragraph><Paragraph lims:inforce-start-date="2019-12-16" lims:enacted-date="2019-06-10" lims:fid="1210443" lims:id="1210443"><Label>(b)</Label><Text>the medical device incident involves only a medical device that is the subject of an authorization issued under subsection 72(1) or 83(1).</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2019-12-16" lims:enacted-date="2019-06-10" lims:fid="1210444" lims:id="1210444"><Label>(4)</Label><Text>The following definitions apply in this section.</Text><Definition lims:inforce-start-date="2019-12-16" lims:enacted-date="2019-06-10" lims:fid="1210445" lims:id="1210445"><Text><DefinedTermEn>hospital</DefinedTermEn> means a facility</Text><Paragraph lims:inforce-start-date="2019-12-16" lims:enacted-date="2019-06-10" lims:fid="1210446" lims:id="1210446"><Label>(a)</Label><Text>that is licensed, approved or designated as a hospital by a province in accordance with the laws of the province to provide care or treatment to persons suffering from any form of disease or illness; or</Text></Paragraph><Paragraph lims:inforce-start-date="2019-12-16" lims:enacted-date="2019-06-10" lims:fid="1210447" lims:id="1210447"><Label>(b)</Label><Text>that is operated by the Government of Canada and that provides health services to in-patients. (<DefinedTermFr>hôpital</DefinedTermFr>)</Text></Paragraph></Definition><Definition lims:inforce-start-date="2019-12-16" lims:enacted-date="2019-06-10" lims:fid="1210448" lims:id="1210448"><Text><DefinedTermEn>medical device incident</DefinedTermEn> means an incident related to a failure of a medical device, a deterioration in its effectiveness or any inadequacy in its labelling or in its directions for use that has led to the death or a serious deterioration in the state of health of a patient, user or other person or could do so were it to recur. (<DefinedTermFr>incident lié à un instrument médical</DefinedTermFr>)</Text></Definition></Subsection><Subsection lims:inforce-start-date="2019-12-16" lims:enacted-date="2019-06-10" lims:fid="1210449" lims:id="1210449"><Label>(5)</Label><Text>For the purposes of the Act, <DefinitionRef>medical device incident</DefinitionRef> has the same meaning as in subsection (4).</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2019-12-16" lims:enacted-date="2019-06-10" lims:fid="1210451" lims:id="1210451" lims:enactId="1139206">SOR/2019-191, s. 1</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1300822" lims:id="1300822" level="2"><TitleText>Assessments Ordered Under Section 21.31 of the Act</TitleText></Heading><Section lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:lastAmendedDate="2021-06-23" lims:fid="1300823" lims:id="1300823"><Label>62.1</Label><Subsection lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1300824" lims:id="1300824"><Label>(1)</Label><Text>The Minister’s power to make an order under section 21.31 of the Act in respect of a medical device is subject to the following conditions:</Text><Paragraph lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1300825" lims:id="1300825"><Label>(a)</Label><Text>the person to whom the order is made shall be the holder of a medical device licence issued in respect of the device; and</Text></Paragraph><Paragraph lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1300826" lims:id="1300826"><Label>(b)</Label><Text>the Minister shall have reasonable grounds to believe that the benefits — or the risks to the health or safety of patients, users or other persons — that are associated with the device are significantly different than they were when the medical device licence was issued or amended.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1300827" lims:id="1300827"><Label>(2)</Label><Text>The Minister shall, after examining the results of an assessment that was ordered under section 21.31 of the Act in respect of a medical device,</Text><Paragraph lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1300828" lims:id="1300828"><Label>(a)</Label><Text>provide the holder of the medical device licence issued in respect of the device with the results of the examination; and</Text></Paragraph><Paragraph lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1300829" lims:id="1300829"><Label>(b)</Label><Text>ensure that a summary of the results of the examination, together with a description of any steps that the Minister has taken or may take as a consequence of the examination, is published on the Government of Canada website.</Text></Paragraph></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1300831" lims:id="1300831" lims:enactId="1278690">SOR/2020-262, s. 17</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1300832" lims:id="1300832" level="2"><TitleText>Activities Ordered Under Section 21.32 of the Act</TitleText></Heading><Section lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:lastAmendedDate="2021-06-23" lims:fid="1300833" lims:id="1300833"><Label>62.2</Label><Text>The Minister’s power to make an order under section 21.32 of the Act in respect of a medical device is subject to the following conditions:</Text><Paragraph lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1300834" lims:id="1300834"><Label>(a)</Label><Text>the person to whom the order is made shall be the holder of a medical device licence issued in respect of the device;</Text></Paragraph><Paragraph lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1300835" lims:id="1300835"><Label>(b)</Label><Text>the Minister shall have reasonable grounds to believe that</Text><Subparagraph lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1300836" lims:id="1300836"><Label>(i)</Label><Text>there are significant uncertainties relating to the benefits or adverse effects associated with the device,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1300837" lims:id="1300837"><Label>(ii)</Label><Text>the licensee is unable to provide the Minister with information that is sufficient to manage those uncertainties, and</Text></Subparagraph><Subparagraph lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1300838" lims:id="1300838"><Label>(iii)</Label><Text>the applicable requirements of these Regulations, together with any terms and conditions that have been imposed on the medical device licence, do not allow for sufficient information to be obtained to manage those uncertainties; and</Text></Subparagraph></Paragraph><Paragraph lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1300839" lims:id="1300839"><Label>(c)</Label><Text>the Minister shall take into account the following matters:</Text><Subparagraph lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1300840" lims:id="1300840"><Label>(i)</Label><Text>whether the activities that the licensee will be ordered to undertake are feasible, and</Text></Subparagraph><Subparagraph lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1300841" lims:id="1300841"><Label>(ii)</Label><Text>whether there are less burdensome ways of obtaining additional information about the device’s effects on the health or safety of patients, users or other persons.</Text></Subparagraph></Paragraph><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1300843" lims:id="1300843" lims:enactId="1278690">SOR/2020-262, s. 17</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339847" lims:id="1339847" level="2"><TitleText>Shortages</TitleText></Heading><Section lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:lastAmendedDate="2022-03-02" lims:fid="1339848" lims:id="1339848"><Label>62.21</Label><Text>The following definitions apply in this section and in sections 62.22 to 62.26.</Text><Definition lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339849" lims:id="1339849"><Text><DefinedTermEn>List of Medical Devices – Notification of Shortages</DefinedTermEn> means the <XRefExternal reference-type="other">List of Medical Devices – Notification of Shortages</XRefExternal> that is published by the Government of Canada on its website, as amended from time to time. (<DefinedTermFr>Liste d’instruments médicaux – avis de pénuries</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339850" lims:id="1339850"><Text><DefinedTermEn>specified medical device</DefinedTermEn> means a medical device that belongs to a category of medical devices that is set out in the <XRefExternal reference-type="other">List of Medical Devices – Notification of Shortages</XRefExternal>. (<DefinedTermFr>instrument médical inscrit</DefinedTermFr>)</Text></Definition><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339852" lims:id="1339852" lims:enactId="1314957">SOR/2021-199, s. 7</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:lastAmendedDate="2022-03-02" lims:fid="1339853" lims:id="1339853"><Label>62.22</Label><Text>The Minister may add a category of medical devices to the <XRefExternal reference-type="other">List of Medical Devices – Notification of Shortages</XRefExternal> only if the Minister has reasonable grounds to believe that a shortage of a device that belongs to the category presents or may present a risk of injury to human health.</Text><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339855" lims:id="1339855" lims:enactId="1314957">SOR/2021-199, s. 7</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:lastAmendedDate="2023-02-22" lims:fid="1339856" lims:id="1339856"><Label>62.23</Label><Subsection lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339857" lims:id="1339857"><Label>(1)</Label><Text>Subject to subsections (2), (7) and (9), if a shortage of a specified medical device exists or is likely to occur, the manufacturer of the device and, in the case of a Class I device, the importer of the device shall each provide the following information to the Minister electronically in a format specified by or acceptable to the Minister:</Text><Paragraph lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339858" lims:id="1339858"><Label>(a)</Label><Text>the name and contact information of the manufacturer and, if the information is provided by the importer, the name and contact information of the importer;</Text></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1339859" lims:id="1391375"><Label>(b)</Label><Text>in the case of a licensed device, the medical device licence number;</Text></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391374" lims:id="1391374"><Label>(b.1)</Label><Text>in the case of a device for which the manufacturer holds an authorization issued under section 68.12, the authorization number;</Text></Paragraph><Paragraph lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339860" lims:id="1339860"><Label>(c)</Label><Text>the identifier of the device, including the identifier of any medical device that is part of a system, test kit, medical device group, medical device family or medical device group family;</Text></Paragraph><Paragraph lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339861" lims:id="1339861"><Label>(d)</Label><Text>the name of the device, including, if applicable, the model name, in English and French;</Text></Paragraph><Paragraph lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339862" lims:id="1339862"><Label>(e)</Label><Text>a description of the device and of its packaging and an indication of whether it is a single-use device;</Text></Paragraph><Paragraph lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339863" lims:id="1339863"><Label>(f)</Label><Text>the date when the shortage began or is anticipated to begin;</Text></Paragraph><Paragraph lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339864" lims:id="1339864"><Label>(g)</Label><Text>the anticipated date when the manufacturer will be able to meet the demand for the device if that date can be anticipated;</Text></Paragraph><Paragraph lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339865" lims:id="1339865"><Label>(h)</Label><Text>the reason for the shortage; and</Text></Paragraph><Paragraph lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339866" lims:id="1339866"><Label>(i)</Label><Text>a summary of the information that the manufacturer or importer relied on to determine that a shortage of the device exists or is likely to occur.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339867" lims:id="1339867"><Label>(2)</Label><Text>If the manufacturer of a specified medical device decides to discontinue the sale of the device in Canada, the following rules apply:</Text><Paragraph lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339868" lims:id="1339868"><Label>(a)</Label><Text>the manufacturer or importer is required to provide only the information referred to in paragraphs (1)(a) to (f) in respect of the shortage that results from the decision and shall also provide under subsection (1) the reason for the discontinuation; and</Text></Paragraph><Paragraph lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339869" lims:id="1339869"><Label>(b)</Label><Text>paragraph 4(a) does not apply to the manufacturer.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1339870" lims:id="1391376"><Label>(3)</Label><Text>For greater certainty, subsections (1) and (2) do not remove the requirement for</Text><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391377" lims:id="1391377"><Label>(a)</Label><Text>a manufacturer that is the holder of a medical device licence to inform the Minister under subsection 43(3); or</Text></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391378" lims:id="1391378"><Label>(b)</Label><Text>a manufacturer that is the holder of an authorization issued under section 68.12 to inform the Minister under section 68.25.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339871" lims:id="1339871"><Label>(4)</Label><Text>Subject to subsection (8), the information that is required under subsection (1) shall be provided</Text><Paragraph lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339872" lims:id="1339872"><Label>(a)</Label><Text>if the manufacturer or importer did not anticipate the shortage, within five business days after the day on which the manufacturer or importer becomes aware of it; and</Text></Paragraph><Paragraph lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339873" lims:id="1339873"><Label>(b)</Label><Text>if the manufacturer or importer anticipates that there will be a shortage, within five business days after the day on which the manufacturer or importer anticipates it.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339874" lims:id="1339874"><Label>(5)</Label><Text>If any of the information that was provided under subsection (1) changes, the manufacturer or importer shall provide the new information to the Minister electronically in a format specified by or acceptable to the Minister within two business days after the day on which the manufacturer or importer makes or becomes aware of the change.</Text></Subsection><Subsection lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339875" lims:id="1339875"><Label>(6)</Label><Text>Within two business days after the day on which the manufacturer is again able to meet the demand for the specified medical device, the manufacturer or importer shall notify the Minister electronically in a format specified by or acceptable to the Minister of the manufacturer’s ability to do so.</Text></Subsection><Subsection lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339876" lims:id="1339876"><Label>(7)</Label><Text>The manufacturer or importer need not provide the information that is required under subsection (1) if, within the applicable period referred to in paragraph (4)(a) or (b), the manufacturer or importer anticipates that the manufacturer will be able to meet the demand for the specified medical device within 30 days after the day on which the manufacturer or importer anticipated or became aware of the shortage.</Text></Subsection><Subsection lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339877" lims:id="1339877"><Label>(8)</Label><Text>Despite subsection (7), if the manufacturer or importer subsequently concludes that the manufacturer will be unable to meet the demand within the 30-day period, the manufacturer or the importer shall provide the information that is required under subsection (1) within five business days after the day on which the manufacturer or importer reaches that conclusion.</Text></Subsection><Subsection lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339878" lims:id="1339878"><Label>(9)</Label><Text>The manufacturer or importer need not provide the information that is required under subsection (1) if the manufacturer</Text><Paragraph lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339879" lims:id="1339879"><Label>(a)</Label><Text>is also the manufacturer of another medical device that can be substituted for the specified medical device in respect of which a shortage exists or is likely to occur; and</Text></Paragraph><Paragraph lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339880" lims:id="1339880"><Label>(b)</Label><Text>is able to meet the demand for the substitute medical device.</Text></Paragraph></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339882" lims:id="1339882" lims:enactId="1314957">SOR/2021-199, s. 7</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391379" lims:id="1391379" lims:enactId="1390907">SOR/2023-19, s. 6</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:lastAmendedDate="2022-03-02" lims:fid="1339883" lims:id="1339883"><Label>62.24</Label><Subsection lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339884" lims:id="1339884"><Label>(1)</Label><Text>Despite section 62.23, the manufacturer of a specified medical device may permit the importer of the device to provide the information that is required under that section on the manufacturer’s behalf if the information that the manufacturer and importer must provide is identical.</Text></Subsection><Subsection lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339885" lims:id="1339885"><Label>(2)</Label><Text>The manufacturer shall notify the Minister electronically in a format specified by or acceptable to the Minister if the manufacturer has permitted the importer to provide the information on the manufacturer’s behalf.</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339887" lims:id="1339887" lims:enactId="1314957">SOR/2021-199, s. 7</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:lastAmendedDate="2022-03-02" lims:fid="1339888" lims:id="1339888"><Label>62.25</Label><Subsection lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339889" lims:id="1339889"><Label>(1)</Label><Text>The Minister shall publish, on the Government of Canada website, the information that the Minister receives under section 62.23, other than the information referred to in subparagraph 62.23(1)(i).</Text></Subsection><Subsection lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339890" lims:id="1339890"><Label>(2)</Label><Text>Subsection (1) does not apply if the Minister has reasonable grounds to believe that a situation, in respect of which information was provided under section 62.23, does not constitute a shortage.</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339892" lims:id="1339892" lims:enactId="1314957">SOR/2021-199, s. 7</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:lastAmendedDate="2022-03-02" lims:fid="1339893" lims:id="1339893"><Label>62.26</Label><Subsection lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339894" lims:id="1339894"><Label>(1)</Label><Text>The Minister may request that the manufacturer of a medical device — or any importer or distributor of a medical device — provide the Minister with information that is in their control if the Minister has reasonable grounds to believe that</Text><Paragraph lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339895" lims:id="1339895"><Label>(a)</Label><Text>there is a shortage or risk of shortage of the device;</Text></Paragraph><Paragraph lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339896" lims:id="1339896"><Label>(b)</Label><Text>a shortage of the device presents or may present a risk of injury to human health;</Text></Paragraph><Paragraph lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339897" lims:id="1339897"><Label>(c)</Label><Text>the information is necessary to establish or assess</Text><Subparagraph lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339898" lims:id="1339898"><Label>(i)</Label><Text>the existence of a shortage or risk of shortage of the device,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339899" lims:id="1339899"><Label>(ii)</Label><Text>the reason for a shortage or risk of shortage of the device,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339900" lims:id="1339900"><Label>(iii)</Label><Text>the effects or potential effects on human health of a shortage of the device, or</Text></Subparagraph><Subparagraph lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339901" lims:id="1339901"><Label>(iv)</Label><Text>measures that could be taken to prevent or alleviate a shortage of the device; and</Text></Subparagraph></Paragraph><Paragraph lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339902" lims:id="1339902"><Label>(d)</Label><Text>the manufacturer, importer or distributor will not provide the information without a legal obligation to do so.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339903" lims:id="1339903"><Label>(2)</Label><Text>The manufacturer, importer or distributor shall provide the requested information electronically in a format specified by or acceptable to the Minister within the time limit specified by the Minister.</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339905" lims:id="1339905" lims:enactId="1314957">SOR/2021-199, s. 7</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:lastAmendedDate="2022-03-02" lims:fid="1339906" lims:id="1339906"><Label>62.27</Label><Text>The following definitions apply in this section and in sections 62.28 to 62.32.</Text><Definition lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339907" lims:id="1339907"><Text><DefinedTermEn>designated medical device</DefinedTermEn> means a medical device that is set out in the <XRefExternal reference-type="other">List of Medical Devices for Exceptional Importation and Sale</XRefExternal>. (<DefinedTermFr>instrument médical désigné</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339908" lims:id="1339908"><Text><DefinedTermEn>List of Medical Devices for Exceptional Importation and Sale</DefinedTermEn> means the <XRefExternal reference-type="other">List of Medical Devices for Exceptional Importation and Sale</XRefExternal> that is published by the Government of Canada on its website, as amended from time to time. (<DefinedTermFr>Liste d’instruments médicaux destinés aux importations et aux ventes exceptionnelles</DefinedTermFr>)</Text></Definition><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339910" lims:id="1339910" lims:enactId="1314957">SOR/2021-199, s. 7</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:lastAmendedDate="2022-03-02" lims:fid="1339911" lims:id="1339911"><Label>62.28</Label><Text>The Minister may add a medical device to the <XRefExternal reference-type="other">List of Medical Devices for Exceptional Importation and Sale</XRefExternal> only if the Minister has reasonable grounds to believe that</Text><Paragraph lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339912" lims:id="1339912"><Label>(a)</Label><Text>there is a shortage or risk of shortage of another medical device; and</Text></Paragraph><Paragraph lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339913" lims:id="1339913"><Label>(b)</Label><Text>the device to be added to that list can be substituted for the device referred to in paragraph (a).</Text></Paragraph><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339915" lims:id="1339915" lims:enactId="1314957">SOR/2021-199, s. 7</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:lastAmendedDate="2022-03-02" lims:fid="1339916" lims:id="1339916"><Label>62.29</Label><Text>The holder of an establishment licence may import a designated medical device if the following conditions are met:</Text><Paragraph lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339917" lims:id="1339917"><Label>(a)</Label><Text>the holder provides the Minister, electronically in a format specified by or acceptable to the Minister and not later than the fifth business day before the day on which the designated medical device is imported, with a notification that contains the following information:</Text><Subparagraph lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339918" lims:id="1339918"><Label>(i)</Label><Text>the holder’s name and contact information,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339919" lims:id="1339919"><Label>(ii)</Label><Text>in respect of the designated medical device,</Text><Clause lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339920" lims:id="1339920"><Label>(A)</Label><Text>its name and the name of each of its components, parts and accessories, including, if applicable, the model name,</Text></Clause><Clause lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339921" lims:id="1339921"><Label>(B)</Label><Text>its identifier, including the identifier of any medical device that is part of a system, test kit, medical device group, medical device family or medical device group family,</Text></Clause><Clause lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339922" lims:id="1339922"><Label>(C)</Label><Text>the name and contact information of the manufacturer of the device as it appears on the device label,</Text></Clause><Clause lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339923" lims:id="1339923"><Label>(D)</Label><Text>the name and address of the establishment where it is manufactured, if different from the information referred to in clause (C), and</Text></Clause><Clause lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339924" lims:id="1339924"><Label>(E)</Label><Text>a detailed description of the medical conditions, purposes and uses for which it is manufactured, sold or represented, as well as its performance specifications if those specifications are necessary for proper use,</Text></Clause></Subparagraph><Subparagraph lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339925" lims:id="1339925"><Label>(iii)</Label><Text>the intended port of entry into Canada,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339926" lims:id="1339926"><Label>(iv)</Label><Text>the estimated date of arrival of the shipment of the designated medical device, and</Text></Subparagraph><Subparagraph lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339927" lims:id="1339927"><Label>(v)</Label><Text>the total number of units of the designated medical device that are intended to be imported on the date referred to in subparagraph (iv);</Text></Subparagraph></Paragraph><Paragraph lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339928" lims:id="1339928"><Label>(b)</Label><Text>the designated medical device is authorized to be sold by a regulatory agency within its jurisdiction or, if the device is not required to be authorized by a regulatory agency within its jurisdiction, the device complies with the applicable legal requirements within its jurisdiction;</Text></Paragraph><Paragraph lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339929" lims:id="1339929"><Label>(c)</Label><Text>the following information is set out in the <XRefExternal reference-type="other">List of Medical Devices for Exceptional Importation and Sale</XRefExternal> in respect of the designated medical device:</Text><Subparagraph lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339930" lims:id="1339930"><Label>(i)</Label><Text>its name,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339931" lims:id="1339931"><Label>(ii)</Label><Text>its class,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339932" lims:id="1339932"><Label>(iii)</Label><Text>the name of its manufacturer,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339933" lims:id="1339933"><Label>(iv)</Label><Text>the establishment licence number of the holder,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339934" lims:id="1339934"><Label>(v)</Label><Text>the name of the regulatory agency referred to in paragraph (b), and</Text></Subparagraph><Subparagraph lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339935" lims:id="1339935"><Label>(vi)</Label><Text>the date after which it may no longer be imported;</Text></Subparagraph></Paragraph><Paragraph lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339936" lims:id="1339936"><Label>(d)</Label><Text>the total number of units of the designated medical device that the holder imports does not exceed the maximum limit specified in the list referred to in paragraph (c) in respect of the device, if applicable;</Text></Paragraph><Paragraph lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339937" lims:id="1339937"><Label>(e)</Label><Text>the designated medical device is imported on or before the date referred to in subparagraph (c)(vi); and</Text></Paragraph><Paragraph lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339938" lims:id="1339938"><Label>(f)</Label><Text>the holder has prepared a plan that specifies the measures to be taken in order for the holder to comply with section 62.32.</Text></Paragraph><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339940" lims:id="1339940" lims:enactId="1314957">SOR/2021-199, s. 7</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:lastAmendedDate="2022-03-02" lims:fid="1339941" lims:id="1339941"><Label>62.3</Label><Text>Sections 21 to 21.2 and 26 do not apply to the importation, under section 62.29, of a designated medical device by the holder of an establishment licence.</Text><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339943" lims:id="1339943" lims:enactId="1314957">SOR/2021-199, s. 7</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:lastAmendedDate="2022-03-02" lims:fid="1339944" lims:id="1339944"><Label>62.31</Label><Subsection lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339945" lims:id="1339945"><Label>(1)</Label><Text>The provisions of these Regulations — other than this section and sections 44 to 62.2, and 62.32 to 65.1 — do not apply to the sale of a designated medical device that is imported under section 62.29.</Text></Subsection><Subsection lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339946" lims:id="1339946"><Label>(2)</Label><Text>Subsection (1) ceases to apply to the sale of a designated medical device on the earlier of</Text><Paragraph lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339947" lims:id="1339947"><Label>(a)</Label><Text>the expiry date of the designated medical device, if the device has one, and</Text></Paragraph><Paragraph lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339948" lims:id="1339948"><Label>(b)</Label><Text>the end of the two-year period that begins on the day that follows the date referred to in subparagraph 62.29(c)(vi).</Text></Paragraph></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339950" lims:id="1339950" lims:enactId="1314957">SOR/2021-199, s. 7</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:lastAmendedDate="2022-03-02" lims:fid="1339951" lims:id="1339951"><Label>62.32</Label><Subsection lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339952" lims:id="1339952"><Label>(1)</Label><Text>The holder of an establishment licence shall not sell a designated medical device that they imported under section 62.29 unless they ensure that the information referred to in clause 62.29(a)(ii)(E) is available in English and French and in a manner that permits the safe use of the device.</Text></Subsection><Subsection lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339953" lims:id="1339953"><Label>(2)</Label><Text>Subject to subsection (3), the holder shall ensure that the information is available in accordance with subsection (1) until at least the end of the day on the latest expiry date of the designated medical devices that they imported.</Text></Subsection><Subsection lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339954" lims:id="1339954"><Label>(3)</Label><Text>If the designated medical device does not have an expiry date, the holder shall ensure that the information is available in accordance with subsection (1) until at least the expiration of the period that corresponds to the projected useful life of whichever of the devices that they imported has the latest projected useful life.</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2022-03-02" lims:enacted-date="2021-08-12" lims:fid="1339956" lims:id="1339956" lims:enactId="1314957">SOR/2021-199, s. 7</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-12-29" lims:fid="1021872" lims:id="1021872" level="2"><TitleText>Recall</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1021873" lims:id="1021873"><Label>63</Label><Text lims:inforce-start-date="2006-03-22" lims:fid="1458181" lims:id="1458181">Sections 64 and 65 do not apply to</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021874" lims:id="1021874"><Label>(a)</Label><Text>a retailer; or</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021875" lims:id="1021875"><Label>(b)</Label><Text>a health care facility in respect of a medical device that is distributed for use within that facility.</Text></Paragraph></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1021876" lims:id="1021876"><Label>64</Label><Text>The manufacturer and the importer of a medical device shall, on or before undertaking a recall of the device, each provide the Minister with the following:</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021877" lims:id="1021877"><Label>(a)</Label><Text>the name of the device and its identifier, including the identifier of any medical device that is part of a system, test kit, medical device group, medical device family or medical device group family;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021878" lims:id="1021878"><Label>(b)</Label><Text>the name and address of the manufacturer and importer, and the name and address of the establishment where the device was manufactured, if different from that of the manufacturer;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021879" lims:id="1021879"><Label>(c)</Label><Text>the reason for the recall, the nature of the defectiveness or possible defectiveness and the date on and circumstances under which the defectiveness or possible defectiveness was discovered;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021880" lims:id="1021880"><Label>(d)</Label><Text>an evaluation of the risk associated with the defectiveness or possible defectiveness;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021881" lims:id="1021881"><Label>(e)</Label><Text>the number of affected units of the device that the manufacturer or importer</Text><Subparagraph lims:inforce-start-date="2006-03-22" lims:fid="1021882" lims:id="1021882"><Label>(i)</Label><Text>manufactured in Canada,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2006-03-22" lims:fid="1021883" lims:id="1021883"><Label>(ii)</Label><Text>imported into Canada, and</Text></Subparagraph><Subparagraph lims:inforce-start-date="2006-03-22" lims:fid="1021884" lims:id="1021884"><Label>(iii)</Label><Text>sold in Canada;</Text></Subparagraph></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021885" lims:id="1021885"><Label>(f)</Label><Text>the period during which the affected units of the device were distributed in Canada by the manufacturer or importer;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021886" lims:id="1021886"><Label>(g)</Label><Text>the name of each person to whom the affected device was sold by the manufacturer or importer and the number of units of the device sold to each person;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021887" lims:id="1021887"><Label>(h)</Label><Text>a copy of any communication issued with respect to the recall;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021888" lims:id="1021888"><Label>(i)</Label><Text>the proposed strategy for conducting the recall, including the date for beginning the recall, information as to how and when the Minister will be informed of the progress of the recall and the proposed date for its completion;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021889" lims:id="1021889"><Label>(j)</Label><Text>the proposed action to prevent a recurrence of the problem; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021890" lims:id="1021890"><Label>(k)</Label><Text>the name, title and telephone number of the representative of the manufacturer or importer to contact for any information concerning the recall.</Text></Paragraph></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1021891" lims:id="1021891"><Label>65</Label><Text lims:inforce-start-date="2006-03-22" lims:fid="1458288" lims:id="1458288">The manufacturer and the importer of a medical device shall, as soon as possible after the completion of a recall, each report to the Minister</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021892" lims:id="1021892"><Label>(a)</Label><Text>the results of the recall; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021893" lims:id="1021893"><Label>(b)</Label><Text>the action taken to prevent a recurrence of the problem.</Text></Paragraph></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1021894" lims:id="1021894"><Label>65.1</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1021895" lims:id="1021895"><Label>(1)</Label><Text>Despite sections 64 and 65, the manufacturer of a medical device may permit the importer of the device to prepare and submit, on the manufacturer’s behalf, the information and documents with respect to the recall if the information and documents that the manufacturer and importer must submit are identical.</Text></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1021896" lims:id="1021896"><Label>(2)</Label><Text>The manufacturer shall advise the Minister in writing if the manufacturer has permitted the importer to prepare and submit the information and documents with respect to the recall on the manufacturer’s behalf.</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2006-03-22" lims:fid="1021898" lims:id="1021898">SOR/2002-190, s. 6</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-12-29" lims:fid="1021899" lims:id="1021899" level="2"><TitleText>Implant Registration</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1021900" lims:id="1021900"><Label>66</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1021901" lims:id="1021901"><Label>(1)</Label><Text>Subject to section 68, the manufacturer of an implant shall provide, with the implant, two implant registration cards that contain</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021902" lims:id="1021902"><Label>(a)</Label><Text>the name and address of the manufacturer;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021903" lims:id="1021903"><Label>(b)</Label><Text>the name and address of any person designated by the manufacturer for the collection of implant registration information;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021904" lims:id="1021904"><Label>(c)</Label><Text>a notice advising the patient that the purpose of the cards is to enable the manufacturer to notify the patient of new information concerning the safety, effectiveness or performance of the implant, and any required corrective action; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021905" lims:id="1021905"><Label>(d)</Label><Text>a statement advising the patient to notify the manufacturer of any change of address.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1021906" lims:id="1021906"><Label>(2)</Label><Text>An implant registration card shall be designed for the recording of the following information:</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021907" lims:id="1021907"><Label>(a)</Label><Text>the name of the device, its control number and its identifier, including the identifier of any medical device that is part of a system, test kit, medical device group, medical device family or medical device group family;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021908" lims:id="1021908"><Label>(b)</Label><Text>the name and address of the health care professional who carried out the implant procedure;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021909" lims:id="1021909"><Label>(c)</Label><Text>the date on which the device was implanted;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021910" lims:id="1021910"><Label>(d)</Label><Text>the name and address of the health care facility at which the implant procedure took place; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021911" lims:id="1021911"><Label>(e)</Label><Text>the patient’s name and address or the identification number used by the health care facility to identify the patient.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1021912" lims:id="1021912"><Label>(3)</Label><Text>The two implant registration cards referred to in subsection (1) shall be printed in both official languages; however, the manufacturer may choose to provide four cards, two in English and two in French.</Text></Subsection></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1021913" lims:id="1021913"><Label>67</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1021914" lims:id="1021914"><Label>(1)</Label><Text>Subject to subsection (2), a member of the staff of the health care facility where an implant procedure takes place shall, as soon as possible after the completion of the procedure, enter the information required by subsection 66(2) on each implant registration card, give one card to the implant patient and forward one card to the manufacturer of the implant or the person designated pursuant to paragraph 66(1)(b).</Text></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1021915" lims:id="1021915"><Label>(2)</Label><Text>The patient’s name and address shall not be entered on the implant registration card forwarded to the manufacturer or person designated pursuant to paragraph 66(1)(b) except with the patient’s written consent.</Text></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1021916" lims:id="1021916"><Label>(3)</Label><Text>The health care facility, the manufacturer or the person designated pursuant to paragraph 66(1)(b) shall not disclose the patient’s name or address, or any information that might identify the patient, unless the disclosure is required by law.</Text></Subsection></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1021917" lims:id="1021917"><Label>68</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1021918" lims:id="1021918"><Label>(1)</Label><Text>The manufacturer of an implant may apply in writing to the Minister for authorization to use an implant registration method other than the implant registration cards described in section 66.</Text></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1021919" lims:id="1021919"><Label>(2)</Label><Text>The Minister shall authorize the use of the implant registration method proposed in the application referred to in subsection (1) if the Minister determines that the method will enable the manufacturer to achieve the purpose set out in paragraph 66(1)(c) as effectively as the use of implant registration cards.</Text></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1021920" lims:id="1021920"><Label>(3)</Label><Text>Where an authorization has been granted pursuant to subsection (2), the manufacturer shall implement the alternative implant registration method, and sections 66 and 67 shall apply with such modifications as are necessary.</Text></Subsection></Section><Heading lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1391390" lims:id="1436627" level="1"><Label>PART 1.1</Label><TitleText>Medical Devices for an Urgent Public Health Need</TitleText><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436629" lims:id="1436629" lims:enactId="1434904">SOR/2023-277, s. 1</HistoricalNoteSubItem></HistoricalNote></Heading><Heading lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1391391" lims:id="1436630" level="2"><TitleText>Definitions and Interpretation</TitleText><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436632" lims:id="1436632" lims:enactId="1434906">SOR/2023-277, s. 2</HistoricalNoteSubItem></HistoricalNote></Heading><Section lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:lastAmendedDate="2024-01-03" lims:fid="1391392" lims:id="1391392"><Label>68.01</Label><Text>The following definitions apply in this Part.</Text><Definition lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391393" lims:id="1391393"><Text><DefinedTermEn>authorization</DefinedTermEn> means, unless the context requires otherwise, an authorization that is issued under section 68.12. (<DefinedTermFr>autorisation</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1391394" lims:id="1437389"><Text><DefinedTermEn>COVID-19</DefinedTermEn><Repealed>[Repealed, SOR/2023-277, s. 3]</Repealed></Text></Definition><Definition lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1391395" lims:id="1437390"><Text><DefinedTermEn>COVID-19 medical device</DefinedTermEn><Repealed>[Repealed, SOR/2023-277, s. 3]</Repealed></Text></Definition><Definition lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1391396" lims:id="1436633" generate-in-text="no"><Text><DefinedTermEn>List of Medical Devices for an Urgent Public Health Need</DefinedTermEn> means the <XRefExternal reference-type="other">List of Medical Devices for an Urgent Public Health Need</XRefExternal> that is published by the Government of Canada on its website, as amended from time to time. (<DefinedTermFr>Liste d’instruments médicaux pour des besoins urgents en matière de santé publique</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1391397" lims:id="1436634" generate-in-text="no"><Text><DefinedTermEn>List of Medical Devices for Expanded Use</DefinedTermEn> means the <XRefExternal reference-type="other">List of Medical Devices for Expanded Use</XRefExternal> that is published by the Government of Canada on its website, as amended from time to time. (<DefinedTermFr>Liste d’instruments médicaux destinés à un usage élargi</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1391398" lims:id="1436635" generate-in-text="no"><Text><DefinedTermEn>UPHN medical device</DefinedTermEn> means any of the following medical devices for an urgent public health need:</Text><Paragraph lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436636" lims:id="1436636"><Label>(a)</Label><Text>a medical device that is set out in column 2 of Part 1 of the <XRefExternal reference-type="other">List of Medical Devices for an Urgent Public Health Need</XRefExternal> and that is manufactured, sold or represented for use in relation to the corresponding medical condition that is set out in column 1;</Text></Paragraph><Paragraph lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436637" lims:id="1436637"><Label>(b)</Label><Text>a medical device that belongs to a category of medical devices that is set out in column 2 of Part 2 of that list and that is manufactured, sold or represented for use in relation to the corresponding medical condition that is set out in column 1. (<DefinedTermFr>instrument médical BUSP</DefinedTermFr>)</Text></Paragraph></Definition><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391402" lims:id="1391402" lims:enactId="1390912">SOR/2023-19, s. 7</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436638" lims:id="1436638" lims:enactId="1434908">SOR/2023-277, s. 3</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:lastAmendedDate="2024-01-03" lims:fid="1436639" lims:id="1436639"><Label>68.011</Label><Text>For the purposes of paragraphs 68.21(1)(h), (i) and (j), and sections 68.24, 68.3, 68.31 and 68.34, a medical device for which the manufacturer holds an authorization is considered not to be a UPHN medical device if</Text><Paragraph lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436640" lims:id="1436640"><Label>(a)</Label><Text>the device is not set out in column 2 of Part 1 of the <XRefExternal reference-type="other">List of Medical Devices for an Urgent Public Health Need</XRefExternal> and does not belong to a category of medical devices that is set out in column 2 of Part 2 of that list; or</Text></Paragraph><Paragraph lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436641" lims:id="1436641"><Label>(b)</Label><Text>the device is set out in column 2 of Part 1 of that list or belongs to a category of medical devices that is set out in column 2 of Part 2 of that list but is not authorized in relation to a corresponding medical condition that is set out, as the case may be, in column 1 of Part 1 or column 1 of Part 2.</Text></Paragraph><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436643" lims:id="1436643" lims:enactId="1434912">SOR/2023-277, s. 4</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391403" lims:id="1391403" level="2"><TitleText>Application</TitleText></Heading><Section lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:lastAmendedDate="2024-01-03" lims:fid="1391404" lims:id="1391404"><Label>68.02</Label><Subsection lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391405" lims:id="1391405"><Label>(1)</Label><Text>This Part applies to medical devices that are not subject to Part 2 or 3.</Text></Subsection><Subsection lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1391406" lims:id="1436644"><Label>(2)</Label><Text><Repealed>[Repealed, SOR/2023-277, s. 5]</Repealed></Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391408" lims:id="1391408" lims:enactId="1390912">SOR/2023-19, s. 7</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436645" lims:id="1436645" lims:enactId="1434914">SOR/2023-277, s. 5</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391409" lims:id="1391409" level="2"><TitleText>Authorization</TitleText></Heading><Heading lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391424" lims:id="1391424" level="3"><TitleText>Non-application of Part 1 — Importation and Sale</TitleText></Heading><Section lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:lastAmendedDate="2024-01-03" lims:fid="1391425" lims:id="1391425"><Label>68.03</Label><Subsection lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1391426" lims:id="1436646"><Label>(1)</Label><Text>Despite section 8, Part 1 does not apply in respect of the importation or sale of a medical device if the manufacturer holds an authorization for the device.</Text></Subsection><Subsection lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391427" lims:id="1391427"><Label>(2)</Label><Text lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1435037" lims:id="1436738">However, the following provisions of Part 1 apply in respect of the importation or sale of the medical device:</Text><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391428" lims:id="1391428"><Label>(a)</Label><Text>in the case of an importer, sections 59 to 61;</Text></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391429" lims:id="1391429"><Label>(b)</Label><Text>in the case of an importer or distributor, sections 44 to 51.1; and</Text></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391430" lims:id="1391430"><Label>(c)</Label><Text>sections 21, 23 and 27, 52 to 58, 62 and 62.21 to 65.1.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1391431" lims:id="1436739"><Label>(3)</Label><Text>Despite paragraph (2)(b), subsection 44(3) does not apply if the medical device that is imported is a Class I device and the person from whom the device is imported is the manufacturer.</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391433" lims:id="1391433" lims:enactId="1390912">SOR/2023-19, s. 7</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436647" lims:id="1436647" lims:enactId="1434915">SOR/2023-277, s. 6</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436786" lims:id="1436786" lims:enactId="1434959">SOR/2023-277, s. 25</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436648" lims:id="1436648" level="3"><TitleText>Advertising — Authorized Class I Medical Device</TitleText></Heading><Section lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:lastAmendedDate="2024-01-03" lims:fid="1436649" lims:id="1436649"><Label>68.031</Label><Text>No person shall advertise for the purpose of sale a Class I medical device for which the manufacturer holds an authorization if the device has been subjected to a change described in section 68.13 unless</Text><Paragraph lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436650" lims:id="1436650"><Label>(a)</Label><Text>the manufacturer holds an amended authorization; or</Text></Paragraph><Paragraph lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436651" lims:id="1436651"><Label>(b)</Label><Text>the advertisement is placed only in a catalogue that includes a clear and visible warning that the devices advertised in the catalogue may not have been authorized in accordance with Canadian law.</Text></Paragraph><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436653" lims:id="1436653" lims:enactId="1434917">SOR/2023-277, s. 7</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391434" lims:id="1391434" level="3"><TitleText>Deemed Authorization</TitleText></Heading><Section lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:lastAmendedDate="2024-01-03" lims:fid="1391435" lims:id="1436654"><Label>68.04</Label><Text><Repealed>[Repealed, SOR/2023-277, s. 8]</Repealed></Text></Section><Section lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:lastAmendedDate="2023-02-22" lims:fid="1391438" lims:id="1391438"><Label>68.05</Label><Text>In sections 68.06 to 68.09, <DefinedTermEn>authorized</DefinedTermEn>, in relation to a medical device, means that the device is the subject of an authorization.</Text><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391440" lims:id="1391440" lims:enactId="1390912">SOR/2023-19, s. 7</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:lastAmendedDate="2023-02-22" lims:fid="1391441" lims:id="1391441"><Label>68.06</Label><Text>If a system is authorized, all of its components or parts that are manufactured by the manufacturer of the system are deemed, for the purposes of its importation, sale or advertisement, to be authorized.</Text><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391443" lims:id="1391443" lims:enactId="1390912">SOR/2023-19, s. 7</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:lastAmendedDate="2023-02-22" lims:fid="1391444" lims:id="1391444"><Label>68.07</Label><Text>If a test kit is authorized, all of its reagents or articles that are manufactured by the manufacturer of the test kit are deemed, for the purposes of its importation, sale or advertisement, to be authorized.</Text><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391446" lims:id="1391446" lims:enactId="1390912">SOR/2023-19, s. 7</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:lastAmendedDate="2023-02-22" lims:fid="1391447" lims:id="1391447"><Label>68.08</Label><Text>If a medical device or medical device group is authorized and forms part of a medical device family or medical device group family, as the case may be, all other medical devices or medical device groups in the family are deemed to be authorized.</Text><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391449" lims:id="1391449" lims:enactId="1390912">SOR/2023-19, s. 7</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:lastAmendedDate="2023-02-22" lims:fid="1391450" lims:id="1391450"><Label>68.09</Label><Subsection lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391451" lims:id="1391451"><Label>(1)</Label><Text>If all the medical devices that form part of a medical device group are authorized, that medical device group is deemed to be authorized.</Text></Subsection><Subsection lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391452" lims:id="1391452"><Label>(2)</Label><Text>If a medical device group is authorized, all the medical devices that form part of the medical device group are deemed, for the purposes of its importation, sale or advertisement, to be authorized.</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391454" lims:id="1391454" lims:enactId="1390912">SOR/2023-19, s. 7</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391455" lims:id="1391455" level="3"><TitleText>Application for an Authorization</TitleText></Heading><Section lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:lastAmendedDate="2024-01-03" lims:fid="1391456" lims:id="1436655"><Label>68.1</Label><Subsection lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436656" lims:id="1436656"><Label>(1)</Label><Text>The Minister may add a medical condition to column 1 of Part 1 or Part 2 of the <XRefExternal reference-type="other">List of Medical Devices for an Urgent Public Health Need</XRefExternal> only if the Minister has reasonable grounds to believe that</Text><Paragraph lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436657" lims:id="1436657"><Label>(a)</Label><Text>the medical condition presents, or is the result of, a significant risk to public health in Canada; and</Text></Paragraph><Paragraph lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436658" lims:id="1436658"><Label>(b)</Label><Text>immediate action is required to deal with the risk.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436659" lims:id="1436659"><Label>(2)</Label><Text>The Minister may add a medical device to column 2 of Part 1 of the <XRefExternal reference-type="other">List of Medical Devices for an Urgent Public Health Need</XRefExternal> only if the Minister has reasonable grounds to believe that there is an urgent public health need for the device that is related to the corresponding medical condition that is set out in column 1.</Text></Subsection><Subsection lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436660" lims:id="1436660"><Label>(3)</Label><Text>The Minister may add a category of medical devices to column 2 of Part 2 of the <XRefExternal reference-type="other">List of Medical Devices for an Urgent Public Health Need</XRefExternal> only if the Minister has reasonable grounds to believe that there is an urgent public health need for the devices that belong to that category that is related to the corresponding medical condition set out in column 1.</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391460" lims:id="1391460" lims:enactId="1390912">SOR/2023-19, s. 7</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436661" lims:id="1436661" lims:enactId="1434920">SOR/2023-277, s. 9</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:lastAmendedDate="2024-01-03" lims:fid="1391461" lims:id="1391461"><Label>68.11</Label><Subsection lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1391462" lims:id="1436740"><Label>(1)</Label><Text>A manufacturer of a medical device may submit to the Minister an application for an authorization for the device if it is a UPHN medical device.</Text></Subsection><Subsection lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391463" lims:id="1391463"><Label>(2)</Label><Text>The application shall be submitted in a form established by the Minister. The application shall contain sufficient information and documents to enable the Minister to determine whether to issue the authorization, including</Text><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391464" lims:id="1391464"><Label>(a)</Label><Text>the name of the device;</Text></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391465" lims:id="1391465"><Label>(b)</Label><Text>the class of the device;</Text></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391466" lims:id="1391466"><Label>(c)</Label><Text>the identifier of the device, including the identifier of any medical device that is part of a system, test kit, medical device group, medical device family or medical device group family;</Text></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391467" lims:id="1391467"><Label>(d)</Label><Text>the name and address of the manufacturer as it appears on the device label;</Text></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391468" lims:id="1391468"><Label>(e)</Label><Text>the name and address of the establishment where the device is manufactured, if different from those referred to in paragraph (d);</Text></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391469" lims:id="1391469"><Label>(f)</Label><Text>a description of the medical conditions, purposes and uses for which the device is manufactured, sold or represented;</Text></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391470" lims:id="1391470"><Label>(g)</Label><Text>information respecting the safety and effectiveness of the device;</Text></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391471" lims:id="1391471"><Label>(h)</Label><Text>evidence that establishes that the manufacturer has a quality management system in place in respect of the device;</Text></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391472" lims:id="1391472"><Label>(i)</Label><Text>the directions for use, unless directions are not required for the device to be used safely and effectively;</Text></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391473" lims:id="1391473"><Label>(j)</Label><Text>an attestation by the manufacturer that documented procedures are in place in respect of distribution records, complaint handling, incident reporting and recalls; and</Text></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391474" lims:id="1391474"><Label>(k)</Label><Text>a copy of the device label.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391475" lims:id="1391475"><Label>(3)</Label><Text lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1435038" lims:id="1436741">An application in respect of a Class III or IV medical device shall contain, in addition to the information and documents referred to in subsection (2),</Text><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391476" lims:id="1391476"><Label>(a)</Label><Text>a description of the materials used in the manufacture and packaging of the device; and</Text></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391477" lims:id="1391477"><Label>(b)</Label><Text>a list of the countries, other than Canada, where the device has been sold, the total number of units sold in those countries and a summary of any reported problems with the device and any recalls of the device in those countries.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391478" lims:id="1391478"><Label>(4)</Label><Text>Despite subsection (2) and subsection (3), the application need not include the information and documents referred to in paragraphs (2)(g) and (h) and, if applicable, subsection (3) if</Text><Paragraph lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1391479" lims:id="1436742"><Label>(a)</Label><Text>the application includes information that demonstrates that an authorization or licence for sale of the medical device has been issued by a regulatory agency and that the authorization or licence has not been suspended or revoked; and</Text></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391480" lims:id="1391480"><Label>(b)</Label><Text>the name of the regulatory agency appears in the <XRefExternal reference-type="other">List of Regulatory Agencies for the Purposes of Subsection 68.11(4) of the Medical Devices Regulations</XRefExternal>, published by the Government of Canada on its website, as amended from time to time.</Text></Paragraph></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391482" lims:id="1391482" lims:enactId="1390912">SOR/2023-19, s. 7</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436772" lims:id="1436772" lims:enactId="1434959">SOR/2023-277, s. 25</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391483" lims:id="1391483" level="3"><TitleText>Issuance</TitleText></Heading><Section lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:lastAmendedDate="2024-01-03" lims:fid="1391484" lims:id="1391484"><Label>68.12</Label><Text lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1435039" lims:id="1436743">The Minister shall issue an authorization for a medical device if the following requirements are met:</Text><Paragraph lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1391485" lims:id="1436771"><Label>(a)</Label><Text>the manufacturer has submitted an application to the Minister that meets the requirements set out in section 68.11;</Text></Paragraph><Paragraph lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1391486" lims:id="1436662"><Label>(b)</Label><Text><Repealed>[Repealed, SOR/2023-277, s. 10]</Repealed></Text></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391487" lims:id="1391487"><Label>(c)</Label><Text>the Minister has sufficient evidence to support the conclusion that the benefits associated with the device outweigh the risks associated with it, having regard to</Text><Subparagraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391488" lims:id="1391488"><Label>(i)</Label><Text>the uncertainties relating to those benefits and risks, and</Text></Subparagraph><Subparagraph lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1391489" lims:id="1436663"><Label>(ii)</Label><Text>the urgent public health need for the device or the absence of any such need;</Text></Subparagraph></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391490" lims:id="1391490"><Label>(d)</Label><Text>the Minister has sufficient evidence to support the conclusion that the manufacturer has a quality management system in place that is adequate to</Text><Subparagraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391491" lims:id="1391491"><Label>(i)</Label><Text>control the quality and, if applicable, the purity and sterility of the device and the materials used in the manufacture of the device, and</Text></Subparagraph><Subparagraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391492" lims:id="1391492"><Label>(ii)</Label><Text>ensure that the device meets the specifications of the device; and</Text></Subparagraph></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391493" lims:id="1391493"><Label>(e)</Label><Text>the Minister determines that the health or safety of patients, users or other persons will not be unduly affected by the device.</Text></Paragraph><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391495" lims:id="1391495" lims:enactId="1390912">SOR/2023-19, s. 7</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436664" lims:id="1436664" lims:enactId="1434922">SOR/2023-277, s. 10</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436773" lims:id="1436773" lims:enactId="1434959">SOR/2023-277, s. 25</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436789" lims:id="1436789" lims:enactId="1434979">SOR/2023-277, s. 26</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391496" lims:id="1391496" level="3"><TitleText>Amendment</TitleText></Heading><Section lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:lastAmendedDate="2024-01-03" lims:fid="1391497" lims:id="1391497"><Label>68.13</Label><Text lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1435040" lims:id="1436744">No person shall import or sell a medical device for which the manufacturer holds an authorization if the device has been the subject of any of the following changes unless the manufacturer holds an amended authorization:</Text><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391498" lims:id="1391498"><Label>(a)</Label><Text>in the case of a Class III or IV device, a significant change;</Text></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391499" lims:id="1391499"><Label>(b)</Label><Text>a change that would result in a change of the class of the device;</Text></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391500" lims:id="1391500"><Label>(c)</Label><Text>a change in the name of the manufacturer;</Text></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391501" lims:id="1391501"><Label>(d)</Label><Text>a change in the name of the device;</Text></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391502" lims:id="1391502"><Label>(e)</Label><Text>a change in the identifier of the device, including the identifier of any medical device that is part of a system, test kit, medical device group, medical device family or medical device group family;</Text></Paragraph><Paragraph lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1391503" lims:id="1436665"><Label>(f)</Label><Text>in the case of a Class I or II device, a change in the medical conditions, purposes or uses for which the device is manufactured, sold or represented.</Text></Paragraph><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391505" lims:id="1391505" lims:enactId="1390912">SOR/2023-19, s. 7</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436666" lims:id="1436666" lims:enactId="1434926">SOR/2023-277, s. 11</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436774" lims:id="1436774" lims:enactId="1434959">SOR/2023-277, s. 25</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:lastAmendedDate="2023-02-22" lims:fid="1391506" lims:id="1391506"><Label>68.14</Label><Text>An application to amend an authorization shall be submitted to the Minister by the holder of the authorization in a form established by the Minister. The application shall contain sufficient information and documents to enable the Minister to determine whether to amend the authorization, including the information and documents referred to in subsection 68.11(2) and (3) that relate to the change referred to in section 68.13 for which an amendment to the authorization is required.</Text><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391508" lims:id="1391508" lims:enactId="1390912">SOR/2023-19, s. 7</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:lastAmendedDate="2024-01-03" lims:fid="1391509" lims:id="1391509"><Label>68.15</Label><Text lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1435041" lims:id="1436745">The Minister shall amend an authorization for a medical device if the following requirements are met:</Text><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391510" lims:id="1391510"><Label>(a)</Label><Text>the holder of the authorization has submitted an application to the Minister that meets the requirements set out in section 68.14;</Text></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391511" lims:id="1391511"><Label>(b)</Label><Text>the Minister has sufficient evidence to support the conclusion that the benefits associated with the device outweigh the risks associated with it, having regard to</Text><Subparagraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391512" lims:id="1391512"><Label>(i)</Label><Text>the uncertainties relating to those benefits and risks, and</Text></Subparagraph><Subparagraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391513" lims:id="1391513"><Label>(ii)</Label><Text>the urgent public health need for the device or the absence of any such need; and</Text></Subparagraph></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391514" lims:id="1391514"><Label>(c)</Label><Text>the Minister determines that the health or safety of patients, users or other persons will not be unduly affected by the device.</Text></Paragraph><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391516" lims:id="1391516" lims:enactId="1390912">SOR/2023-19, s. 7</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436775" lims:id="1436775" lims:enactId="1434959">SOR/2023-277, s. 25</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391517" lims:id="1391517" level="3"><TitleText>Refusal</TitleText></Heading><Section lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:lastAmendedDate="2024-01-03" lims:fid="1391518" lims:id="1391518"><Label>68.16</Label><Text lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1435042" lims:id="1436746">The Minister may refuse to issue or amend an authorization for a medical device if</Text><Paragraph lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1391519" lims:id="1436767"><Label>(a)</Label><Text>the Minister has reasonable grounds to believe that the manufacturer has contravened these Regulations or any provision of the Act relating to medical devices;</Text></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391520" lims:id="1391520"><Label>(b)</Label><Text>the Minister has reasonable grounds to believe that the device is not labelled in accordance with sections 21 and 23; or</Text></Paragraph><Paragraph lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1391521" lims:id="1436768"><Label>(c)</Label><Text>the manufacturer has not submitted to the Minister all information, documents or material that was requested under section 68.23 to enable the Minister to determine whether to issue or amend the authorization, within the time limit specified in the request.</Text></Paragraph><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391523" lims:id="1391523" lims:enactId="1390912">SOR/2023-19, s. 7</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436776" lims:id="1436776" lims:enactId="1434959">SOR/2023-277, s. 25</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436790" lims:id="1436790" lims:enactId="1434979">SOR/2023-277, s. 26</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:lastAmendedDate="2024-01-03" lims:fid="1391524" lims:id="1436667"><Label>68.17</Label><Text>The Minister shall refuse to amend an authorization for a medical device if the effect of the proposed amendment would be that the device would not be authorized in relation to at least one of the following medical conditions:</Text><Paragraph lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436668" lims:id="1436668"><Label>(a)</Label><Text>a medical condition that qualified the device as a UPHN medical device when the application for the authorization was submitted under section 68.11;</Text></Paragraph><Paragraph lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436669" lims:id="1436669"><Label>(b)</Label><Text>a medical condition in relation to which the device was authorized when the application to amend the authorization was submitted under section 68.14, in the case where</Text><Subparagraph lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436670" lims:id="1436670"><Label>(i)</Label><Text>the holder of the authorization previously submitted an application to amend the authorization under section 68.14 to have the device authorized in relation to the medical condition,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436671" lims:id="1436671"><Label>(ii)</Label><Text>the medical condition qualified the device as a UPHN medical device when that previous application was submitted, and</Text></Subparagraph><Subparagraph lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436672" lims:id="1436672"><Label>(iii)</Label><Text>the authorization was amended under section 68.15 on the basis of that previous application;</Text></Subparagraph></Paragraph><Paragraph lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436673" lims:id="1436673"><Label>(c)</Label><Text>a medical condition in relation to which the device was not authorized when the application to amend the authorization was submitted under section 68.14, in the case where</Text><Subparagraph lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436674" lims:id="1436674"><Label>(i)</Label><Text>the holder of the authorization submitted the application to have the device authorized in relation to the medical condition, and</Text></Subparagraph><Subparagraph lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436675" lims:id="1436675"><Label>(ii)</Label><Text>the medical condition qualified the device as a UPHN medical device when the application was submitted.</Text></Subparagraph></Paragraph><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391526" lims:id="1391526" lims:enactId="1390912">SOR/2023-19, s. 7</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436676" lims:id="1436676" lims:enactId="1434928">SOR/2023-277, s. 12</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:lastAmendedDate="2024-01-03" lims:fid="1391527" lims:id="1436747"><Label>68.18</Label><Text>If the Minister refuses to issue or amend an authorization, the Minister shall notify the manufacturer of the medical device in writing of the reasons for the refusal and give them an opportunity to be heard.</Text><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391529" lims:id="1391529" lims:enactId="1390912">SOR/2023-19, s. 7</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436748" lims:id="1436748" lims:enactId="1434959">SOR/2023-277, s. 25</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391530" lims:id="1391530" level="3"><TitleText>Terms and Conditions</TitleText></Heading><Section lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:lastAmendedDate="2024-01-03" lims:fid="1391531" lims:id="1436749"><Label>68.19</Label><Text>The Minister may, at any time, impose terms and conditions on an authorization for a medical device or amend those terms and conditions.</Text><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391533" lims:id="1391533" lims:enactId="1390912">SOR/2023-19, s. 7</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436750" lims:id="1436750" lims:enactId="1434959">SOR/2023-277, s. 25</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391534" lims:id="1391534" level="3"><TitleText>Applications Submitted Under Part 1</TitleText></Heading><Section lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:lastAmendedDate="2024-01-03" lims:fid="1391535" lims:id="1391535"><Label>68.2</Label><Text lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1435043" lims:id="1436751">Despite section 68.03, the holder of an authorization for a medical device may submit</Text><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391536" lims:id="1391536"><Label>(a)</Label><Text>in the case of a Class I device, an application under section 45 for an establishment licence that would authorize the holder to sell or import the device; or</Text></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391537" lims:id="1391537"><Label>(b)</Label><Text>in the case of a Class II, III or IV device, an application under section 32 for a licence for the device.</Text></Paragraph><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391539" lims:id="1391539" lims:enactId="1390912">SOR/2023-19, s. 7</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436777" lims:id="1436777" lims:enactId="1434959">SOR/2023-277, s. 25</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391540" lims:id="1391540" level="3"><TitleText>Cancellation</TitleText></Heading><Section lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:lastAmendedDate="2024-01-03" lims:fid="1391541" lims:id="1391541"><Label>68.21</Label><Subsection lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391542" lims:id="1391542"><Label>(1)</Label><Text lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1435044" lims:id="1436752">The Minister may cancel an authorization for a medical device by written notice to the holder, giving reasons, if</Text><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391543" lims:id="1391543"><Label>(a)</Label><Text>the Minister has reasonable grounds to believe that the holder has contravened these Regulations or any provision of the Act relating to medical devices;</Text></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391544" lims:id="1391544"><Label>(b)</Label><Text>the Minister has reasonable grounds to believe that the risks associated with the device outweigh the benefits associated with it, having regard to</Text><Subparagraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391545" lims:id="1391545"><Label>(i)</Label><Text>the uncertainties relating to those benefits and risks, and</Text></Subparagraph><Subparagraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391546" lims:id="1391546"><Label>(ii)</Label><Text>the urgent public health need for the device or the absence of any such need;</Text></Subparagraph></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391547" lims:id="1391547"><Label>(c)</Label><Text>the Minister has reasonable grounds to believe that the holder does not have a quality management system in place that is adequate to</Text><Subparagraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391548" lims:id="1391548"><Label>(i)</Label><Text>control the quality and, if applicable, the purity and sterility of the device and the materials used in the manufacture of the device, and</Text></Subparagraph><Subparagraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391549" lims:id="1391549"><Label>(ii)</Label><Text>ensure that the device meets the specifications of the device;</Text></Subparagraph></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391550" lims:id="1391550"><Label>(d)</Label><Text>the Minister has reasonable grounds to believe that the health or safety of patients, users or other persons may be unduly affected by the device;</Text></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391551" lims:id="1391551"><Label>(e)</Label><Text>the Minister has reasonable grounds to believe that the holder has failed to comply with the terms and conditions of the authorization;</Text></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391552" lims:id="1391552"><Label>(f)</Label><Text>in the case of an authorization issued in respect of an application submitted on the basis of subsection 68.11(4), the Minister becomes aware that the authorization or licence for sale of the device that had been issued by the regulatory agency is suspended or revoked;</Text></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391553" lims:id="1391553"><Label>(g)</Label><Text>the holder has not submitted to the Minister all information, documents or material that was requested under section 68.23 to enable the Minister to determine whether to cancel the authorization, within the time limit specified in the request;</Text></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391554" lims:id="1391554"><Label>(h)</Label><Text>in the case of a Class I device that is not a UPHN medical device,</Text><Subparagraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391555" lims:id="1391555"><Label>(i)</Label><Text>the holder does not, within 120 days after the day on which the device ceases to be a UPHN medical device, submit an application under section 45 for an establishment licence that would authorize the holder to sell or import the device,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391556" lims:id="1391556"><Label>(ii)</Label><Text>the Minister refuses to issue an establishment licence to the holder under section 47, or</Text></Subparagraph><Subparagraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391557" lims:id="1391557"><Label>(iii)</Label><Text>the holder withdraws the application referred to in subparagraph (i);</Text></Subparagraph></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391558" lims:id="1391558"><Label>(i)</Label><Text>in the case of a Class II device that is not a UPHN medical device,</Text><Subparagraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391559" lims:id="1391559"><Label>(i)</Label><Text>the holder does not, within 120 days after the day on which the device ceases to be a UPHN medical device, provide the Minister with a copy of a contract, signed by both the holder and a registrar recognized by the Minister under section 32.1, that meets the following conditions:</Text><Clause lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391560" lims:id="1391560"><Label>(A)</Label><Text>the contract indicates that the holder has begun the certification process to determine whether they have a quality management system that satisfies the standard referred to in paragraph 32(2)(f), and</Text></Clause><Clause lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391561" lims:id="1391561"><Label>(B)</Label><Text>the contract is in effect when that period expires, or</Text></Clause></Subparagraph><Subparagraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391562" lims:id="1391562"><Label>(ii)</Label><Text>the holder does not, within two years after the day on which the device ceases to be a UPHN medical device, provide the Minister with a copy of the quality management system certificate referred to in paragraph 32(2)(f); or</Text></Subparagraph></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391563" lims:id="1391563"><Label>(j)</Label><Text>in the case of a Class III or IV device that is not a UPHN medical device,</Text><Subparagraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391564" lims:id="1391564"><Label>(i)</Label><Text>the holder does not, within 120 days after the day on which the device ceases to be a UPHN medical device, provide the Minister with a copy of a contract, signed by both the holder and a registrar recognized by the Minister under section 32.1, that meets the following conditions:</Text><Clause lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391565" lims:id="1391565"><Label>(A)</Label><Text>the contract indicates that the holder has begun the certification process to determine whether they have a quality management system that satisfies the standard referred to in paragraph 32(3)(j) or (4)(p), as the case may be, and</Text></Clause><Clause lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391566" lims:id="1391566"><Label>(B)</Label><Text>the contract is in effect when that period expires, or</Text></Clause></Subparagraph><Subparagraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391567" lims:id="1391567"><Label>(ii)</Label><Text>the holder does not, within two years after the day on which the device ceases to be a UPHN medical device, provide the Minister with a copy of the quality management system certificate referred to in paragraph 32(3)(j) or (4)(p), as the case may be.</Text></Subparagraph></Paragraph></Subsection><Subsection lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436677" lims:id="1436677"><Label>(1.1)</Label><Text>If a medical device ceases to be a UPHN medical device after an application for an authorization is submitted under section 68.11 but before the Minister issues the authorization under section 68.12, the reference to “the device ceases to be a UPHN medical device” in subparagraph (1)(h)(i), (i)(i) or (j)(i), as the case may be, shall be read as “the Minister issued the authorization”.</Text></Subsection><Subsection lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436678" lims:id="1436678"><Label>(1.2)</Label><Text>Subsection (1.1) ceases to apply in respect of the medical device if the device is authorized in relation to a medical condition that qualifies it as a UPHN medical device.</Text></Subsection><Subsection lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391568" lims:id="1391568"><Label>(2)</Label><Text>A ground for cancellation specified in subparagraph (1)(i)(i) or (j)(i) does not apply if the holder has already provided the Minister with a copy of the quality management system certificate referred to in paragraph 32(2)(f), (3)(j) or (4)(p), as the case may be, or a copy of the contract referred to in the applicable subparagraph.</Text></Subsection><Subsection lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391569" lims:id="1391569"><Label>(3)</Label><Text>A ground for cancellation specified in subparagraph (1)(i)(ii) or (j)(ii) does not apply if the holder has already provided the Minister with a copy of the quality management system certificate referred to in paragraph 32(2)(f), (3)(j) or (4)(p), as the case may be.</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391571" lims:id="1391571" lims:enactId="1390912">SOR/2023-19, s. 7</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436679" lims:id="1436679" lims:enactId="1434930">SOR/2023-277, s. 13</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436778" lims:id="1436778" lims:enactId="1434959">SOR/2023-277, s. 25</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:lastAmendedDate="2024-01-03" lims:fid="1391572" lims:id="1391572"><Label>68.22</Label><Text lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1435045" lims:id="1436753">An authorization for a medical device is cancelled if</Text><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391573" lims:id="1391573"><Label>(a)</Label><Text>in the case of a Class I device, the holder of the authorization is issued an establishment licence under section 46 that authorizes the holder to sell or import the device;</Text></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391574" lims:id="1391574"><Label>(b)</Label><Text>in the case of a Class II, III or IV device, the holder of the authorization is issued a licence for the device under section 36; or</Text></Paragraph><Paragraph lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1391575" lims:id="1436680"><Label>(c)</Label><Text>the holder of the authorization informs the Minister under section 68.25 that the holder has discontinued the sale of the device in Canada.</Text></Paragraph><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391577" lims:id="1391577" lims:enactId="1390912">SOR/2023-19, s. 7</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436681" lims:id="1436681" lims:enactId="1434932">SOR/2023-277, s. 14(E)</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436779" lims:id="1436779" lims:enactId="1434959">SOR/2023-277, s. 25</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391578" lims:id="1391578" level="3"><TitleText>Additional Information and Material</TitleText></Heading><Section lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:lastAmendedDate="2024-01-03" lims:fid="1391579" lims:id="1436754"><Label>68.23</Label><Text>The Minister may request that the manufacturer of a medical device who has submitted an application for an authorization or the holder of an authorization submit to the Minister, within a specified time limit, any additional information or documents or any material, including samples, that is necessary to enable the Minister to determine whether to issue, amend or cancel the authorization.</Text><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391581" lims:id="1391581" lims:enactId="1390912">SOR/2023-19, s. 7</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436780" lims:id="1436780" lims:enactId="1434959">SOR/2023-277, s. 25</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391582" lims:id="1391582" level="3"><TitleText>Annual Review</TitleText></Heading><Section lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:lastAmendedDate="2024-01-03" lims:fid="1391583" lims:id="1391583"><Label>68.24</Label><Text lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1435046" lims:id="1436755">The holder of an authorization for a Class II, III or IV medical device that is not a UPHN medical device shall, annually before November 1 and in a form established by the Minister, provide the Minister with a statement signed by the holder or a person authorized to sign on the holder’s behalf</Text><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391584" lims:id="1391584"><Label>(a)</Label><Text>confirming that all the information and documents submitted by the holder with respect to the device are still correct; or</Text></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391585" lims:id="1391585"><Label>(b)</Label><Text>describing any change to the information and documents submitted by the holder with respect to the device, other than those to be submitted under section 68.14 or 68.34.</Text></Paragraph><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391587" lims:id="1391587" lims:enactId="1390912">SOR/2023-19, s. 7</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436781" lims:id="1436781" lims:enactId="1434959">SOR/2023-277, s. 25</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436682" lims:id="1436682" level="3"><TitleText>Notification — Suspension or Revocation</TitleText></Heading><Section lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:lastAmendedDate="2024-01-03" lims:fid="1436683" lims:id="1436683"><Label>68.241</Label><Subsection lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436684" lims:id="1436684"><Label>(1)</Label><Text>This section applies to the holder of an authorization for a medical device that was issued in respect of an application submitted on the basis of subsection 68.11(4).</Text></Subsection><Subsection lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436685" lims:id="1436685"><Label>(2)</Label><Text>If the holder of an authorization for a medical device receives or becomes aware of information to the effect that the authorization or licence for sale of the device that was issued by the regulatory agency is suspended or revoked, the holder shall notify the Minister within 72 hours after they receive or become aware of the information, whichever occurs first.</Text></Subsection><Subsection lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436686" lims:id="1436686"><Label>(3)</Label><Text>However, the holder is not required to notify the Minister if they or the holder referred to in paragraph 68.3(1)(b) submits that information under section 68.3.</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436688" lims:id="1436688" lims:enactId="1434934">SOR/2023-277, s. 15</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391588" lims:id="1391588" level="3"><TitleText>Discontinuance</TitleText></Heading><Section lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:lastAmendedDate="2024-01-03" lims:fid="1391589" lims:id="1436756"><Label>68.25</Label><Text>If the holder of an authorization for a medical device discontinues the sale of the device in Canada, the holder shall inform the Minister within 30 days after the discontinuance.</Text><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391591" lims:id="1391591" lims:enactId="1390912">SOR/2023-19, s. 7</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436782" lims:id="1436782" lims:enactId="1434959">SOR/2023-277, s. 25</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391592" lims:id="1391592" level="3"><TitleText>Importation — Copy of Authorization</TitleText></Heading><Section lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:lastAmendedDate="2024-01-03" lims:fid="1391593" lims:id="1436689"><Label>68.26</Label><Text>If the manufacturer of a medical device holds an authorization for the device, the importer of a shipment of the device shall ensure that the shipment is accompanied by a copy of the authorization.</Text><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391595" lims:id="1391595" lims:enactId="1390912">SOR/2023-19, s. 7</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436690" lims:id="1436690" lims:enactId="1434936">SOR/2023-277, s. 16</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391596" lims:id="1391596" level="3"><TitleText>Incident Reporting</TitleText></Heading><Section lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:lastAmendedDate="2024-01-03" lims:fid="1391597" lims:id="1391597"><Label>68.27</Label><Subsection lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391598" lims:id="1391598"><Label>(1)</Label><Text lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1435047" lims:id="1436757">The holder of an authorization for a medical device shall submit a preliminary report to the Minister in respect of any incident that comes to their attention occurring in Canada that involves the device</Text><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391599" lims:id="1391599"><Label>(a)</Label><Text>within 10 days after becoming aware of the incident, if the incident has led to the death or a serious deterioration in the state of health of a patient, user or other person; or</Text></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391600" lims:id="1391600"><Label>(b)</Label><Text>within 30 days after becoming aware of the incident, if the incident has not led to the death or a serious deterioration in the state of health of a patient, user or other person but could do so were it to recur.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391601" lims:id="1391601"><Label>(2)</Label><Text>The preliminary report shall contain the following information:</Text><Paragraph lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1391602" lims:id="1436758"><Label>(a)</Label><Text>the name of the medical device and its identifier, including the identifier of any medical device that is part of a system, test kit, medical device group, medical device family or medical device group family;</Text></Paragraph><Paragraph lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1391603" lims:id="1436759"><Label>(b)</Label><Text>the names and addresses of the holder and of any known importer of the medical device as well as the name, title and contact information of a representative of the holder to contact for any information concerning the incident;</Text></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391604" lims:id="1391604"><Label>(c)</Label><Text>the date on which the holder became aware of the incident;</Text></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391605" lims:id="1391605"><Label>(d)</Label><Text>the details known in respect of the incident, including the date on which the incident occurred and the consequences for the patient, user or other person;</Text></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391606" lims:id="1391606"><Label>(e)</Label><Text>the name and contact information, if known, of the person who reported the incident to the holder;</Text></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391607" lims:id="1391607"><Label>(f)</Label><Text>the names of any other medical devices involved in the incident, including any accessories, if known;</Text></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391608" lims:id="1391608"><Label>(g)</Label><Text>the preliminary comments of the holder with respect to the incident;</Text></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391609" lims:id="1391609"><Label>(h)</Label><Text>the course of action, including an investigation, that the holder proposes to follow in respect of the incident and a timetable for carrying out any proposed action and submitting a final report; and</Text></Paragraph><Paragraph lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1391610" lims:id="1436760"><Label>(i)</Label><Text>a statement indicating whether a previous report has been made to the Minister with respect to the medical device and, if so, the date of the report.</Text></Paragraph></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391612" lims:id="1391612" lims:enactId="1390912">SOR/2023-19, s. 7</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436783" lims:id="1436783" lims:enactId="1434959">SOR/2023-277, s. 25</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:lastAmendedDate="2024-01-03" lims:fid="1391613" lims:id="1391613"><Label>68.28</Label><Subsection lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391614" lims:id="1391614"><Label>(1)</Label><Text>The holder of the authorization shall, after making the preliminary report, submit a final report to the Minister in accordance with the timetable established under paragraph 68.27(2)(h).</Text></Subsection><Subsection lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391615" lims:id="1391615"><Label>(2)</Label><Text>The final report shall contain the following information:</Text><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391616" lims:id="1391616"><Label>(a)</Label><Text>a description of the incident, including the number of persons who have died or experienced a serious deterioration in the state of their health;</Text></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391617" lims:id="1391617"><Label>(b)</Label><Text>a detailed explanation of the cause of the incident and a justification for the actions taken in respect of the incident; and</Text></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391618" lims:id="1391618"><Label>(c)</Label><Text lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1435050" lims:id="1436761">any actions taken in respect of the medical device as a result of the investigation referred to in paragraph 68.27(2)(h), which may include</Text><Subparagraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391619" lims:id="1391619"><Label>(i)</Label><Text>increased post-market surveillance of the device,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391620" lims:id="1391620"><Label>(ii)</Label><Text>corrective and preventive action respecting the design and manufacture of the device, and</Text></Subparagraph><Subparagraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391621" lims:id="1391621"><Label>(iii)</Label><Text>recall of the device.</Text></Subparagraph></Paragraph></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391623" lims:id="1391623" lims:enactId="1390912">SOR/2023-19, s. 7</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436784" lims:id="1436784" lims:enactId="1434959">SOR/2023-277, s. 25</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:lastAmendedDate="2023-02-22" lims:fid="1391624" lims:id="1391624"><Label>68.29</Label><Text>The holder of the authorization is not required to submit the preliminary report referred to in section 68.27 or the final report referred to in section 68.28 if</Text><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391625" lims:id="1391625"><Label>(a)</Label><Text>the information that the holder would be required to include in that preliminary report is identical to the information that the importer of the device is required to include in the preliminary report referred to in subsection 59(1);</Text></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391626" lims:id="1391626"><Label>(b)</Label><Text>the information that the holder would be required to include in that final report is identical to the information that the importer of the device is required to include in the final report referred to in subsection 59(1); and</Text></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391627" lims:id="1391627"><Label>(c)</Label><Text>the holder advises the Minister in writing that the importer of the device is submitting the preliminary report and the final report under subsection 59(1).</Text></Paragraph><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391629" lims:id="1391629" lims:enactId="1390912">SOR/2023-19, s. 7</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391630" lims:id="1391630" level="3"><TitleText>Serious Risk of Injury to Human Health</TitleText></Heading><Section lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:lastAmendedDate="2024-01-03" lims:fid="1391631" lims:id="1436691"><Label>68.3</Label><Subsection lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436692" lims:id="1436692"><Label>(1)</Label><Text>This section applies to the following holders of therapeutic product authorizations:</Text><Paragraph lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436693" lims:id="1436693"><Label>(a)</Label><Text>a holder of an authorization for a Class II, III or IV medical device that is not a UPHN medical device; and</Text></Paragraph><Paragraph lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436694" lims:id="1436694"><Label>(b)</Label><Text>a holder of an establishment licence to import Class II, III or IV medical devices that imports a device referred to in paragraph (a).</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436695" lims:id="1436695"><Label>(2)</Label><Text>The holder of a therapeutic product authorization shall submit to the Minister information in respect of any serious risk of injury to human health that the holder receives or becomes aware of and that is relevant to the safety of a device referred to in paragraph (1)(a), regarding</Text><Paragraph lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436696" lims:id="1436696"><Label>(a)</Label><Text>risks that have been communicated by any regulatory agency that is set out in the <XRefExternal reference-type="other">List of Regulatory Agencies for the Purposes of Sections 61.2 and 68.3 of the Medical Devices Regulations</XRefExternal>, published by the Government of Canada on its website, as amended from time to time, or by any person who is authorized to manufacture or sell a medical device within the jurisdiction of such a regulatory agency, and the manner of the communication;</Text></Paragraph><Paragraph lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436697" lims:id="1436697"><Label>(b)</Label><Text>changes that have been made to the labelling of any medical device and that have been communicated to or requested by any regulatory agency that is set out in that list; and</Text></Paragraph><Paragraph lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436698" lims:id="1436698"><Label>(c)</Label><Text>recalls, reassessments and suspensions or revocations of authorizations, including licences, in respect of any medical device, that have taken place within the jurisdiction of any regulatory agency that is set out in that list.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436699" lims:id="1436699"><Label>(3)</Label><Text>The information shall be submitted to the Minister within 72 hours after the holder receives or becomes aware of it, whichever occurs first.</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391641" lims:id="1391641" lims:enactId="1390912">SOR/2023-19, s. 7</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436700" lims:id="1436700" lims:enactId="1434938">SOR/2023-277, s. 17</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:lastAmendedDate="2024-01-03" lims:fid="1436706" lims:id="1436706"><Label>68.301</Label><Subsection lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436707" lims:id="1436707"><Label>(1)</Label><Text>Despite subsection 68.3(2), if the holder of a therapeutic product authorization issued in respect of a medical device is the manufacturer, they may permit the importer of the device to submit the information required under that subsection on the manufacturer’s behalf if the information that the manufacturer and the importer must submit is identical.</Text></Subsection><Subsection lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436708" lims:id="1436708"><Label>(2)</Label><Text>The manufacturer shall advise the Minister in writing if the manufacturer has permitted the importer to submit the information on the manufacturer’s behalf.</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436710" lims:id="1436710" lims:enactId="1434938">SOR/2023-277, s. 17</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391642" lims:id="1391642" level="3"><TitleText>Summary Report</TitleText></Heading><Section lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:lastAmendedDate="2024-01-03" lims:fid="1391643" lims:id="1391643"><Label>68.31</Label><Subsection lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391644" lims:id="1391644"><Label>(1)</Label><Text lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1435034" lims:id="1436711">The holder of an authorization for a Class II, III or IV medical device that is not a UPHN medical device shall prepare</Text><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391645" lims:id="1391645"><Label>(a)</Label><Text>in the case of a Class II device, on a biennial basis, a summary report of the information referred to in subsection (2) that the holder received or became aware of during the previous 24 months; and</Text></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391646" lims:id="1391646"><Label>(b)</Label><Text>in the case of a Class III or IV device, on an annual basis, a summary report of the information referred to in subsection (2) that the holder received or became aware of during the previous 12 months.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391647" lims:id="1391647"><Label>(2)</Label><Text>The information to be covered by the summary report is that in respect of</Text><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391648" lims:id="1391648"><Label>(a)</Label><Text>adverse effects;</Text></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391649" lims:id="1391649"><Label>(b)</Label><Text>problems referred to in paragraph 57(1)(a);</Text></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391650" lims:id="1391650"><Label>(c)</Label><Text>incidents referred to in subsection 68.27(1); and</Text></Paragraph><Paragraph lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1391651" lims:id="1436762"><Label>(d)</Label><Text>serious risks of injury to human health that are relevant to the safety of the medical device and are referred to in subsection 68.3(1).</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391652" lims:id="1391652"><Label>(3)</Label><Text>The summary report shall contain a concise critical analysis of the information referred to in subsection (2).</Text></Subsection><Subsection lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391653" lims:id="1391653"><Label>(4)</Label><Text lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1435048" lims:id="1436763">In preparing the summary report, the holder shall determine, on the basis of the critical analysis, whether what is known about the benefits and risks associated with the medical device has changed in any of the following ways:</Text><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391654" lims:id="1391654"><Label>(a)</Label><Text>the potential benefits for patients through the use of the device may be less;</Text></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391655" lims:id="1391655"><Label>(b)</Label><Text>in respect of each of the risks,</Text><Subparagraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391656" lims:id="1391656"><Label>(i)</Label><Text>the harm associated with the risk is more likely to occur, or</Text></Subparagraph><Subparagraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391657" lims:id="1391657"><Label>(ii)</Label><Text>if the harm associated with the risk occurs, the consequences for the health or safety of patients, users or other persons could be more serious; and</Text></Subparagraph></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391658" lims:id="1391658"><Label>(c)</Label><Text>a new risk has been identified.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391659" lims:id="1391659"><Label>(5)</Label><Text>The holder shall include the conclusions they reach under subsection (4) in the summary report.</Text></Subsection><Subsection lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1391660" lims:id="1436764"><Label>(6)</Label><Text>If, in preparing the summary report, the holder concludes that what is known about the benefits and risks associated with the medical device has changed in any of the ways referred to in paragraphs (4)(a) to (c), they shall notify the Minister, in writing, within 72 hours after having reached the conclusion, unless that has already been done.</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391662" lims:id="1391662" lims:enactId="1390912">SOR/2023-19, s. 7</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436712" lims:id="1436712" lims:enactId="1434940">SOR/2023-277, s. 18</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436785" lims:id="1436785" lims:enactId="1434959">SOR/2023-277, s. 25</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:lastAmendedDate="2024-01-03" lims:fid="1391663" lims:id="1391663"><Label>68.32</Label><Subsection lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391664" lims:id="1391664"><Label>(1)</Label><Text lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1435049" lims:id="1436765">The Minister may, for the purposes of determining whether there is sufficient evidence to support the conclusion that the benefits associated with a medical device outweigh the risks, request that the holder of an authorization for the device submit, within a specified time limit, any of the following:</Text><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391665" lims:id="1391665"><Label>(a)</Label><Text>summary reports; or</Text></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391666" lims:id="1391666"><Label>(b)</Label><Text>information on the basis of which summary reports were prepared.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391667" lims:id="1391667"><Label>(2)</Label><Text>The holder shall submit to the Minister the summary reports or information, or both, that the Minister requests within the time limit specified in the request.</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391669" lims:id="1391669" lims:enactId="1390912">SOR/2023-19, s. 7</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436787" lims:id="1436787" lims:enactId="1434959">SOR/2023-277, s. 25</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:lastAmendedDate="2024-01-03" lims:fid="1391670" lims:id="1391670"><Label>68.33</Label><Subsection lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1391671" lims:id="1436766"><Label>(1)</Label><Text>The holder of an authorization for a medical device shall maintain records of the summary reports and the information on the basis of which those reports were prepared.</Text></Subsection><Subsection lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391672" lims:id="1391672"><Label>(2)</Label><Text>The holder shall retain the records for seven years after the day on which they were created.</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391674" lims:id="1391674" lims:enactId="1390912">SOR/2023-19, s. 7</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436788" lims:id="1436788" lims:enactId="1434959">SOR/2023-277, s. 25</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391675" lims:id="1391675" level="3"><TitleText>Obligation to Submit Certificate</TitleText></Heading><Section lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:lastAmendedDate="2024-01-03" lims:fid="1391676" lims:id="1391676"><Label>68.34</Label><Subsection lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1391677" lims:id="1436713"><Label>(1)</Label><Text>If a new or modified quality management system certificate is issued in respect of a medical device for which the manufacturer holds an authorization and that is not a UPHN medical device, the manufacturer shall submit a copy of the certificate to the Minister within 30 days after it is issued.</Text></Subsection><Subsection lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391678" lims:id="1391678"><Label>(2)</Label><Text>Subsection (1) does not apply if the manufacturer includes the new or modified quality management system certificate in an application to amend the authorization that is submitted under section 68.14.</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391680" lims:id="1391680" lims:enactId="1390912">SOR/2023-19, s. 7</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436714" lims:id="1436714" lims:enactId="1434942">SOR/2023-277, s. 19</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391681" lims:id="1391681" level="3"><TitleText>Sale — Cancellation of Authorization</TitleText></Heading><Section lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:lastAmendedDate="2024-01-03" lims:fid="1391682" lims:id="1436715"><Label>68.35</Label><Text>Subject to sections 21, 23 and 44, if an authorization for a medical device is cancelled under paragraph 68.21(1)(h), (i) or (j), a person other than the manufacturer may sell the device, despite any other provision in Part 1, for a period of six months beginning on the day on which the authorization is cancelled.</Text><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391684" lims:id="1391684" lims:enactId="1390912">SOR/2023-19, s. 7</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436716" lims:id="1436716" lims:enactId="1434944">SOR/2023-277, s. 20</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391685" lims:id="1391685" level="2"><TitleText>Expanded Use</TitleText></Heading><Section lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:lastAmendedDate="2024-01-03" lims:fid="1436717" lims:id="1436717"><Label>68.351</Label><Text>The Minister may add a medical condition to column 1 of the <XRefExternal reference-type="other">List of Medical Devices for Expanded Use</XRefExternal> only if the Minister has reasonable grounds to believe that</Text><Paragraph lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436718" lims:id="1436718"><Label>(a)</Label><Text>the medical condition presents, or is the result of, a significant risk to public health in Canada; and</Text></Paragraph><Paragraph lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436719" lims:id="1436719"><Label>(b)</Label><Text>immediate action is required to deal with the risk.</Text></Paragraph><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436721" lims:id="1436721" lims:enactId="1434946">SOR/2023-277, s. 21</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:lastAmendedDate="2024-01-03" lims:fid="1391686" lims:id="1391686"><Label>68.36</Label><Subsection lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391687" lims:id="1391687"><Label>(1)</Label><Text lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1435035" lims:id="1436722">The Minister may add a licensed medical device, or a Class II, III or IV medical device for which the manufacturer holds an authorization, to column 2 of the <XRefExternal reference-type="other">List of Medical Devices for Expanded Use</XRefExternal> and an expanded use to column 3 only if the following conditions are met:</Text><Paragraph lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1391688" lims:id="1436723"><Label>(a)</Label><Text>the Minister has reasonable grounds to believe that there is an urgent public health need for the expanded use of the device that is related to the corresponding medical condition that is set out in column 1;</Text></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391689" lims:id="1391689"><Label>(b)</Label><Text>the Minister has sufficient evidence to support the conclusion that the benefits associated with the expanded use outweigh the risks associated with it, having regard to</Text><Subparagraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391690" lims:id="1391690"><Label>(i)</Label><Text>the uncertainties relating to those benefits and risks, and</Text></Subparagraph><Subparagraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391691" lims:id="1391691"><Label>(ii)</Label><Text>the urgent public health need for the device; and</Text></Subparagraph></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391692" lims:id="1391692"><Label>(c)</Label><Text>the Minister determines that the health or safety of patients, users or other persons will not be unduly affected by the expanded use of the device.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391693" lims:id="1391693"><Label>(2)</Label><Text>In the case of a licensed medical device, sections 26 and 27, as they relate to an expanded use of the device, do not apply in respect of the importation, sale or advertisement of the device if</Text><Paragraph lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1391694" lims:id="1436724"><Label>(a)</Label><Text>the medical condition to which the expanded use relates is set out in column 1 of the <XRefExternal reference-type="other">List of Medical Devices for Expanded Use</XRefExternal>;</Text></Paragraph><Paragraph lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1391695" lims:id="1436725"><Label>(b)</Label><Text>the device is set out in column 2 of that list; and</Text></Paragraph><Paragraph lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436727" lims:id="1436727"><Label>(c)</Label><Text>the expanded use of the device is set out in column 3 of that list.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1391696" lims:id="1436728"><Label>(3)</Label><Text>In the case of a Class II, III or IV medical device for which the manufacturer holds an authorization, sections 27 and 68.13, as they relate to an expanded use of the device, do not apply in respect of the importation, sale or advertisement of the device if</Text><Paragraph lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436729" lims:id="1436729"><Label>(a)</Label><Text>the medical condition to which the expanded use relates is set out in column 1 of the <XRefExternal reference-type="other">List of Medical Devices for Expanded Use</XRefExternal>;</Text></Paragraph><Paragraph lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436730" lims:id="1436730"><Label>(b)</Label><Text>the device is set out in column 2 of that list; and</Text></Paragraph><Paragraph lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436731" lims:id="1436731"><Label>(c)</Label><Text>the expanded use of the device is set out in column 3 of that list.</Text></Paragraph></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391700" lims:id="1391700" lims:enactId="1390912">SOR/2023-19, s. 7</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436732" lims:id="1436732" lims:enactId="1434948">SOR/2023-277, s. 22</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:lastAmendedDate="2024-01-03" lims:fid="1391701" lims:id="1391701"><Label>68.37</Label><Text lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1435036" lims:id="1436733">The Minister shall publish on the Government of Canada website supplementary information pertaining to the expanded use, set out in column 3 of the <XRefExternal reference-type="other">List of Medical Devices for Expanded Use</XRefExternal>, of a licensed medical device — or a Class II, III or IV medical device for which the manufacturer holds an authorization —, set out in column 2 of that list, including</Text><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391702" lims:id="1391702"><Label>(a)</Label><Text>a statement of the expanded use;</Text></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391703" lims:id="1391703"><Label>(b)</Label><Text>a statement of the known and potential benefits and risks; and</Text></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391704" lims:id="1391704"><Label>(c)</Label><Text>any supplement to the directions for use, unless a supplement is not required for the device to be used safely and effectively.</Text></Paragraph><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391706" lims:id="1391706" lims:enactId="1390912">SOR/2023-19, s. 7</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436734" lims:id="1436734" lims:enactId="1434955">SOR/2023-277, s. 23</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:lastAmendedDate="2024-01-03" lims:fid="1391707" lims:id="1391707"><Label>68.38</Label><Subsection lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1391708" lims:id="1436735"><Label>(1)</Label><Text>The Minister may request from the holder of a medical device licence, in respect of the medical device that is set out in column 2 of the <XRefExternal reference-type="other">List of Medical Devices for Expanded Use</XRefExternal> for which the licence was issued, any information in relation to the expanded use that is set out in column 3 of that list that the holder possesses or to which they have reasonable access.</Text></Subsection><Subsection lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1391709" lims:id="1436736"><Label>(2)</Label><Text>The Minister may request from the holder of an authorization, in respect of the Class II, III or IV medical device set out in column 2 of the <XRefExternal reference-type="other">List of Medical Devices for Expanded Use</XRefExternal> for which the authorization was issued, any information in relation to the expanded use set out in column 3 of that list that the holder possesses or to which they have reasonable access.</Text></Subsection><Subsection lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391710" lims:id="1391710"><Label>(3)</Label><Text>The holder of the licence or authorization shall submit to the Minister the information that the Minister requests within the time limit specified in the request.</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391712" lims:id="1391712" lims:enactId="1390912">SOR/2023-19, s. 7</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2024-01-03" lims:enacted-date="2023-12-19" lims:fid="1436737" lims:id="1436737" lims:enactId="1434957">SOR/2023-277, s. 24</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-12-29" lims:fid="1021921" lims:id="1021921" level="1"><Label>PART 2</Label><TitleText>Custom-Made Devices and Medical Devices to Be Imported or Sold for Special Access</TitleText></Heading><Heading lims:inforce-start-date="2018-12-29" lims:fid="1021922" lims:id="1021922" level="2"><TitleText>Application</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1021923" lims:id="1021923"><Label>69</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1021924" lims:id="1021924"><Label>(1)</Label><Text>This Part applies to custom-made devices and medical devices that are to be imported or sold for special access.</Text></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1021925" lims:id="1021925"><Label>(2)</Label><Text>In this Part, <DefinedTermEn>special access</DefinedTermEn> means access to a medical device for emergency use or if conventional therapies have failed, are unavailable or are unsuitable.</Text></Subsection></Section><Heading lims:inforce-start-date="2018-12-29" lims:fid="1021926" lims:id="1021926" level="2"><TitleText>General</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1021927" lims:id="1021927"><Label>70</Label><Text>No person shall import or sell a Class III or IV custom-made device or a medical device for special access unless the Minister has issued an authorization for its sale or importation.</Text></Section><Heading lims:inforce-start-date="2018-12-29" lims:fid="1021928" lims:id="1021928" level="2"><TitleText>Authorization</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2023-02-22" lims:fid="1021929" lims:id="1021929"><Label>71</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1021930" lims:id="1021930"><Label>(1)</Label><Text>If a health care professional wishes to obtain a medical device referred to in section 70, the professional shall apply to the Minister for an authorization that would permit the manufacturer or importer of the device to sell, or to import and sell, the device to that professional.</Text></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1021931" lims:id="1021931"><Label>(2)</Label><Text>The application shall contain the following:</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021932" lims:id="1021932"><Label>(a)</Label><Text>the name of the device, its class and its identifier, including the identifier of any medical device that is part of a system, test kit, medical device group, medical device family or medical device group family;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021933" lims:id="1021933"><Label>(b)</Label><Text>the number of units required;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021934" lims:id="1021934"><Label>(c)</Label><Text>the name and address of the manufacturer or importer;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021935" lims:id="1021935"><Label>(d)</Label><Text>the name, title and telephone number of the representative of the manufacturer or importer to contact for any information concerning the device;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021936" lims:id="1021936"><Label>(e)</Label><Text>the diagnosis, treatment or prevention for which the device is required;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021937" lims:id="1021937"><Label>(f)</Label><Text>a statement that sets out</Text><Subparagraph lims:inforce-start-date="2006-03-22" lims:fid="1021938" lims:id="1021938"><Label>(i)</Label><Text>the reasons the device was chosen for the diagnosis, treatment or prevention,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2006-03-22" lims:fid="1021939" lims:id="1021939"><Label>(ii)</Label><Text>the risks and benefits that are associated with its use, and</Text></Subparagraph><Subparagraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1021940" lims:id="1391380"><Label>(iii)</Label><Text>the reasons the diagnosis, treatment or prevention could not be accomplished using</Text><Clause lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391381" lims:id="1391381"><Label>(A)</Label><Text>a licensed medical device that is available for sale in Canada, or</Text></Clause><Clause lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391382" lims:id="1391382"><Label>(B)</Label><Text>a medical device for which the manufacturer of that device holds an authorization issued under section 68.12 and that is available for sale in Canada;</Text></Clause></Subparagraph></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021941" lims:id="1021941"><Label>(g)</Label><Text>the name and address of each health care facility at which the device is to be used by that professional;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021942" lims:id="1021942"><Label>(h)</Label><Text>the known safety and effectiveness information in respect of the device;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021943" lims:id="1021943"><Label>(i)</Label><Text>a written undertaking by the health care professional that the professional will inform the patient for whom the device is intended of the risks and benefits associated with its use;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021944" lims:id="1021944"><Label>(j)</Label><Text>the directions for use, unless directions are not required for the device to be used safely and effectively; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021945" lims:id="1021945"><Label>(k)</Label><Text>in the case of a custom-made device, a copy of the health care professional’s written direction to the manufacturer giving the design characteristics of the device.</Text></Paragraph></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391384" lims:id="1391384" lims:enactId="1390914">SOR/2023-19, s. 8</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2023-02-22" lims:fid="1021946" lims:id="1021946"><Label>72</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1021947" lims:id="1021947"><Label>(1)</Label><Text>The Minister shall issue an authorization referred to in subsection 71(1) to a manufacturer or importer if the Minister determines that</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021948" lims:id="1021948"><Label>(a)</Label><Text>the benefits that may be obtained by the patient through the use of the device outweigh the risks associated with its use;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021949" lims:id="1021949"><Label>(b)</Label><Text>the health or safety of patients, users or other persons will not be unduly affected;</Text></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1021950" lims:id="1391386"><Label>(c)</Label><Text>a licensed device that would adequately meet the requirements of the patient is not available in Canada;</Text></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391385" lims:id="1391385"><Label>(c.1)</Label><Text>a medical device for which the manufacturer of that device holds an authorization issued under section 68.12 and that would adequately meet the requirements of the patient is not available for sale in Canada; and</Text></Paragraph><Paragraph lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1021951" lims:id="1391387"><Label>(d)</Label><Text>the authorization is not being used by the manufacturer or importer to circumvent the requirements of Part 1 or 1.1.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1021952" lims:id="1021952"><Label>(2)</Label><Text>The authorization issued under subsection (1) shall specify</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021953" lims:id="1021953"><Label>(a)</Label><Text>the number of units of the device authorized to be imported;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021954" lims:id="1021954"><Label>(b)</Label><Text>the number of units of the device authorized to be sold; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021955" lims:id="1021955"><Label>(c)</Label><Text>the name of the health care professional to whom the manufacturer or importer may sell the device.</Text></Paragraph></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2023-02-22" lims:enacted-date="2023-02-03" lims:fid="1391389" lims:id="1391389" lims:enactId="1390916">SOR/2023-19, s. 9</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-12-29" lims:fid="1021956" lims:id="1021956" level="2"><TitleText>Additional Information</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1021957" lims:id="1021957"><Label>73</Label><Text>If the information and documents submitted in respect of an application made pursuant to section 71 are insufficient to enable the Minister to determine whether the conditions set out in subsection 72(1) have been met, the manufacturer, importer or health care professional shall, at the request of the Minister, submit any further information relevant to the application that the Minister may request.</Text></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1021958" lims:id="1021958"><Label>74</Label><Text>The Minister may, in respect of an authorization that has been issued,</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021959" lims:id="1021959"><Label>(a)</Label><Text>request the manufacturer, importer or health care professional to submit information in respect of the device if the Minister believes on reasonable grounds, after reviewing a report or information brought to the Minister’s attention, that the device for which the authorization has been issued no longer meets the conditions set out in subsection 72(1); and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021960" lims:id="1021960"><Label>(b)</Label><Text>issue a written cancellation of the authorization, giving reasons, if</Text><Subparagraph lims:inforce-start-date="2006-03-22" lims:fid="1021961" lims:id="1021961"><Label>(i)</Label><Text>the Minister determines that the conditions set out in subsection 72(1) are no longer met, or</Text></Subparagraph><Subparagraph lims:inforce-start-date="2006-03-22" lims:fid="1021962" lims:id="1021962"><Label>(ii)</Label><Text>the information referred to in paragraph (a) has not been submitted.</Text></Subparagraph></Paragraph></Section><Heading lims:inforce-start-date="2018-12-29" lims:fid="1021963" lims:id="1021963" level="2"><TitleText>Labelling</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1021964" lims:id="1021964"><Label>75</Label><Text>No person shall import or sell a medical device in respect of which an authorization has been issued pursuant to section 72, or a Class I or II custom-made device, unless the device has a label that</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021965" lims:id="1021965"><Label>(a)</Label><Text>sets out the name of the manufacturer;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021966" lims:id="1021966"><Label>(b)</Label><Text>sets out the name of the device; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021967" lims:id="1021967"><Label>(c)</Label><Text>specifies whether the device is a custom-made device or is being imported or sold for special access.</Text></Paragraph></Section><Heading lims:inforce-start-date="2018-12-29" lims:fid="1021968" lims:id="1021968" level="2"><TitleText>Distribution Records</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1021969" lims:id="1021969"><Label>76</Label><Text>The manufacturer or importer of a medical device in respect of which an authorization has been issued pursuant to section 72 shall maintain a distribution record in respect of the device in accordance with sections 52 to 56.</Text></Section><Heading lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1021970" lims:id="1300844" level="2"><TitleText>Incident Reporting</TitleText><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1300846" lims:id="1300846" lims:enactId="1278692">SOR/2020-262, s. 18(E)</HistoricalNoteSubItem></HistoricalNote></Heading><Section lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:lastAmendedDate="2021-06-23" lims:fid="1021971" lims:id="1300847"><Label>77</Label><Text>The health care professional referred to in subsection 71(1) shall, within 72 hours after becoming aware of an incident that involves the medical device for which an authorization has been issued under section 72 and that meets the following conditions, report the incident to the Minister and to the manufacturer or importer of the device and specify the nature of the incident and the circumstances surrounding it:</Text><Paragraph lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1300848" lims:id="1300848"><Label>(a)</Label><Text>the incident is related to a failure of the device or a deterioration in its effectiveness or any inadequacy in its labelling or in its directions for use; and</Text></Paragraph><Paragraph lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1300849" lims:id="1300849"><Label>(b)</Label><Text>the incident has led to the death or a serious deterioration in the state of health of a patient, user or other person or could do so were the incident to recur.</Text></Paragraph><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1300851" lims:id="1300851" lims:enactId="1278694">SOR/2020-262, s. 19</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-12-29" lims:fid="1021972" lims:id="1021972" level="2"><TitleText>Implant Registration</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1021973" lims:id="1021973"><Label>78</Label><Text>Sections 66 to 68 apply in respect of an implant that is imported or sold for special access.</Text><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2006-03-22" lims:fid="1021975" lims:id="1021975">SOR/2002-190, s. 7</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-12-29" lims:fid="1021976" lims:id="1021976" level="1"><Label>PART 3</Label><TitleText>Medical Devices for Investigational Testing Involving Human Subjects</TitleText></Heading><Heading lims:inforce-start-date="2018-12-29" lims:fid="1021977" lims:id="1021977" level="2"><TitleText>Application</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1021978" lims:id="1021978"><Label>79</Label><Text>This Part applies to medical devices that are to be imported or sold for investigational testing involving human subjects.</Text></Section><Heading lims:inforce-start-date="2018-12-29" lims:fid="1021979" lims:id="1021979" level="2"><TitleText>General</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1021980" lims:id="1021980"><Label>80</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1021981" lims:id="1021981"><Label>(1)</Label><Text>Subject to subsections (2) and (3), no person shall import or sell a medical device for investigational testing.</Text></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1021982" lims:id="1021982"><Label>(2)</Label><Text>A manufacturer or importer of a Class II, III or IV medical device may sell the device to a qualified investigator for the purpose of conducting investigational testing if the manufacturer or importer holds an authorization issued under subsection 83(1) and possesses records that contain all the information and documents required by section 81.</Text></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1021983" lims:id="1021983"><Label>(3)</Label><Text>A manufacturer or importer of a Class I medical device may sell the device to a qualified investigator for the purpose of conducting investigational testing if the manufacturer or importer possesses records that contain all the information and documents required by section 81.</Text></Subsection></Section><Heading lims:inforce-start-date="2018-12-29" lims:fid="1021984" lims:id="1021984" level="2"><TitleText>Records</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2021-06-23" lims:fid="1021985" lims:id="1021985"><Label>81</Label><Text>The records referred to in section 80 shall contain the following:</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021986" lims:id="1021986"><Label>(a)</Label><Text>the name, address and telephone number of the manufacturer and the importer of the device;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021987" lims:id="1021987"><Label>(b)</Label><Text>the name of the device, its class and its identifier, including the identifier of any medical device that is part of a system, test kit, medical device group, medical device family or medical device group family;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021988" lims:id="1021988"><Label>(c)</Label><Text>a description of the device and of the materials used in its manufacture and packaging;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021989" lims:id="1021989"><Label>(d)</Label><Text>a description of the features of the device that permit it to be used for the medical conditions, purposes and uses for which it is manufactured, sold or represented;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021990" lims:id="1021990"><Label>(e)</Label><Text>a list of the countries other than Canada where the device has been sold, the total number of units sold in those countries, and a summary of any reported problems with the device and any recalls of the device in those countries;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021991" lims:id="1021991"><Label>(f)</Label><Text>a risk assessment comprising an analysis and evaluation of the risks, and the risk reduction measures adopted for the purposes of conducting investigational testing of the device, including, as appropriate,</Text><Subparagraph lims:inforce-start-date="2006-03-22" lims:fid="1021992" lims:id="1021992"><Label>(i)</Label><Text>the results of any previous research, testing and studies conducted with respect to the device,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2006-03-22" lims:fid="1021993" lims:id="1021993"><Label>(ii)</Label><Text>a description of the methods currently used to diagnose or treat the medical condition in respect of which the investigational testing is being proposed, and</Text></Subparagraph><Subparagraph lims:inforce-start-date="2006-03-22" lims:fid="1021994" lims:id="1021994"><Label>(iii)</Label><Text>information respecting any cautions, warnings, contra-indications and possible adverse effects associated with the use of the device;</Text></Subparagraph></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021995" lims:id="1021995"><Label>(g)</Label><Text>the names of all the qualified investigators to whom the device is proposed to be sold and their qualifications, including their training and experience;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021996" lims:id="1021996"><Label>(h)</Label><Text>the name and address of each institution at which the investigational testing is proposed to be conducted and, in the case of a Class III or IV device, written approval from the institution indicating that the investigational testing may be carried out there;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021997" lims:id="1021997"><Label>(i)</Label><Text>a protocol of the proposed investigational testing, including the number of units of the device proposed to be used for the testing, the hypothesis for and objective of the testing, the period of time during which the testing will be carried out and a copy of the patient consent form;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021998" lims:id="1021998"><Label>(j)</Label><Text>a copy of the device label; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1021999" lims:id="1021999"><Label>(k)</Label><Text>a written undertaking from each qualified investigator to</Text><Subparagraph lims:inforce-start-date="2006-03-22" lims:fid="1022000" lims:id="1022000"><Label>(i)</Label><Text>conduct the investigational testing in accordance with the protocol provided by the manufacturer,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2006-03-22" lims:fid="1022001" lims:id="1022001"><Label>(ii)</Label><Text>inform a patient who is to be diagnosed or treated using the device of any risks and benefits associated with its use, and obtain the patient’s written consent for its use,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2006-03-22" lims:fid="1022002" lims:id="1022002"><Label>(iii)</Label><Text>not use the device or permit it to be used for any purpose other than the investigational testing specified in the protocol,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2006-03-22" lims:fid="1022003" lims:id="1022003"><Label>(iv)</Label><Text>not permit the device to be used by any other person except under the direction of the qualified investigator, and</Text></Subparagraph><Subparagraph lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1022004" lims:id="1300852"><Label>(v)</Label><Text>in the event of an incident involving the device and that meets the following conditions, report the incident and the circumstances surrounding it to the Minister and to the manufacturer or importer of the device within 72 hours after the qualified investigator becomes aware of the incident:</Text><Clause lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1300853" lims:id="1300853"><Label>(A)</Label><Text>the incident is related to a failure of the device or a deterioration in its effectiveness or any inadequacy in its labelling or in its directions for use, and</Text></Clause><Clause lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1300854" lims:id="1300854"><Label>(B)</Label><Text>the incident has led to the death or a serious deterioration in the state of health of a patient, user or other person or could do so were the incident to recur.</Text></Clause></Subparagraph></Paragraph><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1300856" lims:id="1300856" lims:enactId="1278696">SOR/2020-262, s. 20</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-12-29" lims:fid="1022005" lims:id="1022005" level="2"><TitleText>Authorization</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1022006" lims:id="1022006"><Label>82</Label><Text>An application for an authorization referred to in subsection 80(2) shall be made in writing to the Minister and shall contain</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1022007" lims:id="1022007"><Label>(a)</Label><Text>in the case of a Class II medical device or a Class III or IV <Language xml:lang="la">in vitro</Language> diagnostic device that is not used for patient management, not including a near-patient <Language xml:lang="la">in vitro</Language> diagnostic device, the information set out in paragraphs 81(a), (b) and (h) to (j); and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1022008" lims:id="1022008"><Label>(b)</Label><Text>in the case of a Class III or IV medical device that is not covered by paragraph (a), the information and documents set out in section 81.</Text></Paragraph><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2006-03-22" lims:fid="1022010" lims:id="1022010">SOR/2002-190, s. 8</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1022011" lims:id="1022011"><Label>83</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1022012" lims:id="1022012"><Label>(1)</Label><Text>The Minister shall issue an authorization referred to in subsection 80(2) to a manufacturer or importer if the Minister determines that</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1022013" lims:id="1022013"><Label>(a)</Label><Text>the device can be used for investigational testing without seriously endangering the life, health or safety of patients, users or other persons;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1022014" lims:id="1022014"><Label>(b)</Label><Text>the investigational testing is not contrary to the best interests of patients on whom the testing will be conducted; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1022015" lims:id="1022015"><Label>(c)</Label><Text>the objective of the testing will be achieved.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1022016" lims:id="1022016"><Label>(2)</Label><Text>The authorization referred to subsection (1) shall specify</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1022017" lims:id="1022017"><Label>(a)</Label><Text>the name of any qualified investigator to whom the device may be sold;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1022018" lims:id="1022018"><Label>(b)</Label><Text>the type of diagnosis or treatment for which the device may be sold;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1022019" lims:id="1022019"><Label>(c)</Label><Text>the number of units of the device that are authorized to be sold; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1022020" lims:id="1022020"><Label>(d)</Label><Text>the protocol according to which the investigational testing is to be conducted.</Text></Paragraph></Subsection></Section><Heading lims:inforce-start-date="2018-12-29" lims:fid="1022021" lims:id="1022021" level="2"><TitleText>Additional Information</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1022022" lims:id="1022022"><Label>84</Label><Text>If the information and documents submitted in respect of an application made pursuant to section 82 are insufficient to enable the Minister to determine whether the conditions set out in subsection 83(1) have been met, the manufacturer or importer shall, at the request of the Minister, submit any further information relevant to the application that the Minister may request.</Text></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1022023" lims:id="1022023"><Label>85</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1022024" lims:id="1022024"><Label>(1)</Label><Text>The Minister may, in respect of a medical device in relation to which investigational testing is being conducted, request the manufacturer or importer of the device to submit information in respect of the testing if the Minister believes on reasonable grounds, after reviewing a report or information brought to the Minister’s attention, that one of the following conditions may exist:</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1022025" lims:id="1022025"><Label>(a)</Label><Text>the testing seriously endangers the life, health or safety of patients, users or other persons;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1022026" lims:id="1022026"><Label>(b)</Label><Text>the testing is contrary to the best interests of patients on whom the testing is being conducted;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1022027" lims:id="1022027"><Label>(c)</Label><Text>the objective of the testing will not be achieved;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1022028" lims:id="1022028"><Label>(d)</Label><Text>the qualified investigator who is conducting the testing is not respecting the undertaking required by paragraph 81(k); or</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1022029" lims:id="1022029"><Label>(e)</Label><Text>the information submitted in respect of the testing is false or misleading.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1022030" lims:id="1022030"><Label>(2)</Label><Text>If the information requested pursuant to subsection (1) is not submitted, or if it is submitted and the Minister determines after reviewing it that a condition identified in that subsection exists, the Minister may, by written notice giving reasons,</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1022031" lims:id="1022031"><Label>(a)</Label><Text>in the case of a Class I device, direct the manufacturer or importer of the device to stop selling the device to any qualified investigator named in the notice; or</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1022032" lims:id="1022032"><Label>(b)</Label><Text>in the case of a Class II, III or IV device, cancel the authorization referred to in subsection 83(1), in whole or in part.</Text></Paragraph></Subsection></Section><Heading lims:inforce-start-date="2018-12-29" lims:fid="1022033" lims:id="1022033" level="2"><TitleText>Labelling</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1022034" lims:id="1022034"><Label>86</Label><Text>No person shall import or sell a medical device for investigational testing unless the device has a label that sets out</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1022035" lims:id="1022035"><Label>(a)</Label><Text>the name of the manufacturer;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1022036" lims:id="1022036"><Label>(b)</Label><Text>the name of the device;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1022037" lims:id="1022037"><Label>(c)</Label><Text>the statements “Investigational Device” and “<Language xml:lang="fr">Instrument de recherche</Language>”, or any other statement, in English and French, that conveys that meaning;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1022038" lims:id="1022038"><Label>(d)</Label><Text>the statements “To Be Used by Qualified Investigators Only” and “<Language xml:lang="fr">Réservé uniquement à l’usage de chercheurs compétents</Language>”, or any other statement, in English and French, that conveys that meaning; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1022039" lims:id="1022039"><Label>(e)</Label><Text>in the case of an IVDD, the statements “The performance specifications of this device have not been established” and “<Language xml:lang="fr">Les spécifications de rendement de l’instrument n’ont pas été établies</Language>”, or any other statement, in English and French, that conveys that meaning.</Text></Paragraph></Section><Heading lims:inforce-start-date="2018-12-29" lims:fid="1022040" lims:id="1022040" level="2"><TitleText>Advertising</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1022041" lims:id="1022041"><Label>87</Label><Text>No person shall advertise a medical device that is the subject of investigational testing unless</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1022042" lims:id="1022042"><Label>(a)</Label><Text>that person holds an authorization issued under subsection 83(1) to sell or import the device; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1022043" lims:id="1022043"><Label>(b)</Label><Text>the advertisement clearly indicates that the device is the subject of investigational testing, and the purpose of the investigational testing.</Text></Paragraph></Section><Heading lims:inforce-start-date="2018-12-29" lims:fid="1022044" lims:id="1022044" level="2"><TitleText>Other Requirements</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2021-06-23" lims:fid="1022045" lims:id="1022045"><Label>88</Label><Text>The requirements set out in the following provisions apply to medical devices to which this Part applies:</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1022046" lims:id="1022046"><Label>(a)</Label><Text>sections 52 to 56 with respect to distribution records;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1022047" lims:id="1022047"><Label>(b)</Label><Text>sections 57 and 58 with respect to complaint handling;</Text></Paragraph><Paragraph lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1022048" lims:id="1300857"><Label>(c)</Label><Text>sections 59 to 61.1 with respect to reports on incidents;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1022049" lims:id="1022049"><Label>(d)</Label><Text>sections 63 to 65.1 with respect to recalls; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1022050" lims:id="1022050"><Label>(e)</Label><Text>sections 66 to 68 with respect to implant registration.</Text></Paragraph><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2006-03-22" lims:fid="1022052" lims:id="1022052">SOR/2002-190, s. 9</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1300858" lims:id="1300858" lims:enactId="1278698">SOR/2020-262, s. 21</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:lastAmendedDate="2021-06-23" lims:fid="1300859" lims:id="1300859"><Label>88.1</Label><Text>Subsections 61.2(2) and (3) and section 61.3 apply in respect of medical devices to which this Part applies except that the references to a holder of a therapeutic product authorization in those provisions shall be read as references to a holder of an authorization issued under subsection 83(1).</Text><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2021-06-23" lims:enacted-date="2020-12-04" lims:fid="1300861" lims:id="1300861" lims:enactId="1278700">SOR/2020-262, s. 22</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-12-29" lims:fid="1022053" lims:id="1022053" level="1"><Label>PART 4</Label><TitleText>Export Certificates</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1022054" lims:id="1022054"><Label>89</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1022055" lims:id="1022055"><Label>(1)</Label><Text>For the purposes of section 37 of the Act, Schedule 3 sets out the form to be used for an export certificate for medical devices.</Text></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1022056" lims:id="1022056"><Label>(2)</Label><Text>The export certificate shall be signed and dated by</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1022057" lims:id="1022057"><Label>(a)</Label><Text>where the exporter of the device is a corporation,</Text><Subparagraph lims:inforce-start-date="2006-03-22" lims:fid="1022058" lims:id="1022058"><Label>(i)</Label><Text>the exporter’s senior executive officer in Canada,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2006-03-22" lims:fid="1022059" lims:id="1022059"><Label>(ii)</Label><Text>the exporter’s senior regulatory officer in Canada, or</Text></Subparagraph><Subparagraph lims:inforce-start-date="2006-03-22" lims:fid="1022060" lims:id="1022060"><Label>(iii)</Label><Text>the authorized agent of the person referred to in subparagraph (i) or (ii); or</Text></Subparagraph></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1022061" lims:id="1022061"><Label>(b)</Label><Text>where the exporter of the device is an individual,</Text><Subparagraph lims:inforce-start-date="2006-03-22" lims:fid="1022062" lims:id="1022062"><Label>(i)</Label><Text>the exporter, or</Text></Subparagraph><Subparagraph lims:inforce-start-date="2006-03-22" lims:fid="1022063" lims:id="1022063"><Label>(ii)</Label><Text>the exporter’s authorized agent.</Text></Subparagraph></Paragraph></Subsection></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1022064" lims:id="1022064"><Label>90</Label><Text>No person shall sign an export certificate that is false or misleading or that contains omissions that may affect its accuracy and completeness.</Text></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1022065" lims:id="1022065"><Label>91</Label><Text>The exporter of a device shall maintain, at their principal place of business in Canada, records that contain the completed export certificates and shall, when requested to do so by an inspector, submit the export certificates for examination.</Text></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1022066" lims:id="1022066"><Label>92</Label><Text>The exporter of a device shall retain the export certificate for a period of not less than five years after the date of export.</Text></Section><Heading lims:inforce-start-date="2018-12-29" lims:fid="1022067" lims:id="1022067" level="1"><Label>PART 5</Label><TitleText>Transitional Provisions, Repeal and Coming into Force</TitleText></Heading><Heading lims:inforce-start-date="2018-12-29" lims:fid="1022068" lims:id="1022068" level="2"><TitleText>Transitional Provisions</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1022069" lims:id="1022069" type="transitional"><Label>93</Label><Text>For the purposes of sections 94 and 95, <DefinedTermEn>old regulations</DefinedTermEn> means the <XRefExternal reference-type="regulation" link="SOR-98-282">Medical Devices Regulations</XRefExternal>, C.R.C., c. 871, and <DefinedTermEn>Director</DefinedTermEn> has the meaning assigned to it by those regulations.</Text></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1022070" lims:id="1022070" type="transitional"><Label>94</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1022071" lims:id="1022071" type="transitional"><Label>(1)</Label><Text>Subject to subsection (2), if an application for a notice of compliance has been submitted with respect to a medical device pursuant to Part V of the old regulations but has not been processed by the Director as of June 30, 1998, an application for a medical device licence shall be made pursuant to these Regulations.</Text></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1022072" lims:id="1022072" type="transitional"><Label>(2)</Label><Text>For the purposes of an application for a medical device licence, the information and documents required by paragraphs 32(2)(a) to (e), (3)(a) to (i) or (4)(a) to (o) are deemed to have been submitted if a notice of compliance with respect to the device had been issued under the old regulations.</Text></Subsection></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1022073" lims:id="1022073" type="transitional"><Label>95</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1022074" lims:id="1022074" type="transitional"><Label>(1)</Label><Text>A medical device that, on June 30, 1998, is being sold in Canada pursuant to the old regulations is not required to be licensed until February 1, 1999, if,</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1022075" lims:id="1022075" type="transitional"><Label>(a)</Label><Text>in the case of a device that is subject to Part V of the old regulations, the manufacturer</Text><Subparagraph lims:inforce-start-date="2006-03-22" lims:fid="1022076" lims:id="1022076" type="transitional"><Label>(i)</Label><Text>has a notice of compliance in respect of the device that is in effect on June 30, 1998, or</Text></Subparagraph><Subparagraph lims:inforce-start-date="2006-03-22" lims:fid="1022077" lims:id="1022077" type="transitional"><Label>(ii)</Label><Text>does not have a notice of compliance in respect of the device that is in effect on June 30, 1998, but has met, during the period beginning on October 8, 1982, and ending on March 31, 1983, the requirements for device notification pursuant to Part II of the old regulations in respect of the device; and</Text></Subparagraph></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1022078" lims:id="1022078" type="transitional"><Label>(b)</Label><Text>in the case of a device that is not subject to Part V of the old regulations, the manufacturer has, by June 30, 1998, furnished the Director with the notification required in subsection 24(1) of the old regulations in respect of the device.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1022079" lims:id="1022079" type="transitional"><Label>(2)</Label><Text>If an initial application for licensing of a medical device that is referred to in subsection (1) is submitted before February 1, 1999, the information and documents required by paragraphs 32(2)(a) to (e), (3)(a) to (i) or (4)(a) to (o) are deemed to have been submitted if</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1022080" lims:id="1022080" type="transitional"><Label>(a)</Label><Text>in the case of a device that is subject to Part V of the old regulations, the manufacturer</Text><Subparagraph lims:inforce-start-date="2006-03-22" lims:fid="1022081" lims:id="1022081" type="transitional"><Label>(i)</Label><Text>has a notice of compliance in respect of the device that is in effect on June 30, 1998, or</Text></Subparagraph><Subparagraph lims:inforce-start-date="2006-03-22" lims:fid="1022082" lims:id="1022082" type="transitional"><Label>(ii)</Label><Text>does not have a notice of compliance that is in effect on June 30, 1998, in respect of the device, but has met, during the period beginning on October 8, 1982, and ending on March 31, 1983, the requirements for device notification pursuant to Part II of the old regulations in respect of the device;</Text></Subparagraph></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1022083" lims:id="1022083" type="transitional"><Label>(b)</Label><Text>in the case of a device that is not subject to Part V of the old regulations, the manufacturer has, by June 30, 1998, furnished the Director with the notification required in subsection 24(1) of the old regulations in respect of the device.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1022084" lims:id="1022084" type="transitional"><Label>(3)</Label><Text>Subsections (1) and (2) cease to apply in respect of a medical device if a change described in section 34 is made in respect of the device or if the notice of compliance is suspended or cancelled under section 40 of the old regulations.</Text></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1022085" lims:id="1022085" type="transitional"><Label>(4)</Label><Text>For the purposes of this section, a notice of compliance may be suspended or cancelled under section 40 of the old regulations as if that section were still in force.</Text></Subsection></Section><Heading lims:inforce-start-date="2018-12-29" lims:fid="1022086" lims:id="1022086" level="2"><TitleText>Repeal</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1022087" lims:id="1022087" type="amending"><Label>96</Label><Text>[Repeal]</Text></Section><Heading lims:inforce-start-date="2018-12-29" lims:fid="1022088" lims:id="1022088" level="2"><TitleText>Coming into Force</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1022089" lims:id="1022089" type="transitional"><Label>97</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1022090" lims:id="1022090" type="transitional"><Label>(1)</Label><Text>Subject to subsections (2) to (5), these Regulations come into force on July 1, 1998.</Text></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1022091" lims:id="1022091" type="transitional"><Label>(2)</Label><Text>Section 32, except paragraphs (2)(f), (3)(j) and (4)(p), comes into force</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1022092" lims:id="1022092" type="transitional"><Label>(a)</Label><Text>in the case of a medical device referred to in section 94 or 95, on September 1, 1998;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="1022093" lims:id="1022093" type="transitional"><Label>(b)</Label><Text>in the case of any other medical device, on July 1, 1998.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1022094" lims:id="1022094" type="transitional"><Label>(3)</Label><Text>Paragraphs 32(2)(f), (3)(j) and (4)(p) come into force on January 1, 2003.</Text></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1022095" lims:id="1022095" type="transitional"><Label>(4)</Label><Text>Sections 43 and 44 come into force on January 1, 1999.</Text></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="1022096" lims:id="1022096" type="transitional"><Label>(5)</Label><Text>Sections 45 to 51 come into force on November 1, 1998.</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2006-03-22" lims:fid="1022098" lims:id="1022098">SOR/2001-217, s. 1</HistoricalNoteSubItem></HistoricalNote></Section></Body><Schedule lims:inforce-start-date="2007-06-07" lims:lastAmendedDate="2007-06-07" lims:fid="1022099" lims:id="1022099" spanlanguages="no" bilingual="no"><ScheduleFormHeading lims:inforce-start-date="2007-06-07" lims:fid="1022100" lims:id="1022100"><Label>SCHEDULE 1</Label><OriginatingRef>(Section 6)</OriginatingRef><TitleText>Classification Rules for Medical Devices</TitleText></ScheduleFormHeading><Heading lims:inforce-start-date="2007-06-07" lims:fid="1022101" lims:id="1022101" level="1"><Label>PART 1</Label><TitleText>Medical Devices other than in Vitro Diagnostic Devices</TitleText></Heading><Heading lims:inforce-start-date="2007-06-07" lims:fid="1022102" lims:id="1022102" level="2"><TitleText>Invasive Devices</TitleText></Heading><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022103" lims:id="1022103" format-ref="indent-0-0" language-align="yes" keep-with-next="yes" list-item="no"><Text><Emphasis style="italic">Rule 1</Emphasis>:</Text><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022104" lims:id="1022104" format-ref="indent-0-0" language-align="yes" list-item="no"><Label>(1)</Label><Text>Subject to subrules (2) and (3), all surgically invasive devices are classified as Class II.</Text></Provision><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022105" lims:id="1022105" format-ref="indent-0-0" language-align="yes" list-item="no"><Label>(2)</Label><Text>A surgically invasive device that is intended to diagnose, monitor, control or correct a defect of the central cardiovascular system or the central nervous system or of a fetus in utero is classified as Class IV.</Text></Provision><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022106" lims:id="1022106" format-ref="indent-0-0" language-align="yes" list-item="no"><Label>(3)</Label><Text>A surgically invasive device that is intended to be absorbed by the body, or that is normally intended to remain in the body for at least 30 consecutive days, is classified as Class III.</Text></Provision></Provision><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022107" lims:id="1022107" format-ref="indent-0-0" language-align="yes" keep-with-next="yes" list-item="no"><Text><Emphasis style="italic">Rule 2</Emphasis>:</Text><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022108" lims:id="1022108" format-ref="indent-0-0" language-align="yes" list-item="no"><Label>(1)</Label><Text>Subject to subrules (2) to (4), all invasive devices that penetrate the body through a body orifice or that come into contact with the surface of the eye are classified as Class II.</Text></Provision><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022109" lims:id="1022109" format-ref="indent-0-0" language-align="yes" list-item="no"><Label>(2)</Label><Text>A device described in subrule (1) that is intended to be placed in the oral or nasal cavities as far as the pharynx or in the ear canal up to the ear drum is classified as Class I.</Text></Provision><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022110" lims:id="1022110" format-ref="indent-0-0" language-align="yes" list-item="no"><Label>(3)</Label><Text>A device described in subrule (1) that is normally intended to remain in the body or in contact with the surface of the eye for at least 30 consecutive days is classified as Class III.</Text></Provision><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022111" lims:id="1022111" format-ref="indent-0-0" language-align="yes" list-item="no"><Label>(4)</Label><Text>A device described in subrule (1) that is intended to be represented as preventing the transmission of infectious agents during sexual activities or reducing the risk thereof is classified as Class III.</Text></Provision></Provision><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022112" lims:id="1022112" format-ref="indent-0-0" language-align="yes" keep-with-next="yes" list-item="no"><Text><Emphasis style="italic">Rule 3</Emphasis>:</Text><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022113" lims:id="1022113" format-ref="indent-0-0" language-align="no" list-item="no"><Text>Despite rules 1 and 2</Text><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022114" lims:id="1022114" format-ref="indent-1-1" language-align="no" list-item="no"><Label>(a)</Label><Text>all denture materials and orthodontic appliances, and their accessories, are classified as Class II;</Text></Provision><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022115" lims:id="1022115" format-ref="indent-1-1" language-align="no" list-item="no"><Label>(b)</Label><Text>all surgical or dental instruments are classified as Class I; and</Text></Provision><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022116" lims:id="1022116" format-ref="indent-1-1" language-align="no" list-item="no"><Label>(c)</Label><Text>all latex condoms are classified as Class II.</Text></Provision></Provision></Provision><Heading lims:inforce-start-date="2007-06-07" lims:fid="1022117" lims:id="1022117" level="2"><TitleText>Non-invasive Devices</TitleText></Heading><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022118" lims:id="1022118" format-ref="indent-0-0" language-align="yes" keep-with-next="yes" list-item="no"><Text><Emphasis style="italic">Rule 4</Emphasis>:</Text><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022119" lims:id="1022119" format-ref="indent-0-0" language-align="yes" list-item="no"><Label>(1)</Label><Text>Subject to subrule (2), all non-invasive devices that are intended to come into contact with injured skin are classified as Class II.</Text></Provision><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022120" lims:id="1022120" format-ref="indent-0-0" language-align="yes" list-item="no"><Label>(2)</Label><Text>A device described in subrule (1) that is intended to be used as a mechanical barrier, for compression or for absorption of exudations, is classified as Class I.</Text></Provision></Provision><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022121" lims:id="1022121" format-ref="indent-0-0" language-align="yes" keep-with-next="yes" list-item="no"><Text><Emphasis style="italic">Rule 5</Emphasis>:</Text><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022122" lims:id="1022122" format-ref="indent-0-0" language-align="no" list-item="no"><Text>A non-invasive device intended for channelling or storing gases, liquids, tissues or body fluids for the purpose of introduction into the body by means of infusion or other means of administration is classified as Class II.</Text></Provision></Provision><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022123" lims:id="1022123" format-ref="indent-0-0" language-align="yes" keep-with-next="yes" list-item="no"><Text><Emphasis style="italic">Rule 6</Emphasis>:</Text><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022124" lims:id="1022124" format-ref="indent-0-0" language-align="yes" list-item="no"><Label>(1)</Label><Text>Subject to subrules (2) and (3), a non-invasive device intended for modifying the biological or chemical composition of blood or other body fluids, or liquids, for the purpose of introduction into the body by means of infusion or other means of administration is classified as Class III.</Text></Provision><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022125" lims:id="1022125" format-ref="indent-0-0" language-align="yes" list-item="no"><Label>(2)</Label><Text>A device described in subrule (1) whose characteristics are such that the modification process may introduce a foreign substance into the body that is potentially hazardous, taking into account the nature and quantity of the substance, is classified as Class IV.</Text></Provision><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022126" lims:id="1022126" format-ref="indent-0-0" language-align="yes" list-item="no"><Label>(3)</Label><Text>A device described in subrule (1) that accomplishes the modification by centrifugation, gravity filtration or the exchange of gas or heat is classified as Class II.</Text></Provision></Provision><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022127" lims:id="1022127" format-ref="indent-0-0" language-align="yes" keep-with-next="yes" list-item="no"><Text><Emphasis style="italic">Rule 7</Emphasis>:</Text><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022128" lims:id="1022128" format-ref="indent-0-0" language-align="yes" list-item="no"><Label>(1)</Label><Text>Subject to subrule (2), all other non-invasive devices are classified as Class I.</Text></Provision><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022129" lims:id="1022129" format-ref="indent-0-0" language-align="yes" list-item="no"><Label>(2)</Label><Text>A device described in subrule (1) is classified as Class II if it is intended</Text><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022130" lims:id="1022130" format-ref="indent-1-1" language-align="no" list-item="no"><Label>(a)</Label><Text>to act as a calibrator, tester or quality control support to another medical device; or</Text></Provision><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022131" lims:id="1022131" format-ref="indent-1-1" language-align="no" list-item="no"><Label>(b)</Label><Text>to be connected to an active device that is classified as Class II, III or IV.</Text></Provision></Provision></Provision><Heading lims:inforce-start-date="2007-06-07" lims:fid="1022132" lims:id="1022132" level="2"><TitleText>Active Devices</TitleText></Heading><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022133" lims:id="1022133" format-ref="indent-0-0" language-align="yes" keep-with-next="yes" list-item="no"><Text><Emphasis style="italic">Rule 8</Emphasis>:</Text><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022134" lims:id="1022134" format-ref="indent-0-0" language-align="yes" list-item="no"><Label>(1)</Label><Text>Subject to subrules (2) and (3), an active device intended to emit ionizing radiation, including any device or software intended to control or monitor such a device or directly influence its performance, is classified as Class III.</Text></Provision><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022135" lims:id="1022135" format-ref="indent-0-0" language-align="yes" list-item="no"><Label>(2)</Label><Text>A device described in subrule (1) that is intended to be used in radiographic mode is classified as Class II.</Text></Provision><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022136" lims:id="1022136" format-ref="indent-0-0" language-align="yes" list-item="no"><Label>(3)</Label><Text>Despite subrule (2), an active device that is intended to be used for mammographies is classified as Class III.</Text></Provision></Provision><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022137" lims:id="1022137" format-ref="indent-0-0" language-align="yes" keep-with-next="yes" list-item="no"><Text><Emphasis style="italic">Rule 9</Emphasis>:</Text><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022138" lims:id="1022138" format-ref="indent-0-0" language-align="yes" list-item="no"><Label>(1)</Label><Text>Subject to subrules (2) and (3), an active therapeutic device, including any dedicated software, intended to be used to administer or withdraw energy to or from the body is classified as Class II.</Text></Provision><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022139" lims:id="1022139" format-ref="indent-0-0" language-align="yes" list-item="no"><Label>(2)</Label><Text>If the administration or withdrawal by a device described in subrule (1) is potentially hazardous, taking into account the nature of the administration or withdrawal, the intensity of the energy and the part of the body concerned, the device is classified as Class III.</Text></Provision><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022140" lims:id="1022140" format-ref="indent-0-0" language-align="yes" list-item="no"><Label>(3)</Label><Text>A device described in subrule (2) that is intended to control the treatment of a patient’s condition through a closed loop system is classified as Class IV.</Text></Provision></Provision><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022141" lims:id="1022141" format-ref="indent-0-0" language-align="yes" keep-with-next="yes" list-item="no"><Text><Emphasis style="italic">Rule 10</Emphasis>:</Text><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022142" lims:id="1022142" format-ref="indent-0-0" language-align="yes" list-item="no"><Label>(1)</Label><Text>Subject to subrule (2), an active diagnostic device, including any dedicated software, that supplies energy for the purpose of imaging or monitoring physiological processes is classified as Class II.</Text></Provision><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022143" lims:id="1022143" format-ref="indent-0-0" language-align="yes" list-item="no"><Label>(2)</Label><Text>A device described in subrule (1) that is intended to be used to monitor, assess or diagnose a disease, a disorder, an abnormal physical state or a pregnancy, if erroneous readings could result in immediate danger, is classified as Class III.</Text></Provision></Provision><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022144" lims:id="1022144" format-ref="indent-0-0" language-align="yes" keep-with-next="yes" list-item="no"><Text><Emphasis style="italic">Rule 11</Emphasis>:</Text><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022145" lims:id="1022145" format-ref="indent-0-0" language-align="yes" list-item="no"><Label>(1)</Label><Text>Subject to subrules (2) and (3), an active device, including any dedicated software, intended to administer drugs, body fluids or other substances to the body or withdraw them from the body is classified as Class II.</Text></Provision><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022146" lims:id="1022146" format-ref="indent-0-0" language-align="yes" list-item="no"><Label>(2)</Label><Text>If the administration or withdrawal by a device described in subrule (1) is potentially hazardous, taking into account the nature of the administration or withdrawal, the nature of the substance involved and the part of the body concerned, the device is classified as Class III.</Text></Provision><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022147" lims:id="1022147" format-ref="indent-0-0" language-align="yes" list-item="no"><Label>(3)</Label><Text>A device described in subrule (2) that is intended to control the treatment of a patient’s condition through a closed loop system is classified as Class IV.</Text></Provision></Provision><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022148" lims:id="1022148" format-ref="indent-0-0" language-align="yes" keep-with-next="yes" list-item="no"><Text><Emphasis style="italic">Rule 12</Emphasis>:</Text><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022149" lims:id="1022149" format-ref="indent-0-0" language-align="no" list-item="no"><Text>Any other active device is classified as Class I.</Text></Provision></Provision><Heading lims:inforce-start-date="2007-06-07" lims:fid="1022150" lims:id="1022150" level="2"><TitleText>Special Rules</TitleText></Heading><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022151" lims:id="1022151" format-ref="indent-0-0" language-align="yes" keep-with-next="yes" list-item="no"><Text><Emphasis style="italic">Rule 13</Emphasis>:</Text><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022152" lims:id="1022152" format-ref="indent-0-0" language-align="no" list-item="no"><Text>A medical device that is intended to be used for</Text><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022153" lims:id="1022153" format-ref="indent-1-1" language-align="no" list-item="no"><Label>(a)</Label><Text>disinfecting or sterilizing blood, tissues or organs that are intended for transfusion or transplantation is classified as Class IV; and</Text></Provision><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022154" lims:id="1022154" format-ref="indent-1-1" language-align="no" list-item="no"><Label>(b)</Label><Text>disinfecting or sterilizing a medical device is classified as Class II.</Text></Provision></Provision></Provision><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022155" lims:id="1022155" format-ref="indent-0-0" language-align="yes" keep-with-next="yes" list-item="no"><Text><Emphasis style="italic">Rule 14</Emphasis>:</Text><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022156" lims:id="1022156" format-ref="indent-0-0" language-align="yes" list-item="no"><Label>(1)</Label><Text>Subject to subrule (2), the following medical devices are classified as Class IV:</Text><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022157" lims:id="1022157" format-ref="indent-1-1" language-align="no" list-item="no"><Label>(a)</Label><Text>a medical device that is manufactured from or that incorporates human or animal cells or tissues or their derivatives; and</Text></Provision><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022158" lims:id="1022158" format-ref="indent-1-1" language-align="no" list-item="no"><Label>(b)</Label><Text>a medical device that is manufactured from or that incorporates a product produced through the use of recombinant DNA technology.</Text></Provision></Provision><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022159" lims:id="1022159" format-ref="indent-0-0" language-align="yes" list-item="no"><Label>(2)</Label><Text>A device described in subrule (1) that is intended to come into contact with intact skin only is classified as Class I.</Text></Provision></Provision><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022160" lims:id="1022160" format-ref="indent-0-0" language-align="yes" keep-with-next="yes" list-item="no"><Text><Emphasis style="italic">Rule 15</Emphasis>:</Text><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022161" lims:id="1022161" format-ref="indent-0-0" language-align="no" list-item="no"><Text>Any medical device that is a material intended to be sold to a health care professional or dispenser for the specific purpose of configuration or arrangement into a mould or shape to meet the needs of an individual is classified in the class that applies to the finished medical device.</Text></Provision></Provision><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022162" lims:id="1022162" format-ref="indent-0-0" language-align="yes" keep-with-next="yes" list-item="no"><Text><Emphasis style="italic">Rule 16</Emphasis>:</Text><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022163" lims:id="1022163" format-ref="indent-0-0" language-align="no" list-item="no"><Text>Despite rules 1 to 15, a medical device set out in column 1 of an item of the table to this rule is classified as the class set out in column 2 of that item.</Text><TableGroup lims:inforce-start-date="2007-06-07" lims:fid="1022164" lims:id="1022164" pointsize="8" topmarginspacing="4" rowbreak="no" bilingual="no" spanlanguages="no"><Caption lims:inforce-start-date="2007-06-07" lims:fid="1022165" lims:id="1022165" position="over">TABLE</Caption><table lims:inforce-start-date="2007-06-07" lims:fid="1022166" lims:id="1022166" frame="topbot"><tgroup lims:inforce-start-date="2007-06-07" lims:fid="1022167" lims:id="1022167" cols="3"><colspec colname="1" colwidth="56.11*" /><colspec colname="2" colwidth="323.85*" /><colspec colname="3" colwidth="88.01*" /><thead lims:inforce-start-date="2007-06-07" lims:fid="1022168" lims:id="1022168"><row topdouble="yes"><entry morerows="1" colsep="0" rowsep="1" valign="bottom">Item</entry><entry colsep="0" rowsep="0">Column 1</entry><entry colsep="0" rowsep="0">Column 2</entry></row><row><entry colsep="0" rowsep="1" valign="bottom">Medical device</entry><entry colsep="0" rowsep="1" valign="bottom">Class</entry></row></thead><tbody lims:inforce-start-date="2007-06-07" lims:fid="1022169" lims:id="1022169"><row><entry colname="1" colsep="0" rowsep="0" valign="top">1</entry><entry colname="2" colsep="0" rowsep="0" valign="top">Breast implants</entry><entry colname="3" colsep="0" rowsep="0" valign="top">IV</entry></row><row><entry colname="1" colsep="0" rowsep="0" valign="top">2</entry><entry colname="2" colsep="0" rowsep="0" valign="top">Tissue expanders for breast reconstruction and augmentation</entry><entry colname="3" colsep="0" rowsep="0" valign="top">IV</entry></row></tbody></tgroup></table></TableGroup></Provision></Provision><Heading lims:inforce-start-date="2007-06-07" lims:fid="1022170" lims:id="1022170" level="1"><Label>PART 2</Label><TitleText>In Vitro Diagnostic Devices</TitleText></Heading><Heading lims:inforce-start-date="2007-06-07" lims:fid="1022171" lims:id="1022171" level="2"><TitleText>Use with respect to Transmissible Agents</TitleText></Heading><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022172" lims:id="1022172" format-ref="indent-0-0" language-align="yes" keep-with-next="yes" list-item="no"><Text><Emphasis style="italic">Rule 1</Emphasis>:</Text><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022173" lims:id="1022173" format-ref="indent-0-0" language-align="no" list-item="no"><Text>An IVDD that is intended to be used to detect the presence of, or exposure to, a transmissible agent in blood, blood components, blood derivatives, tissues or organs to assess their suitability for transfusion or transplantation is classified as Class IV.</Text></Provision></Provision><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022174" lims:id="1022174" format-ref="indent-0-0" language-align="yes" keep-with-next="yes" list-item="no"><Text><Emphasis style="italic">Rule 2</Emphasis>:</Text><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022175" lims:id="1022175" format-ref="indent-0-0" language-align="no" list-item="no"><Text>An IVDD that is intended to be used to detect the presence of, or exposure to, a transmissible agent is classified as Class II, unless</Text><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022176" lims:id="1022176" format-ref="indent-1-1" language-align="no" list-item="no"><Label>(a)</Label><Text>it is intended to be used to detect the presence of, or exposure to, a transmissible agent that causes a life-threatening disease if there is a risk of propagation in the Canadian population, in which case it is classified as Class IV; or</Text></Provision><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022177" lims:id="1022177" format-ref="indent-1-1" language-align="no" list-item="no"><Label>(b)</Label><Text>it falls into one of the following categories, in which case it is classified as Class III:</Text><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022178" lims:id="1022178" format-ref="indent-2-2" language-align="no" list-item="no"><Label>(i)</Label><Text>it is intended to be used to detect the presence of, or exposure to, a transmissible agent that causes a serious disease where there is a risk of propagation in the Canadian population,</Text></Provision><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022179" lims:id="1022179" format-ref="indent-2-2" language-align="no" list-item="no"><Label>(ii)</Label><Text>it is intended to be used to detect the presence of, or exposure to, a sexually transmitted agent,</Text></Provision><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022180" lims:id="1022180" format-ref="indent-2-2" language-align="no" list-item="no"><Label>(iii)</Label><Text>it is intended to be used to detect the presence of an infectious agent in cerebrospinal fluid or blood, or</Text></Provision><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022181" lims:id="1022181" format-ref="indent-2-2" language-align="no" list-item="no"><Label>(iv)</Label><Text>there is a risk that an erroneous result would cause death or severe disability to the individual being tested, or to the individual’s offspring.</Text></Provision></Provision></Provision></Provision><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022182" lims:id="1022182" format-ref="indent-0-0" language-align="yes" keep-with-next="yes" list-item="no"><Text><Emphasis style="italic">Rule 3</Emphasis>:</Text><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022183" lims:id="1022183" format-ref="indent-0-0" language-align="no" list-item="no"><Text>An IVDD that is intended to be used for patient management is classified as Class II, unless it falls into one of the following categories, in which case it is classified as Class III:</Text><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022184" lims:id="1022184" format-ref="indent-1-1" language-align="no" list-item="no"><Label>(a)</Label><Text>it is intended to be used for the management of patients suffering from a life-threatening disease; or</Text></Provision><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022185" lims:id="1022185" format-ref="indent-1-1" language-align="no" list-item="no"><Label>(b)</Label><Text>there is a risk that an erroneous result will lead to a patient management decision resulting in an imminent life-threatening situation for the patient.</Text></Provision></Provision></Provision><Heading lims:inforce-start-date="2007-06-07" lims:fid="1022186" lims:id="1022186" level="2"><TitleText>Other Uses</TitleText></Heading><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022187" lims:id="1022187" format-ref="indent-0-0" language-align="yes" keep-with-next="yes" list-item="no"><Text><Emphasis style="italic">Rule 4</Emphasis>:</Text><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022188" lims:id="1022188" format-ref="indent-0-0" language-align="no" list-item="no"><Text>An IVDD that is not subject to rules 1 to 3 and that is intended to be used in diagnosis or patient management is classified as Class II, unless it falls into one of the following categories, in which case it is classified as Class III:</Text><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022189" lims:id="1022189" format-ref="indent-1-1" language-align="no" list-item="no"><Label>(a)</Label><Text>it is intended to be used in screening for or in the diagnosis of cancer;</Text></Provision><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022190" lims:id="1022190" format-ref="indent-1-1" language-align="no" list-item="no"><Label>(b)</Label><Text>it is intended to be used for genetic testing;</Text></Provision><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022191" lims:id="1022191" format-ref="indent-1-1" language-align="no" list-item="no"><Label>(c)</Label><Text>it is intended to be used in screening for congenital disorders in the fetus;</Text></Provision><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022192" lims:id="1022192" format-ref="indent-1-1" language-align="no" list-item="no"><Label>(d)</Label><Text>there is a risk that an erroneous diagnostic result would cause death or severe disability to the patient being tested or to that patient’s offspring;</Text></Provision><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022193" lims:id="1022193" format-ref="indent-1-1" language-align="no" list-item="no"><Label>(e)</Label><Text>it is intended to be used for disease staging; or</Text></Provision><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022194" lims:id="1022194" format-ref="indent-1-1" language-align="no" list-item="no"><Label>(f)</Label><Text>it is intended to be used to monitor levels of drugs, substances or biological components, if there is a risk that an erroneous result will lead to a patient management decision resulting in an imminent life-threatening situation for the patient.</Text></Provision></Provision></Provision><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022195" lims:id="1022195" format-ref="indent-0-0" language-align="yes" keep-with-next="yes" list-item="no"><Text><Emphasis style="italic">Rule 5</Emphasis>:</Text><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022196" lims:id="1022196" format-ref="indent-0-0" language-align="no" list-item="no"><Text>An IVDD that is intended to be used for blood grouping or tissue typing to ensure the immunological compatibility of blood, blood components, tissue or organs that are intended for transfusion or transplantation is classified as Class III.</Text></Provision></Provision><Heading lims:inforce-start-date="2007-06-07" lims:fid="1022197" lims:id="1022197" level="2"><TitleText>Special Rules</TitleText></Heading><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022198" lims:id="1022198" format-ref="indent-0-0" language-align="yes" keep-with-next="yes" list-item="no"><Text><Emphasis style="italic">Rule 6</Emphasis>:</Text><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022199" lims:id="1022199" format-ref="indent-0-0" language-align="no" list-item="no"><Text>A near patient IVDD is classified as Class III.</Text></Provision></Provision><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022200" lims:id="1022200" format-ref="indent-0-0" language-align="yes" keep-with-next="yes" list-item="no"><Text><Emphasis style="italic">Rule 7</Emphasis>:</Text><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022201" lims:id="1022201" format-ref="indent-0-0" language-align="no" list-item="no"><Text>In cases where an IVDD, including its analyzers, reagents and software, is intended to be used with another IVDD, the class of both IVDDs will be that of the IVDD in the class representing the higher risk.</Text></Provision></Provision><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022202" lims:id="1022202" format-ref="indent-0-0" language-align="yes" keep-with-next="yes" list-item="no"><Text><Emphasis style="italic">Rule 8</Emphasis>:</Text><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022203" lims:id="1022203" format-ref="indent-0-0" language-align="no" list-item="no"><Text>If rules 1 to 7 do not apply, all other IVDDs are classified as Class I.</Text></Provision></Provision><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022204" lims:id="1022204" format-ref="indent-0-0" language-align="yes" keep-with-next="yes" list-item="no"><Text><Emphasis style="italic">Rule 9</Emphasis>:</Text><Provision lims:inforce-start-date="2007-06-07" lims:fid="1022205" lims:id="1022205" format-ref="indent-0-0" language-align="no" list-item="no"><Text>Despite rules 1 to 8, an IVDD set out in column 1 of an item of the table to this rule is classified as the class set out in column 2 of that item.</Text><TableGroup lims:inforce-start-date="2007-06-07" lims:fid="1022206" lims:id="1022206" pointsize="8" topmarginspacing="4" rowbreak="no" bilingual="no" spanlanguages="no"><Caption lims:inforce-start-date="2007-06-07" lims:fid="1022207" lims:id="1022207" position="over">TABLE</Caption><table lims:inforce-start-date="2007-06-07" lims:fid="1022208" lims:id="1022208" frame="topbot"><tgroup lims:inforce-start-date="2007-06-07" lims:fid="1022209" lims:id="1022209" cols="3" keep-together="yes"><colspec colname="1" colwidth="55.71*" /><colspec colname="2" colwidth="324.28*" /><colspec colname="3" colwidth="88.02*" /><thead lims:inforce-start-date="2007-06-07" lims:fid="1022210" lims:id="1022210"><row topdouble="yes"><entry morerows="1" colsep="0" rowsep="1" valign="bottom">Item</entry><entry colsep="0" rowsep="0" valign="top">Column 1</entry><entry colsep="0" rowsep="0" valign="top">Column 2</entry></row><row><entry colsep="0" rowsep="1" valign="bottom">IVDD</entry><entry colsep="0" rowsep="1" valign="bottom">Class</entry></row></thead><tbody lims:inforce-start-date="2007-06-07" lims:fid="1022211" lims:id="1022211"><row><entry colname="1" colsep="0" rowsep="0" valign="top">1</entry><entry colname="2" colsep="0" rowsep="0" valign="top">Near patient <Language xml:lang="la">in vitro</Language> diagnostic device for the detection of pregnancy or for fertility testing</entry><entry colname="3" colsep="0" rowsep="0" valign="top">II</entry></row><row><entry colname="1" colsep="0" rowsep="0" valign="top">2</entry><entry colname="2" colsep="0" rowsep="0" valign="top">Near patient <Language xml:lang="la">in vitro</Language> diagnostic device for determining cholesterol level</entry><entry colname="3" colsep="0" rowsep="0" valign="top">II</entry></row><row><entry colname="1" colsep="0" rowsep="0" valign="top">3</entry><entry colname="2" colsep="0" rowsep="0" valign="top">Microbiological media used to identify or infer the identity of a microorganism</entry><entry colname="3" colsep="0" rowsep="0" valign="top">I</entry></row><row><entry colname="1" colsep="0" rowsep="0" valign="top">4</entry><entry colname="2" colsep="0" rowsep="0" valign="top">IVDD used to identify or infer the identity of a cultured microorganism</entry><entry colname="3" colsep="0" rowsep="0" valign="top">I</entry></row></tbody></tgroup></table></TableGroup></Provision></Provision><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2007-06-07" lims:fid="1022213" lims:id="1022213">SOR/2007-119, s. 1</HistoricalNoteSubItem></HistoricalNote></Schedule><Schedule lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2022-09-27" lims:fid="1022214" lims:id="1022214" spanlanguages="no" bilingual="no"><ScheduleFormHeading lims:inforce-start-date="2006-03-22" lims:fid="1022215" lims:id="1022215"><Label>SCHEDULE 2</Label><OriginatingRef>(Section 1)</OriginatingRef><TitleText>Implants</TitleText></ScheduleFormHeading><Provision lims:inforce-start-date="2006-03-22" lims:fid="1022216" lims:id="1022216" format-ref="indent-0-0" language-align="yes" list-item="no"><Label>1</Label><Text>Heart valve</Text></Provision><Provision lims:inforce-start-date="2006-03-22" lims:fid="1022217" lims:id="1022217" format-ref="indent-0-0" language-align="yes" list-item="no"><Label>2</Label><Text>Annuloplasty ring</Text></Provision><Provision lims:inforce-start-date="2006-03-22" lims:fid="1022218" lims:id="1022218" format-ref="indent-0-0" language-align="yes" list-item="no"><Label>3</Label><Text>Active implantable device systems</Text><Provision lims:inforce-start-date="2006-03-22" lims:fid="1022219" lims:id="1022219" format-ref="indent-1-1" language-align="no" list-item="no"><Label>(a)</Label><Text>all models of implantable pacemakers and leads;</Text></Provision><Provision lims:inforce-start-date="2006-03-22" lims:fid="1022220" lims:id="1022220" format-ref="indent-1-1" language-align="no" list-item="no"><Label>(b)</Label><Text>all models of implantable defibrillators and leads;</Text></Provision><Provision lims:inforce-start-date="2006-03-22" lims:fid="1022221" lims:id="1022221" format-ref="indent-1-1" language-align="no" list-item="no"><Label>(c)</Label><Text>artificial heart;</Text></Provision><Provision lims:inforce-start-date="2006-03-22" lims:fid="1022222" lims:id="1022222" format-ref="indent-1-1" language-align="no" list-item="no"><Label>(d)</Label><Text>implantable ventricular support system; and</Text></Provision><Provision lims:inforce-start-date="2006-03-22" lims:fid="1022223" lims:id="1022223" format-ref="indent-1-1" language-align="no" list-item="no"><Label>(e)</Label><Text>implantable drug infusion system</Text></Provision></Provision><Provision lims:inforce-start-date="2006-03-22" lims:fid="1022224" lims:id="1022224" format-ref="indent-0-0" language-align="yes" list-item="no"><Label>4</Label><Text>Devices of human origin</Text><Provision lims:inforce-start-date="2006-03-22" lims:fid="1022225" lims:id="1022225" format-ref="indent-1-1" language-align="no" list-item="no"><Label>(a)</Label><Text>human dura mater; and</Text></Provision><Provision lims:inforce-start-date="2006-03-22" lims:fid="1022226" lims:id="1022226" format-ref="indent-1-1" language-align="no" list-item="no"><Label>(b)</Label><Text>wound covering containing human cells</Text></Provision></Provision><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2022-09-27" lims:enacted-date="2022-09-27" lims:fid="1376722" lims:id="1376722" lims:enactId="1375650">SOR/2022-197, s. 13(F)</HistoricalNoteSubItem></HistoricalNote></Schedule><Schedule lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="1022227" lims:id="1022227" spanlanguages="no" bilingual="no"><ScheduleFormHeading lims:inforce-start-date="2006-03-22" lims:fid="1022228" lims:id="1022228"><Label>SCHEDULE 3</Label><OriginatingRef>(Section 89)</OriginatingRef><TitleText>Export Certificate for Medical Devices</TitleText></ScheduleFormHeading><FormGroup lims:inforce-start-date="2006-03-22" lims:fid="1022229" lims:id="1022229"><Provision lims:inforce-start-date="2006-03-22" lims:fid="1022230" lims:id="1022230" format-ref="indent-0-0" language-align="yes" list-item="no"><Text>UNDER THE <XRefExternal reference-type="regulation" link="SOR-98-282">Medical Devices Regulations</XRefExternal></Text><Provision lims:inforce-start-date="2006-03-22" lims:fid="1022231" lims:id="1022231" format-ref="indent-0-0" language-align="yes" list-item="no"><Text>I, <Leader leader="solid" length="8pc" />, certify that I have knowledge of all matters contained in this certificate and that</Text><Provision lims:inforce-start-date="2006-03-22" lims:fid="1022232" lims:id="1022232" format-ref="indent-1-1" language-align="yes" list-item="no"><Label>1</Label><Text>I am (<Emphasis style="italic">check applicable box</Emphasis>)</Text><Provision lims:inforce-start-date="2006-03-22" lims:fid="1022233" lims:id="1022233" format-ref="indent-1-1" language-align="yes" list-item="no"><Label>(a)</Label><Text>where the medical device described in this certificate is exported by a corporation</Text><Provision lims:inforce-start-date="2006-03-22" lims:fid="1022234" lims:id="1022234" language-align="yes" first-line-indent="2" subsequent-line-indent="3" list-item="yes"><Label>☐</Label><Text>the exporter’s senior executive officer,</Text></Provision><Provision lims:inforce-start-date="2006-03-22" lims:fid="1022235" lims:id="1022235" language-align="yes" first-line-indent="2" subsequent-line-indent="3" list-item="yes"><Label>☐</Label><Text>the exporter’s senior regulatory officer,</Text></Provision><Provision lims:inforce-start-date="2006-03-22" lims:fid="1022236" lims:id="1022236" language-align="yes" first-line-indent="2" subsequent-line-indent="3" list-item="yes"><Label>☐</Label><Text>the authorized agent of the exporter’s senior executive officer, or</Text></Provision><Provision lims:inforce-start-date="2006-03-22" lims:fid="1022237" lims:id="1022237" language-align="yes" first-line-indent="2" subsequent-line-indent="3" list-item="yes"><Label>☐</Label><Text>the authorized agent of the exporter’s senior regulatory officer; and</Text></Provision></Provision><Provision lims:inforce-start-date="2006-03-22" lims:fid="1022238" lims:id="1022238" format-ref="indent-1-1" language-align="yes" list-item="no"><Label>(b)</Label><Text>where the medical device described in this certificate is exported by an individual</Text><Provision lims:inforce-start-date="2006-03-22" lims:fid="1022239" lims:id="1022239" language-align="yes" first-line-indent="2" subsequent-line-indent="3" list-item="yes"><Label>☐</Label><Text>the exporter, or</Text></Provision><Provision lims:inforce-start-date="2006-03-22" lims:fid="1022240" lims:id="1022240" language-align="yes" first-line-indent="2" subsequent-line-indent="3" list-item="yes"><Label>☐</Label><Text>the exporter’s authorized agent.</Text></Provision></Provision><Provision lims:inforce-start-date="2006-03-22" lims:fid="1022241" lims:id="1022241" format-ref="indent-0-0" language-align="no" list-item="no"><Text><LeaderRightJustified leader="solid" /></Text><Provision lims:inforce-start-date="2006-03-22" lims:fid="1022242" lims:id="1022242" format-ref="indent-0-0" language-align="no" list-item="no"><Text><Leader leader="solid" length="6pc" />, (<Emphasis style="italic">State name and address of exporter or, if a corporation, name and address of principal place of business in Canada</Emphasis>).</Text></Provision></Provision></Provision><Provision lims:inforce-start-date="2006-03-22" lims:fid="1022243" lims:id="1022243" format-ref="indent-1-1" language-align="yes" list-item="no"><Label>2</Label><Text>On the <Leader leader="solid" length="3pc" /> day of <Leader leader="solid" length="6pc" />, <Leader leader="solid" length="2.5pc" />, a package containing <Leader leader="solid" length="10pc" /> (<Emphasis style="italic">description of device, including serial number, model name, lot number and quantity, as applicable; if additional space required, attach as Appendix “A”</Emphasis>) is/will be consigned to <Leader leader="solid" length="8pc" /> (<Emphasis style="italic">name and address of consignee</Emphasis>).</Text></Provision><Provision lims:inforce-start-date="2006-03-22" lims:fid="1022244" lims:id="1022244" format-ref="indent-1-1" language-align="yes" list-item="no"><Label>3</Label><Text>The package is marked in distinct overprinting with the word “Export” or “Exportation”.</Text></Provision><Provision lims:inforce-start-date="2006-03-22" lims:fid="1022245" lims:id="1022245" format-ref="indent-1-1" language-align="yes" list-item="no"><Label>4</Label><Text>The medical device was not manufactured for consumption in Canada.</Text></Provision><Provision lims:inforce-start-date="2006-03-22" lims:fid="1022246" lims:id="1022246" format-ref="indent-1-1" language-align="yes" list-item="no"><Label>5</Label><Text>The medical device is not sold for consumption in Canada.</Text></Provision><Provision lims:inforce-start-date="2006-03-22" lims:fid="1022247" lims:id="1022247" format-ref="indent-1-1" language-align="yes" list-item="no"><Label>6</Label><Text>The package and its contents do not contravene any known requirement of the law of the country of <Leader leader="solid" length="6pc" /> (<Emphasis style="italic">state country of consignee</Emphasis>).</Text></Provision><Provision lims:inforce-start-date="2006-03-22" lims:fid="1022248" lims:id="1022248" format-ref="indent-1-1" language-align="yes" list-item="no"><Label>7</Label><Text>All relevant information is contained in this certificate and no relevant information has been knowingly withheld.</Text></Provision><Provision lims:inforce-start-date="2006-03-22" lims:fid="1022249" lims:id="1022249" format-ref="indent-0-0" language-align="no" keep-with-next="yes" list-item="no"><Text><LeaderRightJustified leader="solid" /></Text><Provision lims:inforce-start-date="2006-03-22" lims:fid="1022250" lims:id="1022250" format-ref="indent-2-2" language-align="no" topmarginspacing="0" list-item="no"><Text>Signature</Text></Provision></Provision><Provision lims:inforce-start-date="2006-03-22" lims:fid="1022251" lims:id="1022251" format-ref="indent-0-0" language-align="no" keep-with-next="yes" list-item="no"><Text><LeaderRightJustified leader="solid" /></Text><Provision lims:inforce-start-date="2006-03-22" lims:fid="1022252" lims:id="1022252" format-ref="indent-2-2" language-align="no" topmarginspacing="0" list-item="no"><Text>Position title</Text></Provision></Provision><Provision lims:inforce-start-date="2006-03-22" lims:fid="1022253" lims:id="1022253" format-ref="indent-0-0" language-align="no" keep-with-next="yes" list-item="no"><Text><Leader leader="solid" length="13pc" />, <Leader leader="solid" length="2pc" /></Text><Provision lims:inforce-start-date="2006-03-22" lims:fid="1022254" lims:id="1022254" format-ref="indent-2-2" language-align="no" topmarginspacing="0" list-item="no"><Text>Date</Text></Provision></Provision></Provision></Provision></FormGroup></Schedule><Schedule id="RelatedProvs"><ScheduleFormHeading type="amending"><TitleText>RELATED PROVISIONS</TitleText></ScheduleFormHeading><RegulationPiece><RelatedOrNotInForce><Heading level="5" style="nifrp"><TitleText>
                    — SOR/2003-173, s. 6</TitleText></Heading><Section><Label>6</Label><Text>The manufacturer of a medical device for which a medical device licence has been issued before the coming into force of these Regulations shall, before November 1, 2003, submit to the Minister, together with the statement required by subsection 43(1) of the <XRefExternal reference-type="regulation" link="SOR-98-282">Medical Devices Regulations</XRefExternal>, a copy of the quality system certificate referred to in paragraph 32(2)(f), (3)(j) or (4)(p) of those Regulations, as applicable.]</Text></Section></RelatedOrNotInForce><RelatedOrNotInForce><Heading level="5" style="nifrp"><TitleText>
                    — SOR/2019-63, s. 2</TitleText></Heading><Section><Label>2</Label><Subsection><Label>(1)</Label><Text>Despite subsection 43.12(1) of the <XRefExternal reference-type="regulation" link="SOR-98-282">Medical Devices Regulations</XRefExternal>, <DefinitionRef>information in respect of a clinical study or investigational testing</DefinitionRef>, as defined in section 43.11 of those Regulations, that is confidential business information and that is contained in an application with respect to which one of the following circumstances occurred before the day on which these Regulations come into force ceases to be confidential business information on the day on which these Regulations come into force:</Text><Paragraph><Label>(a)</Label><Text>the Minister issued a licence under paragraph 36(1)(a) of the <XRefExternal reference-type="regulation" link="SOR-98-282">Medical Devices Regulations</XRefExternal>;</Text></Paragraph><Paragraph><Label>(b)</Label><Text>the Minister amended a licence under paragraph 36(1)(b) of the <XRefExternal reference-type="regulation" link="SOR-98-282">Medical Devices Regulations</XRefExternal>;</Text></Paragraph><Paragraph><Label>(c)</Label><Text>the Minister refused to issue or amend a licence under section 38 of the <XRefExternal reference-type="regulation" link="SOR-98-282">Medical Devices Regulations</XRefExternal>.</Text></Paragraph></Subsection><Subsection><Label>(2)</Label><Text>Subsection (1) does not apply to information referred to in subsection 43.12(2) of the <XRefExternal reference-type="regulation" link="SOR-98-282">Medical Devices Regulations</XRefExternal>.</Text></Subsection></Section></RelatedOrNotInForce><RelatedOrNotInForce><Heading level="5" style="nifrp"><TitleText>
                    — SOR/2021-199, s. 10</TitleText></Heading><Section><Label>10</Label><Subsection><Label>(1)</Label><Text>In this section and in sections 11 to 15, <DefinedTermEn>Exceptional Importation and Shortages Interim Order No. 2</DefinedTermEn> means the <XRefExternal reference-type="other">Interim Order No. 2 Respecting Drugs, Medical Devices and Foods for a Special Dietary Purpose in Relation to COVID-19</XRefExternal>, made by the Minister of Health on March 1, 2021 and published in Part I of the <XRefExternal reference-type="other" link="gazette">Canada Gazette</XRefExternal> on March 20, 2021.</Text></Subsection><Subsection><Label>(2)</Label><Text>In sections 11 to 15, <DefinitionRef>designated biocide</DefinitionRef>, <DefinitionRef>designated drug</DefinitionRef>, <DefinitionRef>designated food for a special dietary purpose</DefinitionRef>, <DefinitionRef>designated hand sanitizer</DefinitionRef> and <DefinitionRef>designated medical device</DefinitionRef> have the same meaning as in the Exceptional Importation and Shortages Interim Order No. 2.</Text></Subsection></Section></RelatedOrNotInForce><RelatedOrNotInForce><Heading level="5" style="nifrp"><TitleText>
                    — SOR/2021-199, s. 13</TitleText></Heading><Section><Label>13</Label><Subsection><Label>(1)</Label><Text>Section 62.31 of the <XRefExternal reference-type="regulation" link="SOR-98-282">Medical Devices Regulations</XRefExternal> applies in respect of a designated medical device that was imported under the Exceptional Importation and Shortages Interim Order No. 2.</Text></Subsection><Subsection><Label>(2)</Label><Text>Section 62.32 of those Regulations applies to the holder of an establishment licence in respect of a designated medical device that they imported under that Interim Order.</Text></Subsection></Section></RelatedOrNotInForce><RelatedOrNotInForce><Heading level="5" style="nifrp"><TitleText>
                    — SOR/2021-199, s. 15</TitleText></Heading><Section><Label>15</Label><Text>A person who, immediately before the Exceptional Importation and Shortages Interim Order No. 2 ceased to have effect, was permitted, under subsection 30(2) of that Interim Order, to conduct an activity in respect of a designated hand sanitizer may continue to do so without holding an establishment licence that authorizes them to do so until the earliest of</Text><Paragraph><Label>(a)</Label><Text>the occurrence of one of the circumstances referred to in paragraphs 30(2)(a) to (c) of that Interim Order, and</Text></Paragraph><Paragraph><Label>(b)</Label><Text>September 1, 2023.</Text></Paragraph></Section></RelatedOrNotInForce><RelatedOrNotInForce><Heading level="5" style="nifrp"><TitleText>
                    — SOR/2023-19, s. 10</TitleText></Heading><Section><Label>10</Label><Subsection><Label>(1)</Label><Text>In sections 11 to 19, <DefinedTermEn>Interim Order No. 3</DefinedTermEn> means <XRefExternal reference-type="other">Interim Order No. 3 Respecting the Importation and Sale of Medical Devices for Use in Relation to COVID-19</XRefExternal>, made by the Minister on February 21, 2022 and published in the <XRefExternal reference-type="other" link="gazette">Canada Gazette</XRefExternal>, Part I, on March 12, 2022.</Text></Subsection><Subsection><Label>(2)</Label><Text>Unless the context requires otherwise, words and expressions used in sections 11 to 19 have the same meaning as in the <XRefExternal reference-type="regulation" link="SOR-98-282">Medical Devices Regulations</XRefExternal>.</Text></Subsection><Subsection><Label>(3)</Label><Text>For the purposes of sections 11 to 19, a reference to “instrument médical destiné à être utilisé à l’égard de la COVID-19” in the French version of Interim Order No. 3 and the <XRefExternal reference-type="other">List of Medical Devices for Expanded Use in Relation to the COVID-19 Pandemic</XRefExternal> shall be read as “instrument médical contre la COVID-19”.</Text></Subsection></Section></RelatedOrNotInForce><RelatedOrNotInForce><Heading level="5" style="nifrp"><TitleText>
                    — SOR/2023-19, s. 11</TitleText></Heading><Section><Label>11</Label><Text>Despite subsection 68.11(1) of the <XRefExternal reference-type="regulation" link="SOR-98-282">Medical Devices Regulations</XRefExternal>, an application for an authorization for importation or sale of a COVID-19 medical device that was submitted to the Minister under Interim Order No. 3 before the day on which these Regulations come into force and in respect of which no decision has been made before that day is deemed to be an application for an authorization submitted under section 68.11 of the <XRefExternal reference-type="regulation" link="SOR-98-282">Medical Devices Regulations</XRefExternal>.</Text></Section></RelatedOrNotInForce><RelatedOrNotInForce><Heading level="5" style="nifrp"><TitleText>
                    — SOR/2023-19, s. 12</TitleText></Heading><Section><Label>12</Label><Subsection><Label>(1)</Label><Text>An authorization for importation or sale of a COVID-19 medical device that was issued by the Minister under Interim Order No. 3 before the day on which these Regulations come into force and has not been cancelled before that day is deemed to be an authorization issued under section 68.12 of the <XRefExternal reference-type="regulation" link="SOR-98-282">Medical Devices Regulations</XRefExternal>.</Text></Subsection><Subsection><Label>(2)</Label><Text>Any terms and conditions of an authorization for importation or sale referred to in subsection (1) are deemed to have been imposed by the Minister under section 68.19 of the <XRefExternal reference-type="regulation" link="SOR-98-282">Medical Devices Regulations</XRefExternal> on the other authorization referred to in that subsection.</Text></Subsection></Section></RelatedOrNotInForce><RelatedOrNotInForce><Heading level="5" style="nifrp"><TitleText>
                    — SOR/2023-19, s. 13</TitleText></Heading><Section><Label>13</Label><Text>A COVID-19 medical device for which the manufacturer of the device holds an authorization and that is not labelled in accordance with subsection 21(2) of the <XRefExternal reference-type="regulation" link="SOR-98-282">Medical Devices Regulations</XRefExternal> in the six-month period that begins on the day on which these Regulations come into force the device may, despite that subsection, be sold during that period.</Text></Section></RelatedOrNotInForce><RelatedOrNotInForce><Heading level="5" style="nifrp"><TitleText>
                    — SOR/2023-19, s. 14</TitleText></Heading><Section><Label>14</Label><Text>Section 68.35 of the <XRefExternal reference-type="regulation" link="SOR-98-282">Medical Devices Regulations</XRefExternal> shall be read without reference to subsection 21(2) of those Regulations in regard to any portion of the period referred to in that section that falls within the period referred to in section 13.</Text></Section></RelatedOrNotInForce><RelatedOrNotInForce><Heading level="5" style="nifrp"><TitleText>
                    — SOR/2023-19, s. 15</TitleText></Heading><Section><Label>15</Label><Text>An application to amend an authorization for importation or sale of a COVID-19 medical device that was submitted to the Minister under Interim Order No. 3 before the day on which these Regulations come into force and in respect of which no decision has been made before that day is deemed to be an application to amend an authorization submitted under section 68.14 of the <XRefExternal reference-type="regulation" link="SOR-98-282">Medical Devices Regulations</XRefExternal>.</Text></Section></RelatedOrNotInForce><RelatedOrNotInForce><Heading level="5" style="nifrp"><TitleText>
                    — SOR/2023-19, s. 16</TitleText></Heading><Section><Label>16</Label><Text>An authorization for importation or sale of a COVID-19 medical device that was amended by the Minister under Interim Order No. 3 before the day on which these Regulations come into force and has not been cancelled before that day is deemed to be an authorization that is amended to the same extent under section 68.15 of the <XRefExternal reference-type="regulation" link="SOR-98-282">Medical Devices Regulations</XRefExternal>.</Text></Section></RelatedOrNotInForce><RelatedOrNotInForce><Heading level="5" style="nifrp"><TitleText>
                    — SOR/2023-19, s. 17</TitleText></Heading><Section><Label>17</Label><Text>A request that was made by the Minister under Interim Order No. 3 before the day on which these Regulations come into force for additional information or material, including samples, is deemed to be a request for additional information or material under section 68.23 of the <XRefExternal reference-type="regulation" link="SOR-98-282">Medical Devices Regulations</XRefExternal>.</Text></Section></RelatedOrNotInForce><RelatedOrNotInForce><Heading level="5" style="nifrp"><TitleText>
                    — SOR/2023-19, s. 18</TitleText></Heading><Section><Label>18</Label><Subsection><Label>(1)</Label><Text>In the case of a COVID-19 medical device that is not a UPHN medical device on the day on which these Regulations come into force, a reference in subparagraphs 68.21(1)(h)(i), (i)(i) and (ii) and (j)(i) and (ii) of the <XRefExternal reference-type="regulation" link="SOR-98-282">Medical Devices Regulations</XRefExternal> to “the device ceases to be a UPHN medical device” shall be read as “the <XRefExternal reference-type="regulation">Regulations Amending the Medical Devices Regulations (Interim Order No. 3 Respecting the Importation and Sale of Medical Devices for Use in Relation to COVID-19)</XRefExternal> come into force”.</Text></Subsection><Subsection><Label>(2)</Label><Text>Subsection (1) ceases to apply in respect of a COVID-19 medical device referred to in that subsection if the device becomes a UPHN medical device.</Text></Subsection></Section></RelatedOrNotInForce><RelatedOrNotInForce><Heading level="5" style="nifrp"><TitleText>
                    — SOR/2023-19, s. 19</TitleText></Heading><Section><Label>19</Label><Text>A request that was made by the Minister under Interim Order No. 3 before the day on which these Regulations come into force for information in relation to the expanded use of a COVID-19 medical device or another medical device set out in the <XRefExternal reference-type="other">List of Medical Devices for Expanded Use in Relation to the COVID-19 Pandemic</XRefExternal>, referred to in the definition <DefinitionRef>List of Medical Devices for Expanded Use</DefinitionRef> in subsection 1(1) of the Interim Order, is deemed to be a request for information in relation to the expanded use under subsection 68.38(1) or (2) of the <XRefExternal reference-type="regulation" link="SOR-98-282">Medical Devices Regulations</XRefExternal>, as the case may be.</Text></Section></RelatedOrNotInForce><RelatedOrNotInForce><Heading level="5" style="nifrp"><TitleText>
                    — SOR/2023-277, s. 27</TitleText></Heading><Section><Label>27</Label><Subsection><Label>(1)</Label><Text>In this section, <DefinedTermEn>authorization</DefinedTermEn> has the same meaning as in section 68.01 of the <XRefExternal reference-type="regulation" link="SOR-98-282">Medical Devices Regulations</XRefExternal>.</Text></Subsection><Subsection><Label>(2)</Label><Text>In respect of an authorization for a medical device that is issued before the day on which these Regulations come into force, paragraph 68.17(a) of the <XRefExternal reference-type="regulation" link="SOR-98-282">Medical Devices Regulations</XRefExternal> is to be read as follows:</Text><Paragraph><Label>(a)</Label><Text>COVID-19;</Text></Paragraph></Subsection><Subsection><Label>(3)</Label><Text>Section 68.17 of the <XRefExternal reference-type="regulation" link="SOR-98-282">Medical Devices Regulations</XRefExternal>, as it read immediately before the day on which these Regulations come into force, applies in respect of an application to amend an authorization that was submitted under section 68.14 of the <XRefExternal reference-type="regulation" link="SOR-98-282">Medical Devices Regulations</XRefExternal> before the day on which these Regulations come into force and in respect of which no decision has been made before that day.</Text></Subsection></Section></RelatedOrNotInForce></RegulationPiece></Schedule><Schedule id="NifProvs"><ScheduleFormHeading type="amending"><TitleText>AMENDMENTS NOT IN FORCE</TitleText></ScheduleFormHeading><RegulationPiece><RelatedOrNotInForce><Heading level="5" style="nifrp"><TitleText>
                    — SOR/2024-110, s. 83</TitleText></Heading><Section type="amending"><Label>83</Label><Text>The <XRefExternal reference-type="regulation" link="SOR-98-282">Medical Devices Regulations</XRefExternal><FootnoteRef idref="fn_81200-2-587_hq_1707138141">2</FootnoteRef> are amended by adding the following after section 2:</Text><Footnote id="fn_81200-2-587_hq_1707138141" placement="page" status="official"><Label>2</Label><Text>SOR/98-282</Text></Footnote><AmendedText><Section><Label>2.1</Label><Text>For greater certainty, these Regulations apply to a medical device that is a drug referred to in paragraph (b) or (c) of the definition <DefinitionRef>biocide</DefinitionRef> in subsection 1(1) of the <XRefExternal reference-type="regulation" link="SOR-2024-110">Biocides Regulations</XRefExternal>.</Text></Section></AmendedText></Section></RelatedOrNotInForce><RelatedOrNotInForce><Heading level="5" style="nifrp"><TitleText>
                    — SOR/2024-136, s. 6</TitleText></Heading><Section type="amending"><Label>6</Label><Text>The definition <DefinedTermEn>recall</DefinedTermEn> in section 1 of the <XRefExternal reference-type="regulation">Medical Devices Regulations<FootnoteRef idref="fn_81200-2-647_hq_1658243303">2</FootnoteRef></XRefExternal> is replaced by the following:</Text><Footnote id="fn_81200-2-647_hq_1658243303" placement="page" status="official"><Label>2</Label><Text>SOR/98-282</Text></Footnote><AmendedText><SectionPiece><Definition generate-in-text="no"><Text><DefinedTermEn>recall</DefinedTermEn> means</Text><Paragraph><Label>(a)</Label><Text>a recall ordered by the Minister under section 21.3 of the Act; or</Text></Paragraph><Paragraph><Label>(b)</Label><Text>any action taken by a manufacturer, importer or distributor of a medical device, after the device has been sold, to recall or correct the device, or to notify its owners and users of its defectiveness or potential defectiveness, after becoming aware that the device</Text><Subparagraph><Label>(i)</Label><Text>may present a risk of injury to health,</Text></Subparagraph><Subparagraph><Label>(ii)</Label><Text>may fail to conform to any claim made by the manufacturer or importer relating to its effectiveness, benefits, performance characteristics or safety, or</Text></Subparagraph><Subparagraph><Label>(iii)</Label><Text>may not meet the requirements of the Act or these Regulations. (<DefinedTermFr>rappel</DefinedTermFr>) </Text></Subparagraph></Paragraph></Definition></SectionPiece></AmendedText></Section></RelatedOrNotInForce><RelatedOrNotInForce><Heading level="5" style="nifrp"><TitleText>
                    — SOR/2024-136, s. 7</TitleText></Heading><Section type="amending"><Label>7</Label><Text>Paragraph 45(b) of the Regulations is replaced by the following:</Text><AmendedText><SectionPiece><Paragraph><Label>(a.1)</Label><Text>any other name under which the person previously conducted activities under these Regulations;</Text></Paragraph><Paragraph><Label>(b)</Label><Text>the name, title and contact information of the representative of the establishment to contact for information concerning the application;</Text></Paragraph></SectionPiece></AmendedText></Section></RelatedOrNotInForce><RelatedOrNotInForce><Heading level="5" style="nifrp"><TitleText>
                    — SOR/2024-136, s. 8</TitleText></Heading><Section type="amending"><Label>8</Label><Text>Section 48 of the English version of the Regulations is replaced by the following:</Text><AmendedText xml:lang="en"><Section><Label>48</Label><Text>If, following the issuance of an establishment licence, there is a change to any of the information referred to in paragraph 45(a) or (b), the holder of the establishment licence shall submit the new information to the Minister within 15 days of the change.</Text></Section></AmendedText></Section></RelatedOrNotInForce><RelatedOrNotInForce><Heading level="5" style="nifrp"><TitleText>
                    — SOR/2024-136, s. 9</TitleText></Heading><Section type="amending"><Label>9</Label><Text>The Regulations are amended by adding the following after section 48:</Text><AmendedText><Heading level="3"><TitleText>Terms and Conditions</TitleText></Heading><Section><Label>48.1</Label><Text>The Minister may, at any time, impose terms and conditions on an establishment licence, or amend those terms and conditions, after considering the following factors:</Text><Paragraph><Label>(a)</Label><Text>whether there are uncertainties relating to the manner in which an activity is or will be conducted;</Text></Paragraph><Paragraph><Label>(b)</Label><Text>whether the requirements under the Act are sufficient to protect patients, users or other persons from risks to health or safety;</Text></Paragraph><Paragraph><Label>(c)</Label><Text>whether compliance with the proposed terms and conditions is feasible; and</Text></Paragraph><Paragraph><Label>(d)</Label><Text>whether there are less burdensome ways to meet the objectives of the proposed terms and conditions.</Text></Paragraph></Section></AmendedText></Section></RelatedOrNotInForce><RelatedOrNotInForce><Heading level="5" style="nifrp"><TitleText>
                    — SOR/2024-136, s. 10</TitleText></Heading><Section type="amending"><Label>10</Label><Text>Section 53 of the Regulations is replaced by the following:</Text><AmendedText><Section><Label>53</Label><Text>The distribution record shall contain sufficient information to permit the complete and rapid recall of the medical device.</Text></Section></AmendedText></Section></RelatedOrNotInForce><RelatedOrNotInForce><Heading level="5" style="nifrp"><TitleText>
                    — SOR/2024-136, s. 11</TitleText></Heading><Section type="amending"><Label>11</Label><Text>Subsection 62.31(1) of the Regulations is replaced by the following:</Text><AmendedText><Section><Label>62.31</Label><Subsection><Label>(1)</Label><Text>The provisions of these Regulations — other than this section and sections 44 to 62.2 and 62.32 to 65.6 — do not apply to the sale of a designated medical device that is imported under section 62.29.</Text></Subsection></Section></AmendedText></Section></RelatedOrNotInForce><RelatedOrNotInForce><Heading level="5" style="nifrp"><TitleText>
                    — SOR/2024-136, s. 12</TitleText></Heading><Section type="amending"><Label>12</Label><Text>The heading before section 63 of the English version of the Regulations is replaced by the following:</Text><AmendedText xml:lang="en"><Heading level="2"><TitleText>Recalls</TitleText></Heading></AmendedText></Section></RelatedOrNotInForce><RelatedOrNotInForce><Heading level="5" style="nifrp"><TitleText>
                    — SOR/2024-136, s. 13</TitleText></Heading><Section type="amending"><Label>13</Label><Text>The Regulations are amended by adding the following before section 63:</Text><AmendedText><Heading level="3"><TitleText>Recall Reporting</TitleText></Heading></AmendedText></Section></RelatedOrNotInForce><RelatedOrNotInForce><Heading level="5" style="nifrp"><TitleText>
                    — SOR/2024-136, s. 14</TitleText></Heading><Section type="amending"><Label>14</Label><Text>The portion of section 63 of the Regulations before paragraph (a) is replaced by the following:</Text><AmendedText><Section><Label>63</Label><Text>Sections 63.2, 64 and 65 do not apply to</Text></Section></AmendedText></Section></RelatedOrNotInForce><RelatedOrNotInForce><Heading level="5" style="nifrp"><TitleText>
                    — SOR/2024-136, s. 15</TitleText></Heading><Section type="amending"><Label>15</Label><Text>The Regulations are amended by adding the following after section 63:</Text><AmendedText><Section><Label>63.1</Label><Text>Sections 63.2, 64 and 65 do not apply to a manufacturer or importer of a medical device unless the device is likely to cause injury to the health of a patient, user or other person, or could cause serious injury to the health of a patient, user or other person.</Text></Section><Section><Label>63.2</Label><Text>A manufacturer or importer of a medical device who decides to recall the device without being ordered to do so by the Minister shall provide the Minister with the following information, in writing, within 24 hours after making the decision:</Text><Paragraph><Label>(a)</Label><Text>the name of the device;</Text></Paragraph><Paragraph><Label>(b)</Label><Text>the identifier of the device, including the identifier of any medical device that is part of a system, test kit, medical device group, medical device family or medical device group family;</Text></Paragraph><Paragraph><Label>(c)</Label><Text>in the case of a licensed device, the medical device licence number;</Text></Paragraph><Paragraph><Label>(d)</Label><Text>in the case of a device for which the manufacturer holds an authorization issued under section 68.12, the authorization number;</Text></Paragraph><Paragraph><Label>(e)</Label><Text>the name and address of</Text><Subparagraph><Label>(i)</Label><Text>the manufacturer,</Text></Subparagraph><Subparagraph><Label>(ii)</Label><Text>the establishment where the device was manufactured, if different from that of the manufacturer, and</Text></Subparagraph><Subparagraph><Label>(iii)</Label><Text>the importer;</Text></Subparagraph></Paragraph><Paragraph><Label>(f)</Label><Text>the reason for the recall, the nature of the defectiveness or potential defectiveness of the device and the date on which and the circumstances under which the defectiveness or potential defectiveness was discovered; and</Text></Paragraph><Paragraph><Label>(g)</Label><Text>a preliminary evaluation of the risk associated with the defectiveness or potential defectiveness of the device.</Text></Paragraph></Section></AmendedText></Section></RelatedOrNotInForce><RelatedOrNotInForce><Heading level="5" style="nifrp"><TitleText>
                    — SOR/2024-136, s. 16</TitleText></Heading><Section type="amending"><Label>16</Label><Text>Section 64 of the Regulations is replaced by the following:</Text><AmendedText><Section><Label>64</Label><Text>A manufacturer or importer of a medical device shall, on or before the day on which the manufacturer or importer begins a recall of the device that has not been ordered by the Minister, provide the Minister with the following information and documents in writing:</Text><Paragraph><Label>(a)</Label><Text>the name of the device;</Text></Paragraph><Paragraph><Label>(b)</Label><Text>the identifier of the device, including the identifier of any medical device that is part of a system, test kit, medical device group, medical device family or medical device group family;</Text></Paragraph><Paragraph><Label>(c)</Label><Text>in the case of a licensed device, the medical device licence number;</Text></Paragraph><Paragraph><Label>(d)</Label><Text>in the case of a device for which the manufacturer holds an authorization issued under section 68.12, the authorization number;</Text></Paragraph><Paragraph><Label>(e)</Label><Text>the name and address of</Text><Subparagraph><Label>(i)</Label><Text>the manufacturer,</Text></Subparagraph><Subparagraph><Label>(ii)</Label><Text>the establishment where the device was manufactured, if different from that of the manufacturer, and</Text></Subparagraph><Subparagraph><Label>(iii)</Label><Text>the importer;</Text></Subparagraph></Paragraph><Paragraph><Label>(f)</Label><Text>the reason for the recall, the nature of the defectiveness or potential defectiveness of the device and the date on which and the circumstances under which the defectiveness or potential defectiveness was discovered;</Text></Paragraph><Paragraph><Label>(g)</Label><Text>an evaluation of the risk associated with the defectiveness or potential defectiveness of the device;</Text></Paragraph><Paragraph><Label>(h)</Label><Text>the number of affected units of the device that the manufacturer or importer</Text><Subparagraph><Label>(i)</Label><Text>manufactured in Canada,</Text></Subparagraph><Subparagraph><Label>(ii)</Label><Text>imported into Canada, and</Text></Subparagraph><Subparagraph><Label>(iii)</Label><Text>sold in Canada;</Text></Subparagraph></Paragraph><Paragraph><Label>(i)</Label><Text>the period during which the affected units of the device were distributed in Canada by the manufacturer or importer;</Text></Paragraph><Paragraph><Label>(j)</Label><Text>the name of each person to whom the affected device was sold by the manufacturer or importer and the number of units of the device sold to each person;</Text></Paragraph><Paragraph><Label>(k)</Label><Text>a copy of any communication issued with respect to the recall;</Text></Paragraph><Paragraph><Label>(l)</Label><Text>the proposed strategy for conducting the recall, including</Text><Subparagraph><Label>(i)</Label><Text>the date for beginning the recall,</Text></Subparagraph><Subparagraph><Label>(ii)</Label><Text>the time and manner in which the Minister will be informed of the progress of the recall, and</Text></Subparagraph><Subparagraph><Label>(iii)</Label><Text>the proposed date of its completion;</Text></Subparagraph></Paragraph><Paragraph><Label>(m)</Label><Text>the proposed action to prevent a recurrence of the problem; and</Text></Paragraph><Paragraph><Label>(n)</Label><Text>the name, title and contact information of the representative of the manufacturer or importer to contact for information concerning the recall.</Text></Paragraph></Section></AmendedText></Section></RelatedOrNotInForce><RelatedOrNotInForce><Heading level="5" style="nifrp"><TitleText>
                    — SOR/2024-136, s. 17</TitleText></Heading><Section type="amending"><Label>17</Label><Text>The portion of section 65 of the Regulations before paragraph (a) is replaced by the following:</Text><AmendedText><Section><Label>65</Label><Text>A manufacturer or importer of a medical device shall, within 30 days after completing a recall of the device that was not ordered by the Minister, provide the Minister with the following information, in writing:</Text></Section></AmendedText></Section></RelatedOrNotInForce><RelatedOrNotInForce><Heading level="5" style="nifrp"><TitleText>
                    — SOR/2024-136, s. 18</TitleText></Heading><Section type="amending"><Label>18</Label><Text>Section 65.1 of the Regulations is replaced by the following:</Text><AmendedText><Section><Label>65.1</Label><Subsection><Label>(1)</Label><Text>A manufacturer of a medical device who recalls the device without being ordered to do so by the Minister may permit the importer of the device to prepare and submit, on the manufacturer’s behalf, the information and documents that are required to be provided under sections 63.2, 64 and 65 if the information and documents that the manufacturer and importer must submit are identical.</Text></Subsection><Subsection><Label>(2)</Label><Text>The manufacturer shall advise the Minister in writing if the manufacturer has permitted the importer to prepare and submit the information and documents referred to in subsection (1) on the manufacturer’s behalf.</Text></Subsection></Section><Section><Label>65.2</Label><Subsection><Label>(1)</Label><Text>A person who is ordered by the Minister to recall a medical device shall provide the Minister with the following information in the time and manner specified by the Minister:</Text><Paragraph><Label>(a)</Label><Text>the name and address of</Text><Subparagraph><Label>(i)</Label><Text>the manufacturer of the device,</Text></Subparagraph><Subparagraph><Label>(ii)</Label><Text>the establishment where the device was manufactured, if different from that of the manufacturer,</Text></Subparagraph><Subparagraph><Label>(iii)</Label><Text>the importer of the device, and</Text></Subparagraph><Subparagraph><Label>(iv)</Label><Text>the person who sold them the device, if the person who is conducting the recall is not the manufacturer;</Text></Subparagraph></Paragraph><Paragraph><Label>(b)</Label><Text>the nature of the defectiveness or potential defectiveness of the device and the date on which and the circumstances under which the defectiveness or potential defectiveness was discovered;</Text></Paragraph><Paragraph><Label>(c)</Label><Text>the number of affected units of the device that the person</Text><Subparagraph><Label>(i)</Label><Text>manufactured in Canada,</Text></Subparagraph><Subparagraph><Label>(ii)</Label><Text>imported into Canada, and</Text></Subparagraph><Subparagraph><Label>(iii)</Label><Text>sold in Canada;</Text></Subparagraph></Paragraph><Paragraph><Label>(d)</Label><Text>the number of affected units of the device in Canada that are in the possession or control of the person;</Text></Paragraph><Paragraph><Label>(e)</Label><Text>the period during which the affected units of the device were distributed in Canada by the person;</Text></Paragraph><Paragraph><Label>(f)</Label><Text>the number of affected units of the device that have been sold by the person at the retail level to consumers in Canada;</Text></Paragraph><Paragraph><Label>(g)</Label><Text>if the person has sold the affected device to persons in Canada other than consumers referred to in paragraph (f), the names of those persons and the number of units of the device sold to each of them;</Text></Paragraph><Paragraph><Label>(h)</Label><Text>the proposed strategy for conducting the recall, including</Text><Subparagraph><Label>(i)</Label><Text>the date for beginning the recall,</Text></Subparagraph><Subparagraph><Label>(ii)</Label><Text>the time and manner in which the Minister will be informed of the progress of the recall, and</Text></Subparagraph><Subparagraph><Label>(iii)</Label><Text>the proposed date of its completion;</Text></Subparagraph></Paragraph><Paragraph><Label>(i)</Label><Text>the proposed action to prevent a recurrence of the problem;</Text></Paragraph><Paragraph><Label>(j)</Label><Text>the name, title and contact information of the representative of the person to contact for information concerning the recall; and</Text></Paragraph><Paragraph><Label>(k)</Label><Text>any other information that the Minister has reasonable grounds to believe is necessary to reduce the risk of injury to health.</Text></Paragraph></Subsection><Subsection><Label>(2)</Label><Text>The person shall notify the Minister without delay of any change to the information referred to in paragraph (1)(j).</Text></Subsection><Subsection><Label>(3)</Label><Text>The person shall</Text><Paragraph><Label>(a)</Label><Text>before beginning the recall, provide the Minister with a copy of any communications that the person intends to use in connection with beginning the recall; and</Text></Paragraph><Paragraph><Label>(b)</Label><Text>after beginning the recall, provide the Minister with, on request and within the time specified by the Minister, a copy of any additional communications that the person uses, or intends to use in connection with the recall.</Text></Paragraph></Subsection><Subsection><Label>(4)</Label><Text>The person shall notify the Minister in writing, within 24 hours, of the beginning and completion of the recall.</Text></Subsection><Subsection><Label>(5)</Label><Text>The person shall, within 30 days after completing the recall, provide the Minister with the following information in writing:</Text><Paragraph><Label>(a)</Label><Text>the results of the recall; and</Text></Paragraph><Paragraph><Label>(b)</Label><Text>the action taken to prevent a recurrence of the problem.</Text></Paragraph></Subsection></Section><Heading level="3"><TitleText>Record Keeping</TitleText></Heading><Section><Label>65.3</Label><Text>A manufacturer or importer of a medical device who recalls the device without being ordered to do so by the Minister shall keep a record of the following:</Text><Paragraph><Label>(a)</Label><Text>a document that sets out the decision to conduct the recall, including</Text><Subparagraph><Label>(i)</Label><Text>the name and title of the individual who made the decision, and</Text></Subparagraph><Subparagraph><Label>(ii)</Label><Text>the date the decision was made;</Text></Subparagraph></Paragraph><Paragraph><Label>(b)</Label><Text>the date the recall was completed;</Text></Paragraph><Paragraph><Label>(c)</Label><Text>the information and documents referred to in sections 63.2, 64 and 65; and</Text></Paragraph><Paragraph><Label>(d)</Label><Text>the document provided to the Minister under subsection 65.1(2), if applicable.</Text></Paragraph></Section><Section><Label>65.4</Label><Subsection><Label>(1)</Label><Text>Subject to subsection (2), a distributor of a medical device who conducts a recall of the device that was not ordered by the Minister shall keep a record of the following:</Text><Paragraph><Label>(a)</Label><Text>the name of the device;</Text></Paragraph><Paragraph><Label>(b)</Label><Text>the identifier of the device, including the identifier of any medical device that is part of a system, test kit, medical device group, medical device family or medical device group family;</Text></Paragraph><Paragraph><Label>(c)</Label><Text>in the case of a licensed device, the medical device licence number;</Text></Paragraph><Paragraph><Label>(d)</Label><Text>in the case of a device for which the manufacturer holds an authorization issued under section 68.12, the authorization number;</Text></Paragraph><Paragraph><Label>(e)</Label><Text>the name and address of</Text><Subparagraph><Label>(i)</Label><Text>the manufacturer,</Text></Subparagraph><Subparagraph><Label>(ii)</Label><Text>the establishment where the device was manufactured, if different from that of the manufacturer,</Text></Subparagraph><Subparagraph><Label>(iii)</Label><Text>the importer, and</Text></Subparagraph><Subparagraph><Label>(iv)</Label><Text>the person who sold them the device;</Text></Subparagraph></Paragraph><Paragraph><Label>(f)</Label><Text>the reason for the recall, the nature of the defectiveness or potential defectiveness of the device and the date on which and circumstances under which the defectiveness or potential defectiveness was discovered;</Text></Paragraph><Paragraph><Label>(g)</Label><Text>the number of affected units of the device that the distributor sold in Canada;</Text></Paragraph><Paragraph><Label>(h)</Label><Text>the period during which the affected units of the device were distributed in Canada by the distributor;</Text></Paragraph><Paragraph><Label>(i)</Label><Text>the name of each person to whom the affected device was sold by the distributor and the number of units of the device sold to each person;</Text></Paragraph><Paragraph><Label>(j)</Label><Text>a copy of any communication issued with respect to the recall;</Text></Paragraph><Paragraph><Label>(k)</Label><Text>the results of the recall; and</Text></Paragraph><Paragraph><Label>(l)</Label><Text>the date the recall was completed.</Text></Paragraph></Subsection><Subsection><Label>(2)</Label><Text>A distributor who initiates the recall shall keep a record of the following:</Text><Paragraph><Label>(a)</Label><Text>the information and documents referred to in subsection (1);</Text></Paragraph><Paragraph><Label>(b)</Label><Text>an evaluation of the risk associated with the defectiveness or potential defectiveness of the medical device to which the recall relates; and</Text></Paragraph><Paragraph><Label>(c)</Label><Text>the actions that were proposed and actions taken to prevent a recurrence of the problem.</Text></Paragraph></Subsection></Section><Section><Label>65.5</Label><Text>A person who is ordered by the Minister to recall a medical device shall keep a record of the information and documents provided to the Minister under section 65.2.</Text></Section><Section><Label>65.6</Label><Subsection><Label>(1)</Label><Text>A manufacturer who is required to keep a record under section 65.3 or 65.5 shall keep it for at least the longer of the following periods:</Text><Paragraph><Label>(a)</Label><Text>the period that is equivalent to the projected useful life of the medical device to which the recall relates plus two years; and</Text></Paragraph><Paragraph><Label>(b)</Label><Text>the period during which the device is sold in Canada.</Text></Paragraph></Subsection><Subsection><Label>(2)</Label><Text>Any other person who is required to keep a record under section 65.3, 65.4 or 65.5 shall keep it for at least a period equivalent to the projected useful life of the device to which the recall relates plus two years.</Text></Subsection><Subsection><Label>(3)</Label><Text>For the purpose of paragraph (1)(a) and subsection (2), the retention period begins on the day on which the recall is completed.</Text></Subsection></Section></AmendedText></Section></RelatedOrNotInForce><RelatedOrNotInForce><Heading level="5" style="nifrp"><TitleText>
                    — SOR/2024-136, s. 19</TitleText></Heading><Section type="amending"><Label>19</Label><Text>Paragraph 68.03(2)(c) of the Regulations is replaced by the following:</Text><AmendedText><SectionPiece><Paragraph><Label>(c)</Label><Text>sections 21, 23, 27, 52 to 58, 62 and 62.21 to 65.6.</Text></Paragraph></SectionPiece></AmendedText></Section></RelatedOrNotInForce><RelatedOrNotInForce><Heading level="5" style="nifrp"><TitleText>
                    — SOR/2024-136, s. 20</TitleText></Heading><Section type="amending"><Label>20</Label><Text>Paragraph 88(d) of the Regulations is replaced by the following:</Text><AmendedText><SectionPiece><Paragraph><Label>(d)</Label><Text>sections 63 to 65.6 with respect to recalls; and</Text></Paragraph></SectionPiece></AmendedText></Section></RelatedOrNotInForce><RelatedOrNotInForce><Heading level="5" style="nifrp"><TitleText>
                    — SOR/2024-136, s. 21</TitleText></Heading><Section><Label>21</Label><Text>Unless the context requires otherwise, the words and expressions used in sections <XRefInternal>22</XRefInternal> and <XRefInternal>23</XRefInternal> have the same meaning as in the <XRefExternal reference-type="regulation" link="SOR-98-282">Medical Devices Regulations</XRefExternal>.</Text></Section></RelatedOrNotInForce><RelatedOrNotInForce><Heading level="5" style="nifrp"><TitleText>
                    — SOR/2024-136, s. 22</TitleText></Heading><Section><Label>22</Label><Text>A person who has submitted an application for an establishment licence under section 45 of the <XRefExternal reference-type="regulation" link="SOR-98-282">Medical Devices Regulations</XRefExternal> before the day on which section <XRefInternal>7</XRefInternal> comes into force and in respect of which no decision has been made before that day must not be issued the licence unless, by that day and in the form established by the Minister, the person provides the Minister with the information referred to in paragraph 45(b) of the <XRefExternal reference-type="regulation" link="SOR-98-282">Medical Devices Regulations</XRefExternal>, as amended by these Regulations.</Text></Section></RelatedOrNotInForce><RelatedOrNotInForce><Heading level="5" style="nifrp"><TitleText>
                    — SOR/2024-136, s. 23</TitleText></Heading><Section><Label>23</Label><Text>The holder of an establishment licence that was issued under section 46 of the <XRefExternal reference-type="regulation" link="SOR-98-282">Medical Devices Regulations</XRefExternal> before the day on which section <XRefInternal>7</XRefInternal> comes into force must, by that day and in the form established by the Minister, provide the Minister with the contact information, other than the telephone number, of the representative of the establishment to contact for information concerning the licence.</Text></Section></RelatedOrNotInForce><RelatedOrNotInForce><Heading level="5" style="nifrp"><TitleText>
                    — SOR/2024-238, s. 41</TitleText></Heading><Section type="amending"><Label>41</Label><Text>Subsections 36(2) to (4) of the <XRefExternal reference-type="regulation" link="SOR-98-282">Medical Devices Regulations</XRefExternal><FootnoteRef idref="fn_81200-2-497_hq_30944">2</FootnoteRef> are replaced by the following:</Text><Footnote id="fn_81200-2-497_hq_30944" placement="page" status="official"><Label>2</Label><Text>SOR/98-282</Text></Footnote><AmendedText><Subsection><Label>(2)</Label><Text>The Minister may, at any time, impose terms and conditions on a medical device licence or amend such terms and conditions after considering</Text><Paragraph><Label>(a)</Label><Text>whether there are uncertainties relating to the benefits or risks associated with the device;</Text></Paragraph><Paragraph><Label>(b)</Label><Text>whether the requirements under the Act are sufficient for the following objectives to be met:</Text><Subparagraph><Label>(i)</Label><Text>maintaining the safety and effectiveness of the device,</Text></Subparagraph><Subparagraph><Label>(ii)</Label><Text>optimizing the benefits and managing the risks associated with the device, and</Text></Subparagraph><Subparagraph><Label>(iii)</Label><Text>identifying any changes relating to those benefits and risks and managing uncertainties related to the benefits and risks;</Text></Subparagraph></Paragraph><Paragraph><Label>(c)</Label><Text>whether the proposed terms and conditions may contribute to those objectives being met;</Text></Paragraph><Paragraph><Label>(d)</Label><Text>whether compliance with the proposed terms and conditions is technically feasible; and</Text></Paragraph><Paragraph><Label>(e)</Label><Text>whether there are less burdensome ways for those objectives to be met.</Text></Paragraph></Subsection></AmendedText></Section></RelatedOrNotInForce><RelatedOrNotInForce><Heading level="5" style="nifrp"><TitleText>
                    — SOR/2024-238, s. 42</TitleText></Heading><Section type="amending"><Label>42</Label><Text>Section 37 of the Regulations is replaced by the following:</Text><AmendedText><Section><Label>37</Label><Text>If the terms and conditions of a medical device licence for an <Language xml:lang="la">in vitro</Language> diagnostic device require that tests be performed to ensure that the device continues to meet the applicable requirements set out in sections 10 to 20, no person shall sell a device from a lot of the <Language xml:lang="la">in vitro</Language> diagnostic device unless</Text><Paragraph><Label>(a)</Label><Text>the results and protocols of the tests performed on devices in the lot have been provided to the Minister; and</Text></Paragraph><Paragraph><Label>(b)</Label><Text>the Minister determines, on the basis of the results and protocols provided that the devices in the lot continue to meet the applicable requirements set out in sections 10 to 20.</Text></Paragraph></Section></AmendedText></Section></RelatedOrNotInForce><RelatedOrNotInForce><Heading level="5" style="nifrp"><TitleText>
                    — SOR/2024-238, s. 50</TitleText></Heading><Section><Label>50</Label><Text>Any terms and conditions that, immediately before the day on which section <XRefInternal>41</XRefInternal> of these Regulations comes into force, are set out in a medical device licence referred to in subsection 36(1) of the <XRefExternal reference-type="regulation" link="SOR-98-282">Medical Devices Regulations</XRefExternal> are deemed to be imposed by the Minister under subsection 36(2) of the <XRefExternal reference-type="regulation" link="SOR-98-282">Medical Devices Regulations</XRefExternal>, as that subsection reads as of that day.</Text></Section></RelatedOrNotInForce></RegulationPiece></Schedule><RecentAmendments><Amendment><AmendmentCitation>SOR/2023-277</AmendmentCitation><AmendmentDate>2024-01-03</AmendmentDate></Amendment><Amendment><AmendmentCitation>SOR/2023-247</AmendmentCitation><AmendmentDate>2023-11-24</AmendmentDate></Amendment><Amendment><AmendmentCitation>SOR/2023-19</AmendmentCitation><AmendmentDate>2023-02-22</AmendmentDate></Amendment><Amendment><AmendmentCitation>SOR/2022-197</AmendmentCitation><AmendmentDate>2022-09-27</AmendmentDate></Amendment><Amendment><AmendmentCitation>SOR/2021-199</AmendmentCitation><AmendmentDate>2022-03-02</AmendmentDate></Amendment><Amendment><AmendmentCitation>SOR/2020-262</AmendmentCitation><AmendmentDate>2021-12-23</AmendmentDate></Amendment><Amendment><AmendmentCitation>SOR/2020-262</AmendmentCitation><AmendmentDate>2021-06-23</AmendmentDate></Amendment><Amendment><AmendmentCitation>SOR/2021-46</AmendmentCitation><AmendmentDate>2021-03-31</AmendmentDate></Amendment><Amendment><AmendmentCitation>SOR/2019-191</AmendmentCitation><AmendmentDate>2019-12-16</AmendmentDate></Amendment><Amendment><AmendmentCitation link="2014_20">2014, c. 20, s. 366(3)</AmendmentCitation><AmendmentDate>2019-06-17</AmendmentDate></Amendment></RecentAmendments></Regulation>